{
  "runner_argument": {
    "topic": "AlphaFold 3\\",
    "retrieve_top_k": 10,
    "max_search_queries": 2,
    "total_conv_turn": 20,
    "max_search_thread": 5,
    "max_search_queries_per_turn": 3,
    "warmstart_max_num_experts": 3,
    "warmstart_max_turn_per_experts": 2,
    "warmstart_max_thread": 3,
    "max_thread_num": 10,
    "max_num_round_table_experts": 2,
    "moderator_override_N_consecutive_answering_turn": 3,
    "node_expansion_trigger_count": 10,
    "disable_moderator": false,
    "disable_multi_experts": false,
    "rag_only_baseline_mode": false
  },
  "lm_config": {
    "question_answering_lm": {
      "temperature": 1.0,
      "max_tokens": 1000,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-4o"
    },
    "discourse_manage_lm": {
      "temperature": 1.0,
      "max_tokens": 500,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "utterance_polishing_lm": {
      "temperature": 1.0,
      "max_tokens": 2000,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "warmstart_outline_gen_lm": {
      "temperature": 1.0,
      "max_tokens": 500,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "question_asking_lm": {
      "temperature": 1.0,
      "max_tokens": 300,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    },
    "knowledge_base_lm": {
      "temperature": 1.0,
      "max_tokens": 1000,
      "top_p": 0.9,
      "frequency_penalty": 0,
      "presence_penalty": 0,
      "n": 1,
      "model": "gpt-3.5-turbo"
    }
  },
  "conversation_history": [
    {
      "utterance": "What makes AlphaFold 3 a groundbreaking advancement in the field of computational structural biology?",
      "raw_utterance": "What makes AlphaFold 3 a groundbreaking advancement in the field of computational structural biology?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3 represents a groundbreaking advancement in computational structural biology due to its unparalleled accuracy and power compared to its predecessor, AlphaFold 2[1]. This new model can predict the structures of a wide range of biomolecules, including proteins, DNA, RNA, and ligands, with exceptional precision[4]. The updated diffusion-based architecture of AlphaFold 3 allows for the prediction of complex structures involving various biomolecules, paving the way for advancements in protein design and research[6][9].",
      "raw_utterance": "AlphaFold 3 represents a groundbreaking advancement in computational structural biology due to its unparalleled accuracy and power compared to its predecessor, AlphaFold 2[1]. This new model can predict the structures of a wide range of biomolecules, including proteins, DNA, RNA, and ligands, with exceptional precision[4]. The updated diffusion-based architecture of AlphaFold 3 allows for the prediction of complex structures involving various biomolecules, paving the way for advancements in protein design and research[6][9].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How has AlphaFold 3 revolutionized drug discovery in the pharmaceutical industry, and what advantages does it offer over traditional methods?",
      "raw_utterance": "How has AlphaFold 3 revolutionized drug discovery in the pharmaceutical industry, and what advantages does it offer over traditional methods?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3 has revolutionized drug discovery in the pharmaceutical industry by offering a more accurate and cost-effective alternative to traditional methods[31][32]. Its predictive prowess, 50% more accurate than traditional methods, provides valuable insights into biomolecular interactions and aids in developing new therapeutics[33][43]. Additionally, AlphaFold 3's computational approach enables scientists to design more effective and targeted therapies by understanding how potential drugs bind to specific proteins, identifying proteins' 3D structures and predicting protein-ligand interactions with unprecedented accuracy[46][47][48].",
      "raw_utterance": "AlphaFold 3 has revolutionized drug discovery in the pharmaceutical industry by offering a more accurate and cost-effective alternative to traditional methods[31][32]. Its predictive prowess, 50% more accurate than traditional methods, provides valuable insights into biomolecular interactions and aids in developing new therapeutics[33][43]. Additionally, AlphaFold 3's computational approach enables scientists to design more effective and targeted therapies by understanding how potential drugs bind to specific proteins, identifying proteins' 3D structures and predicting protein-ligand interactions with unprecedented accuracy[46][47][48].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How has the development of AlphaFold 3 revolutionized the accuracy of protein structure prediction and molecular interactions in the field of biomedicine?",
      "raw_utterance": "How has the development of AlphaFold 3 revolutionized the accuracy of protein structure prediction and molecular interactions in the field of biomedicine?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The development of AlphaFold 3 has revolutionized the accuracy of protein structure prediction and molecular interactions in the field of biomedicine by demonstrating substantially improved accuracy over previous specialized tools[17]. It surpasses existing systems in accuracy for protein\u2013ligand interactions, protein\u2013nucleic acid interactions, and antibody\u2013antigen prediction accuracy compared with previous versions[17]. This advancement is achievable within a single unified deep-learning framework, showcasing the potential to transform drug discovery and structural biology[20]. The model's improved Evoformer module and utilization of a diffusion network similar to AI image generators contribute to the accuracy of its predictions, surpassing all existing systems[18]. The minimum 50% improvement in accuracy for protein interactions with other molecules highlights the significant leap in accuracy that AlphaFold 3 brings to the realm of protein structure prediction[21].",
      "raw_utterance": "The development of AlphaFold 3 has revolutionized the accuracy of protein structure prediction and molecular interactions in the field of biomedicine by demonstrating substantially improved accuracy over previous specialized tools[17]. It surpasses existing systems in accuracy for protein\u2013ligand interactions, protein\u2013nucleic acid interactions, and antibody\u2013antigen prediction accuracy compared with previous versions[17]. This advancement is achievable within a single unified deep-learning framework, showcasing the potential to transform drug discovery and structural biology[20]. The model's improved Evoformer module and utilization of a diffusion network similar to AI image generators contribute to the accuracy of its predictions, surpassing all existing systems[18]. The minimum 50% improvement in accuracy for protein interactions with other molecules highlights the significant leap in accuracy that AlphaFold 3 brings to the realm of protein structure prediction[21].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How can AlphaFold 3 revolutionize the way scientists study and understand protein folding, and what are the key considerations for ensuring responsible and equitable access to its benefits?",
      "raw_utterance": "How can AlphaFold 3 revolutionize the way scientists study and understand protein folding, and what are the key considerations for ensuring responsible and equitable access to its benefits?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3 has the unprecedented capability to accurately predict the structure and interactions of all life's molecules, revolutionizing the way scientists study and understand protein folding[29]. Key considerations for ensuring responsible and equitable access to its benefits include implementing user-centric privacy controls, anonymizing user data, and collaborating with experts in biosecurity, bioethics, and AI safety[60][64][65][27][28].",
      "raw_utterance": "AlphaFold 3 has the unprecedented capability to accurately predict the structure and interactions of all life's molecules, revolutionizing the way scientists study and understand protein folding[29]. Key considerations for ensuring responsible and equitable access to its benefits include implementing user-centric privacy controls, anonymizing user data, and collaborating with experts in biosecurity, bioethics, and AI safety[60][64][65][27][28].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How has the development of AlphaFold 3 by Google's DeepMind Technologies Limited revolutionized the field of biomolecular structure prediction?",
      "raw_utterance": "How has the development of AlphaFold 3 by Google's DeepMind Technologies Limited revolutionized the field of biomolecular structure prediction?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The development of AlphaFold 3 by Google's DeepMind Technologies Limited has revolutionized the field of biomolecular structure prediction through its superior accuracy, power, and speed in predicting protein structures[1][2][3][4][5]. Its updated diffusion-based architecture allows for the joint structure prediction of complex biomolecular interactions, surpassing many existing specialized tools in the field[6][17][18]. Additionally, the introduction of a new web server with a user-friendly interface democratizes access to AlphaFold 3's advanced capabilities for various applications in protein modeling and drug discovery[4][5]. With hardware and memory-optimized building blocks, an expanded training dataset, and support for post-translational modifications and cofactors, AlphaFold 3 sets a new standard in the field of protein structure prediction[53][54][55][56].",
      "raw_utterance": "The development of AlphaFold 3 by Google's DeepMind Technologies Limited has revolutionized the field of biomolecular structure prediction through its superior accuracy, power, and speed in predicting protein structures[1][2][3][4][5]. Its updated diffusion-based architecture allows for the joint structure prediction of complex biomolecular interactions, surpassing many existing specialized tools in the field[6][17][18]. Additionally, the introduction of a new web server with a user-friendly interface democratizes access to AlphaFold 3's advanced capabilities for various applications in protein modeling and drug discovery[4][5]. With hardware and memory-optimized building blocks, an expanded training dataset, and support for post-translational modifications and cofactors, AlphaFold 3 sets a new standard in the field of protein structure prediction[53][54][55][56].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How can the commercialization of AlphaFold 3 revolutionize industries like drug discovery and protein design while still addressing ethical considerations and ensuring equitable access to the benefits of the technology?",
      "raw_utterance": "How can the commercialization of AlphaFold 3 revolutionize industries like drug discovery and protein design while still addressing ethical considerations and ensuring equitable access to the benefits of the technology?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The commercialization of AlphaFold 3 has the potential to revolutionize industries like drug discovery and protein design by providing rapid and accurate protein structure predictions, as seen with the Boulder team obtaining crucial information in just 15 minutes[24]. However, ethical considerations must be carefully addressed to ensure that the benefits of the technology are not overshadowed by potential costs[25]. Additionally, companies looking to utilize AlphaFold 3 are advised to prioritize data privacy and develop user-centric privacy controls to ensure equitable access to the benefits of the technology while addressing concerns about potential misuse[64][65].",
      "raw_utterance": "The commercialization of AlphaFold 3 has the potential to revolutionize industries like drug discovery and protein design by providing rapid and accurate protein structure predictions, as seen with the Boulder team obtaining crucial information in just 15 minutes[24]. However, ethical considerations must be carefully addressed to ensure that the benefits of the technology are not overshadowed by potential costs[25]. Additionally, companies looking to utilize AlphaFold 3 are advised to prioritize data privacy and develop user-centric privacy controls to ensure equitable access to the benefits of the technology while addressing concerns about potential misuse[64][65].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How have collaborations and partnerships with experts in biosecurity, bioethics, and AI safety contributed to the development and ethical considerations of AlphaFold 3?",
      "raw_utterance": "How have collaborations and partnerships with experts in biosecurity, bioethics, and AI safety contributed to the development and ethical considerations of AlphaFold 3?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "Collaborations with experts in biosecurity, bioethics, and AI safety have played a crucial role in the development and ethical considerations of AlphaFold 3[27]. By consulting with more than 50 experts in these fields, DeepMind and Isomorphic Labs were able to address potential ethical challenges and ensure fairness and inclusivity in the data used to train the model[28]. These collaborations have been instrumental in shaping the groundbreaking technology of AlphaFold 3 and navigating the ethical implications of its capabilities[29][30].",
      "raw_utterance": "Collaborations with experts in biosecurity, bioethics, and AI safety have played a crucial role in the development and ethical considerations of AlphaFold 3[27]. By consulting with more than 50 experts in these fields, DeepMind and Isomorphic Labs were able to address potential ethical challenges and ensure fairness and inclusivity in the data used to train the model[28]. These collaborations have been instrumental in shaping the groundbreaking technology of AlphaFold 3 and navigating the ethical implications of its capabilities[29][30].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "How has the development of AlphaFold 3 improved the speed of predicting protein structures compared to its predecessors?",
      "raw_utterance": "How has the development of AlphaFold 3 improved the speed of predicting protein structures compared to its predecessors?",
      "role": "Background discussion moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The development of AlphaFold 3 has significantly improved the speed of predicting protein structures compared to its predecessors. By optimizing the configuration to maximize throughput on a single NVIDIA A100 with 80 GB of memory, AlphaFold 3 has been found to be at least 2 times faster across all token sizes, making it suitable for high-throughput applications[15]. Additionally, the architectural development, including a completely redesigned Structure Module with a diffusion model wrapped around a Transformer, has contributed to this increased speed[16].",
      "raw_utterance": "The development of AlphaFold 3 has significantly improved the speed of predicting protein structures compared to its predecessors. By optimizing the configuration to maximize throughput on a single NVIDIA A100 with 80 GB of memory, AlphaFold 3 has been found to be at least 2 times faster across all token sizes, making it suitable for high-throughput applications[15]. Additionally, the architectural development, including a completely redesigned Structure Module with a diffusion model wrapped around a Transformer, has contributed to this increased speed[16].",
      "role": "Background discussion expert",
      "role_description": "",
      "queries": [],
      "utterance_type": "Potential Answer",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates [2]. This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need [3].",
      "raw_utterance": "How can the increased speed and efficiency of AlphaFold 3 in predicting protein structures impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries? [1][2]",
      "role": "Moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    },
    {
      "utterance": "Absolutely, AlphaFold 3's improved speed and accuracy in predicting protein structures can revolutionize drug discovery by reducing time and costs associated with identifying potential drug candidates [68][69]. Its simplified Pairformer module and ability to model protein interactions contribute to designing more effective and safe drug candidates [70][73][75]. Additionally, its prediction of ADME properties can optimize clinical trial designs, accelerating the drug development process [66][67][71]. Despite limitations in access, AlphaFold 3 holds immense potential for advancing therapies and expediting their delivery to patients [72][74].",
      "raw_utterance": "AlphaFold 3 represents a significant advancement in the field of protein structure prediction, offering improved speed and efficiency, which could greatly benefit drug discovery processes. By predicting protein structures with unprecedented accuracy, AlphaFold 3 can significantly reduce the time and costs associated with identifying potential drug candidates [68][69]. This efficiency stems in part from its simplified Pairformer module, which decreases the computational demands of processing multi-sequence alignment data [70]. Additionally, its ability to model interactions between proteins and other molecules, such as small molecule ligands, aids in designing drug candidates with improved efficacy and safety profiles [73][75].\n\nMoreover, AlphaFold 3's capacity to predict absorption, distribution, metabolism, and excretion (ADME) properties is crucial for optimizing clinical trial designs by providing insights into drug behavior within biological systems [66]. This enhanced predictive power can accelerate the drug discovery pipeline, facilitating more efficient drug development processes [67][71]. However, access to this powerful tool is somewhat limited by DeepMind, which may restrict its broader application across the pharmaceutical industry [72]. Despite these limitations, the potential impact of AlphaFold 3 on drug discovery is substantial, offering transformative possibilities for developing new therapies and delivering them faster to patients in need [74].",
      "role": "General Knowledge Provider",
      "role_description": " Focus on broadly covering the basic facts about the question.",
      "queries": [
        "AlphaFold 3 speed and efficiency improvements",
        "Impact of AlphaFold 3 on drug discovery"
      ],
      "utterance_type": "Potential Answer",
      "claim_to_make": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
      "raw_retrieved_info": [
        {
          "url": "https://medium.com/@falk_hoffmann/alphafold3-and-its-improvements-in-comparison-to-alphafold2-96815ffbb044",
          "description": "Predicting protein structures is one of the most important challenges in biochemistry. Highly accurate protein structures are essential for drug discovery purposes. Here, you can find more about the\u2026",
          "snippets": [
            "Are you curious about what this text holds for you?",
            "The limited number of examples in the datasets generates a relatively high statistical error on those values. AlphaFold3 also improves the prediction of protein-protein complexes, with a significant improvement in antibody-protein interfaces compared to AlphaFold-Multimer v2.3.",
            "We will probably see many additional benchmarks on AlphaFold3 in the coming months, but the reported improvements on different tasks are promising. The following figure shows the overall model of AlphaFold3. The network architecture of AlphaFold 3.",
            "To prevent generating physically plausible structures in unstructured regions during the diffusion process, cross-distillation was used with training data from AlphaFold-Multimer v2.3, which contains loops in those regions. Finally, a confidence module is introduced to measure the confidence of the errors from the atom-level and pairwise calculation. Now, let\u2019s go through all these modules step by step to understand what they are doing and how they contribute to improving the prediction of protein structures compared to their predecessors from AlphaFold2."
          ],
          "title": "AlphaFold3 and its improvements in comparison to AlphaFold2 | by ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "AlphaFold 3 extends its utility to predicting ADME properties, which are crucial for understanding a drug's performance within the body. This capability supports the optimization of clinical trial designs by predicting how drugs behave in different biological systems, thereby improving the safety and efficacy of therapeutic candidates .",
            "AlphaFold 3's expanded predictive abilities include interactions with DNA, RNA, and small molecules, crucial for understanding most disease mechanisms . This broadened scope allows for the identification of new drug targets and the optimization of lead compounds, further enhancing the efficiency and scope of drug discovery efforts. By integrating these advanced predictive tools, AlphaFold 3 not only streamlines the drug discovery process but also opens up new possibilities for innovative therapeutic approaches, ultimately aiming to improve patient outcomes and advance the field of medical science.",
            "Continued advancements in AI, as seen with the introduction of AlphaFold 3, promise further enhancements in biomolecular modeling. The integration of new neural network architectures and iterative refinement processes is expected to improve the accuracy and efficiency of these models, broadening their applicability in scientific research.",
            "The introduction of AlphaFold 3 has the potential to transform drug discovery by providing a more rapid and accurate tool for examining fundamental biology . Its ability to predict the structure of protein-molecule complexes, including those containing DNA and RNA, marks a significant improvement over existing prediction methods. This capability is especially valuable for drug discovery, as it aids in identifying and designing new molecules that could lead to effective treatments. Researchers are excited about the prospect of speedier drug discovery, facilitated by the greater range of predictive abilities offered by AlphaFold 3 ."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/google-deepmind/alphafold3/blob/main/docs/performance.md",
          "description": "If you would like to improve performance, it\u2019s recommended to increase the disk speed (e.g. by leveraging a RAM-backed filesystem), or increase the available CPU cores and add more parallelisation. Also note that for sequences with deep MSAs, Jackhmmer or Nhmmer may need a substantial amount of RAM beyond the recommended 64 GB of RAM. Table 8 in the Supplementary Information of the AlphaFold 3 ...",
          "snippets": [
            "If you would like to improve performance, it\u2019s recommended to increase the disk speed (e.g. by leveraging a RAM-backed filesystem), or increase the available CPU cores and add more parallelisation. Also note that for sequences with deep MSAs, Jackhmmer or Nhmmer may need a substantial amount of RAM beyond the recommended 64 GB of RAM. Table 8 in the Supplementary Information of the AlphaFold 3 paper provides compile-free inference timings for AlphaFold 3 when configured to run on 16 NVIDIA A100s, with 40 GB of memory per device.",
            "AlphaFold 3 inference pipeline. Contribute to google-deepmind/alphafold3 development by creating an account on GitHub.",
            "In contrast, this repository supports running AlphaFold 3 on a single NVIDIA A100 with 80 GB of memory in a configuration optimised to maximise throughput. We compare compile-free inference timings of these two setups in the table below using GPU seconds (i.e. multiplying by 16 when using 16 A100s). The setup in this repository is more efficient (by at least 2\u00d7) across all token sizes, indicating its suitability for high-throughput applications.",
            "We officially support the following configurations, and have extensively tested them for numerical accuracy and throughput efficiency: ... AlphaFold 3 can run on inputs of size up to 4,352 tokens on a single NVIDIA A100 (40 GB) with the following configuration changes:"
          ],
          "title": "alphafold3/docs/performance.md at main \u00b7 google-deepmind/alphafold3",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
          "snippets": [
            "These methods were time consuming and costly, and were a major limiting step in drug discovery and development processes in particular. For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind.",
            "In addition, after processing inputs, AlphaFold 3 uses a \u2018diffusion network\u2019, described by DeepMind as being similar to the tools used in AI image generation. These improvements to the model have led the company to claim that AlphaFold 3 has the highest accuracy yet.",
            "This is reflected in AlphaFold 3\u2019s large training set, which includes a wider range of molecules. How will this technology be used? Through a collaboration with Isomorphic Labs, the tool is now finding its way into the commercial sphere, due to its improved ability to upscale the drug development process.",
            "Although the release of AlphaFold 3 may feel like a huge jump from where we were just a few short years ago, it\u2019s likely that we\u2019ll continue to see improvements to this technology in the not-too-distant future. Even with AI tools like AlphaFold, the latter stages of the drug discovery journey, in particular, still take a significant length of time."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
          "snippets": [
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "Improved Data Efficiency: The modifications in the model architecture and training have made AlphaFold 3 more data-efficient, allowing it to make more accurate predictions with less data compared to AlphaFold 2.",
            "Cross-Molecular Predictive Ability: The ability to accurately model interactions not just between proteins, but also including RNA, DNA, and other molecules, marks a substantial improvement over the specialized models of AlphaFold 2. Training and Inference Efficiency: The shift to a diffusion-based module reduces the complexity of the training and inference processes, potentially leading to quicker and more efficient model training and deployment.",
            "It outperforms not only specialized tools but also previous iterations like AlphaFold-Multimer v2. Generative Training Procedure: The diffusion model is a new addition that trains the system to de-noise \u201cnoised\u201d atomic coordinates, learning protein structures at various scales. This generative aspect allows for a more dynamic exploration of protein structures, improving the prediction of local and global molecular structures."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy.",
            "AlphaFold 3\u2019s capabilities come from its next-generation architecture and training that now covers all of life\u2019s molecules. At the core of the model is an improved version of our Evoformer module \u2014 a deep learning architecture that underpinned AlphaFold 2\u2019s incredible performance.",
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach.",
            "AlphaFold Server helps scientists make novel hypotheses to test in the lab, speeding up workflows and enabling further innovation."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.deeporigin.com/blog/alphafold-3-exciting-advance-yet-unresolved-major-issues-remain",
          "description": "We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations. Here's what we found.",
          "snippets": [
            "AlphaFold 3, which is the next step of AlphaFold 2, models proteins with possibly modified residues, nucleic acids, small molecules and ions. It uses a single ML model for predictions from input of biopolymer sequences, residue modifications, and ligand SMILES, claiming improved accuracy over specialized tools.",
            "For protein-ligand interactions, the paper used PoseBusters benchmark set, composed of 428 protein-ligand structures released to the PDB in 2021 or later, and trained AlphaFold3 using a 2019-09-30 training cutoff. Here we have a time split without homology or ligand similarity splits. This is definitely not the hardest split to use for ML benchmarking. AF3 accuracy on the PoseBusters V1 set is 76.4%, which is 2.8% improvement over their recent technical report.",
            "In conclusion, AlphaFold 3 represents an advancement in the field of biomolecular structure prediction, embodying both notable improvements and significant unresolved problems. Its ability to integrate various molecular components, from proteins to small molecules, using a single machine learning model, may potentially accelerate certain aspects of drug discovery.",
            "The architectural changes introduced\u2014such as the replacement of the EvoFormer with the Pairformer, and the switch to a diffusion module for predicting atomic coordinates\u2014demonstrate innovative approaches to enhancing model accuracy and efficiency. However, despite these advancements, AlphaFold 3 is not without significant limitations."
          ],
          "title": "AlphaFold 3: Exciting Advance yet Unresolved Major Issues Remain ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.scilifelab.se/news/alphafold3-early-pain-points-overshadow-potential-promise/",
          "description": "The scientific community has long awaited the release of AlphaFold3 (AF3), the latest version of DeepMind\u2019s groundbreaking protein structure prediction tool. AlphaFold2 (AF2) set a high bar by revolutionizing our [\u2026]",
          "snippets": [
            "AlphaFold3 is a testament to the continuous advancements in computational biology. Its improvements in accuracy, usability, and speed are noteworthy. However, the concerns regarding its closed nature cannot be ignored.",
            "\u201cI\u2019ve tried using AlphaFold3 for my protein complexes, but they are too large for the program to handle. I\u2019ve seen some colleagues successfully use it for antibody-protein complexes, where it seems to provide likely correct interactions that align with other observations. However, others were disappointed with its predictions for sugars. While the tool\u2019s speed is extremely useful, its lack of openness has generated significant criticism in the community\u201d Marta Carroni, platform director at SciLifeLab Cellular and Molecular Imaging and head of unit at Cryo-EM Stockholm.",
            "AlphaFold is perhaps the most important data-driven example of how AI has transformed the life science landscape. Initially, many were skeptical about the utility of AF2.",
            "Improved accuracy: AF3 has slightly improved accuracy for protein predictions, but a larger improvement in antibody-antigen interactions \u00b7 Speed: DeepMind invested more computational power behind the AF3 app."
          ],
          "title": "AlphaFold3: Early pain points overshadow potential promise - ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.creative-biostructure.com/evolution-of-alphafold-protein-structure-prediction.htm",
          "description": "Pairformer Module: One of the most notable changes in AlphaFold 3 is the replacement of AlphaFold 2's Evoformer module with the simpler Pairformer module. This update reduces the amount of multi-sequence alignment (MSA) data that needs to be processed, thereby improving computational efficiency ...",
          "snippets": [
            "Pairformer Module: One of the most notable changes in AlphaFold 3 is the replacement of AlphaFold 2's Evoformer module with the simpler Pairformer module. This update reduces the amount of multi-sequence alignment (MSA) data that needs to be processed, thereby improving computational efficiency without sacrificing accuracy.",
            "For instance, in benchmarking tests like PoseBusters, AlphaFold 3 demonstrated a 50% improvement over the best traditional methods, which significantly enhances its utility in pharmaceutical and biotechnological applications. Improved Computational Efficiency: By streamlining the neural network architecture and simplifying the complexity of structure handling, AlphaFold 3 operates with much higher computational efficiency.",
            "Explore the evolution of AlphaFold from its groundbreaking debut to AlphaFold 3, revolutionizing protein structure prediction with unparalleled accuracy and applications.",
            "By using neural networks to predict the backbone torsion angles and residue-residue distances, it introduced a novel energy minimization strategy based on gradient descent, thereby predicting the 3D conformation of proteins. Compared to earlier techniques that relied on homology modeling or physics-based simulations, AlphaFold 1 introduced machine learning into the prediction pipeline, which significantly improved the accuracy and speed of predictions."
          ],
          "title": "The Evolution of AlphaFold: A Milestone in Protein Structure ...",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://arxiv.org/html/2404.11068v1",
          "description": "The AlphaFold model was trained on over 10 million samples with 128 TPUs, took over 11 days (7 days initial training and 4 days finetuning) to converge. Such a low efficiency slows down the iterative speed of the research community. As a result, improving the AlphaFold training performance ...",
          "snippets": [
            "The AlphaFold model was trained on over 10 million samples with 128 TPUs, took over 11 days (7 days initial training and 4 days finetuning) to converge. Such a low efficiency slows down the iterative speed of the research community. As a result, improving the AlphaFold training performance has received increasing interest, and MLPerf HPC (Farrell et al., 2021) also incorporated this challenge as a benchmark to promote broader participation111OpenFold is the first trainable public reimplementation of AlphaFold in PyTorch.",
            "Comparing to the original OpenFold setup, the OpenFold in MLPerf HPC v3.0 is formulated as a partial convergence training, with model weights initialized from predefined checkpoint and lowered final accuracy target.. OpenFold (Ahdritz et al., 2022) reproduced the AlphaFold training procedure and used BFloat16 numerical format and gradient checkpointing (Chen et al., 2016) to improve the training efficiency.",
            "By combining this with a series of fine-grained optimizations, which include tracing the training to CUDA Graphs to reduce overheads, the overall communication efficiency was largely improved. We identified critical computation patterns in the AlphaFold training and designed dedicated Triton kernels(Tillet et al., 2019) for each of them, fused fragmented computations throughout the AlphaFold model, and carefully tuned kernel configurations for every workload sizes and target hardware architectures.",
            "Evaluation time must be smaller than training time, or evaluation time would become bottleneck. so we cached all evaluation data into the CPU DRAM instead of disk to improve evaluation performance. This section presents a comprehensive evaluation of ScaleFold\u2019s performance on the NVIDIA A100 and H100 GPUs. Initially, we compared our performance to other AlphaFold2-like models. Then we assess our scale efficiency."
          ],
          "title": "ScaleFold: Reducing AlphaFold Initial Training Time to 10 Hours",
          "meta": {
            "query": "AlphaFold 3 speed and efficiency improvements",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact ...",
          "snippets": [
            "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding",
            "Researchers are excited about the prospect of speedier drug discovery, facilitated by the greater range of predictive abilities offered by AlphaFold 3 . ... To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server.",
            "This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context. This capability is crucial for drug discovery, as many drugs fall under the ligand category.",
            "By integrating these advanced predictive tools, AlphaFold 3 not only streamlines the drug discovery process but also opens up new possibilities for innovative therapeutic approaches, ultimately aiming to improve patient outcomes and advance the field of medical science. ... AlphaFold's capabilities extend into the realm of viral research, significantly impacting the development of therapies."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "All the users of AlphaFold don\u2019t really care about speed, performance, latency, or any of those usual IT topics,\u201d Bangert said. \u201cWhat they really care about is accuracy. And that\u2019s why this move beyond essentially just a language model into molecular dynamics is really a good one.\u201d \u00b7 While R&D productivity rates in biopharma have declined in recent decades, blockbuster drugs still deliver substantial returns."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
          "snippets": [
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-023-02984-w",
          "description": "Nature - Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
          "snippets": [
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "After Google Deepmind\u2019s AlphaFold proved that it could predict the 3D shapes of proteins with high accuracy in 2020, chemists became excited about the promise of using the open-source artificial-intelligence (AI) programme to discover drugs more quickly and cheaply."
          ],
          "title": "AlphaFold touted as next big thing for drug discovery \u2014 but is it?",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d ... a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery...",
          "snippets": [
            "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said. \u201cThis is prior to doing any chemical experimentation, certainly prior to any kind of clinical trials, that even if you did make a mistake, it wouldn't matter because you wouldn't be impacting anything.",
            "\u201cSo far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design,\u201d according to the Google AlphaFold 3 announcement. \u201cAlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences.\u201d"
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "The new study is part of an effort recently launched by Collins\u2019 lab called the Antibiotics-AI Project, which has the goal of using artificial intelligence to discover and design new antibiotics. AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "\u201cBreakthroughs such as AlphaFold are expanding the possibilities for in silico drug discovery efforts, but these developments need to be coupled with additional advances in other aspects of modeling that are part of drug discovery efforts,\u201d Collins says.",
            "\u201cOur study speaks to both the current abilities and the current limitations of computational platforms for drug discovery.\u201d \u00b7 In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://3decision.discngine.com/blog/2023/03/13/the-impact-of-alphafold-in-drug-discovery-and-emerging-ml-methods",
          "description": "This is the result we obtained from both polls: out of 240 scientists voting, around 1/3 of the participants have successfully used AlphaFold to support drug discovery campaigns, while the majority have still not experienced any useful impact.",
          "snippets": [
            "Following our Discngine Labs event and discussion with scientists in early drug discovery, we have summarized insights and experiences of the community on how they use AlphaFold technology to make it more suitable for drug discovery projects.",
            "In 2020, AlphaFold (AF), a deep learning method developed by DeepMind, set a milestone in the field of protein structure prediction; It achieved impressive results in rapidly and accurately predicting 3D protein folds from the primary sequence alone, thus addressing the fundamental \u201cprotein folding problem\u201d. The AF algorithm has so far predicted a huge number of protein structure models (over 200 million), providing scientists with unprecedented structural knowledge which has the potential to accelerate drug discovery. ... Comparison of experimental and theoretical structures of bromodomain-containing protein 4 (DeepMind AlphaFold model in pink and X-Ray structure (PDB ID:6CJ2) in blue) showing the accuracy of the AI model.",
            "However, despite this great accomplishment, the 3D protein structure alone does not tell the whole story. The functional context of AlphaFold models such as their arrangement with non-protein molecules, interactions with drugs, and dynamics, is still missing in the predictions. The scientific community is now using this technology as a starting point to develop methods that predict protein structure models more suitable for drug discovery applications.",
            "Even if the AlphaFold predictions are undoubtedly a breakthrough for fundamental research and protein science, their real contribution to drug discovery is still to demonstrate. After more than one year since their first release, we - at the 3decision team - wondered if and how AlphaFold has started to make a difference in drug discovery."
          ],
          "title": "The impact of AlphaFold in drug discovery and emerging ML-methods ...",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.theatlantic.com/sponsored/google/ai-powered-future-drug-discovery/3962/",
          "description": "AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but also has the potential to ultimately impact ...",
          "snippets": [
            "AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but also has the potential to ultimately impact the overall cost of development.",
            "The pioneering AI model AlphaFold can predict the structure and interactions of molecules with unprecedented accuracy.",
            "In 2021, Hassabis founded Isomorphic Labs as an offshoot of Google DeepMind to specifically focus on rational drug design and apply AI to redefine the drug discovery process from first principles. The latest version, AlphaFold 3, developed by Google DeepMind and Isomorphic Labs, is reshaping the field of structural biology and providing invaluable insights for drug design.",
            "This gives us new ways to design molecules, which is incredibly exciting, and we believe it will completely change how we discover and design new drugs,\u201d says Jaderberg. AlphaFold 3 also has the ability to predict antibody-protein binding, which can help researchers understand immune response and design new antibodies."
          ],
          "title": "The AI-Powered Future of Drug Discovery - Sponsor Content - Google",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations. Let\u2019s delve deeper: Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time ...",
          "snippets": [
            "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations. Let\u2019s delve deeper: Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins.",
            "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
            "By predicting these interactions, AlphaFold 3 can: Reveal how proteins bind to DNA: This helps us understand how genes are turned on and off, crucial for regulating cellular activity. Predict how drugs interact with proteins: This is a game-changer in drug discovery.",
            "Accessibility and Equity: Widespread access to AlphaFold 3 should avoid widening the gap between developed and developing nations regarding scientific progress and healthcare. Misuse in Drug Design: Faster drug discovery could lead to the development of powerful drugs that fall into the wrong hands."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "Impact of AlphaFold 3 on drug discovery",
            "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need ."
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "Absolutely, AlphaFold 3's ability to predict protein structures and interactions with high accuracy is a game-changer in drug discovery. By providing more targeted and effective drug design, it streamlines the identification of viable candidates and opens doors to tackling previously challenging disease targets[78][81][82]. The cost savings and accelerated timelines it offers compared to traditional approaches make it a valuable tool for pharmaceutical companies, with collaborations with industry leaders highlighting its real-world applications and potential for advancing drug development pipelines[80][83]. Its integration into tools like the AlphaFold Server also ensures widespread access for researchers, driving advancements in our understanding of disease mechanisms and drug interactions[79][81]. In essence, AlphaFold 3 revolutionizes drug discovery by offering faster, more cost-effective, and precise solutions for developing life-saving treatments[77][82].",
      "raw_utterance": "AlphaFold 3 is revolutionizing drug discovery by dramatically accelerating and reducing the costs associated with the traditionally lengthy and expensive process of developing new therapies. Pharmaceutical development has often been described as \"playing roulette,\" where success depends on trying countless approaches until one works[76]. AlphaFold 3 changes this dynamic by providing highly accurate predictions of protein structures and their interactions with molecules, which can significantly streamline the identification of viable drug candidates[78][81].\n\nOne of its standout contributions is its ability to predict protein-ligand interactions with greater accuracy than traditional physics-based models, even without structural input data[81]. This capability allows researchers to design more targeted and effective drugs, particularly for challenging or \"intractable\" targets that were previously difficult to address with conventional methods[82][84]. By incorporating insights into how proteins interact with other molecules, DNA, RNA, and small ligands, AlphaFold 3 opens doors to developing treatments for diseases that were once considered out of reach[82].\n\nThe cost savings are another critical advantage. Traditional medicinal chemistry approaches are both time- and resource-intensive, whereas AlphaFold 3 operates at a fraction of that cost, offering a more scalable and accessible solution for pharmaceutical companies[80]. Additionally, collaborations between Isomorphic Labs and pharmaceutical giants like Eli Lilly and Novartis, potentially worth billions of dollars, highlight its real-world applications and value in accelerating drug development pipelines[83].\n\nMoreover, AlphaFold 3\u2019s integration into tools like the AlphaFold Server allows widespread access for researchers, empowering academic studies and advancing our understanding of disease mechanisms and drug interactions. Although commercial restrictions limit some pharmaceutical applications for now, the open-source nature of the platform ensures that its impact will continue to grow in both academic and industrial settings[79][81].\n\nIn essence, AlphaFold 3 represents a game-changing innovation for drug discovery, offering pharmaceutical companies the potential to develop life-saving treatments faster, more cost-effectively, and with unprecedented precision[77][80][82].",
      "role": "Pharmaceutical Industry Representative",
      "role_description": " A seasoned professional in the pharmaceutical industry, this speaker will provide valuable insights into how AlphaFold 3's increased speed and efficiency can transform drug discovery processes. They will focus on the practical applications of AlphaFold 3 in terms of cost savings, accelerated development timelines, and the impact on drug candidate designs.",
      "queries": [
        "AlphaFold 3 applications in drug discovery",
        "AlphaFold 3 pharmaceutical industry benefits"
      ],
      "utterance_type": "Potential Answer",
      "claim_to_make": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
      "raw_retrieved_info": [
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s ...",
          "snippets": [
            "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods.",
            "Some 70% acknowledged AI\u2019s potential in the industry but noted struggles with data integrity and interoperability. The survey found that 63% of respondents were concerned about poor data quality. Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed.",
            "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction"
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server. This easy-to-use research tool allows the scientific community to leverage the model's predictive abilities free. Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives.",
            "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes . This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets.",
            "AlphaFold 3's capability to predict the structure of small molecules paves the way for creating novel biomaterials. These materials could be specifically designed for biocompatibility and functionality, ranging from medical implants to bioengineered enzymes, which could revolutionize multiple industries.",
            "AlphaFold 3 has already established itself as a turning point in the field of computational biochemistry and drug development along with receptor modulation and biomolecular development. With the help of AlphaFold 3 and models similar to this, researchers will gain unparalleled insights into the structural dynamics of proteins and their interactions, opening up new avenues for scientists and doctors to exploit for the benefit of the patient."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years.",
            "Earlier versions of AlphaFold spurred a leap forward in drug development by rapidly and accurately predicting 3-D protein structures, a decades-long problem that had vexed computational biologists seeking to understand how shape affects protein function as a disease indicator.",
            "The AlphaFold 3 program powers the AlphaFold server, which offers a web interface that allows non-coders to input the name of a protein or a nucleic acid and generate structure predictions, including critical information about joint structures with elements such as RNA, DNA, ligands and others."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "A new study from MIT reveals the potential and limitations of one such computational approach. Using protein structures generated by an artificial intelligence program called AlphaFold, the researchers explored whether existing models could accurately predict the interactions between bacterial proteins and antibacterial compounds.",
            "In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say.",
            "AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
          "snippets": [
            "Scientists can access most of its capabilities for free through the newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins. This can result in the development of drugs for currently untreatable diseases, potentially curing them. Materials Science: Materials science, in turn, can similarly benefit from predictions about the action of molecules by designing new materials based on predicted properties.",
            "While AlphaFold 3 offers immense benefits, its power requires careful consideration of some ethical issues:",
            "AlphaFold 3 is a giant leap forward in understanding the building blocks of life. Developed by DeepMind (a subsidiary of Alphabet), it\u2019s an AI model that can predict the 3D structures of various molecules, not just proteins, like its predecessor, AlphaFold 2."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "We\u2019ve already deployed our frontier version of AlphaFold 3 in our own internal pipeline of projects, and in our partnerships with pharmaceutical companies.",
            "To move this understanding forwards, together with Google DeepMind we have developed AlphaFold 3, our breakthrough artificial intelligence (AI) model that provides an accurate atomic-level view of the structure of biomolecular systems.",
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems.",
            "These inputs are processed by AlphaFold 3, which is a generative model composed of a neural network architecture that builds upon a custom Transformer with triangular attention, and uses a diffusion process to generate individual 3D coordinates of every atom in the input-specified system."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "Working together with the research and safety community to take a science-led approach, we have conducted extensive assessments to mitigate potential risks and share the widespread benefits to biology and humanity. Building on the external consultations we carried out for AlphaFold 2, Google DeepMind have now engaged with more than 50 domain experts, in addition to specialist third parties, across biosecurity, research, and industry, to understand the capabilities of successive AlphaFold models and any potential risks.",
            "Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, we at Isomorphic Labs are already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, we are working on drug design for internal projects as well as with pharmaceutical partners."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4983123",
          "description": "AlphaFold 3, the most recent version of Google's DeepMind artificial intelligence engine (AI) used to predict protein structures, is a breakthrough AI with major significance for monoclonal antibody patents, pharmaceutical patents in general, and the future of drug development and the pharmaceutical industry ...",
          "snippets": [
            "AlphaFold 3, the most recent version of Google's DeepMind artificial intelligence engine (AI) used to predict protein structures, is a breakthrough AI with major significance for monoclonal antibody patents, pharmaceutical patents in general, and the future of drug development and the pharmaceutical industry as a whole.",
            "We argue that AlphaFold 3 should support broad patent claims for the developers of therapeutic monoclonal antibodies to novel targets and revolutionize the half-trillion-dollar therapeutic antibodies market. We conclude with a brief discussion of the role of patents and the pharmaceutical industry in a future where much of drug development will be done in silico, many of the types of inventions that are patentable today will become obvious, and the risk of drug development will be far lower than it is today."
          ],
          "title": "AlphaFold 3, AI, Antibody Patents, the Future of Broad Pharmaceutical ...",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
          "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
          "snippets": [
            "Ultimately, AlphaFold3\u2019s impact on drug discovery and development is expected to be substantial. And, while commercial restrictions currently limit pharmaceutical applications, DeepMind\u2019s decision to make the platform open-source means that academic research will inevitably be able to advance scientists\u2019 understanding of disease mechanisms and drug interactions.",
            "As scientists use AlphaFold3 to better understand protein structures and interactions, they can also create better targets for medications, better understand side effects, and delve into new areas of protein-drug interactions that may not have previously been fathomable. \u201cThe drug discovery industry is constantly evolving to explore innovative approaches that go beyond the traditional \u2018one drug per target\u2019 model,\u201d said Tan.",
            "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs.",
            "To learn how to puzzle out the precise atomic structures of molecules, AlphaFold3 uses a diffusion model, similar to ones used for popular text-to-image generation models such as OpenAI\u2019s DALL-E 3."
          ],
          "title": "Can AlphaFold3's open-source platform revolutionize the way we ...",
          "meta": {
            "query": "AlphaFold 3 pharmaceutical industry benefits",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "This review, by exploring advancements ... [6], will attempt to reveal how AlphaFold 3 sets new benchmarks in the accurate modeling of protein structures and their complexes with ligands. Further, we will explore its applications in drug discovery, providing real-life case studies ...",
          "snippets": [
            "This review, by exploring advancements in machine learning and deep learning technologies such as the the innovative use of AI by Bileschi and Colwell  to harness molecular structure predictions and the Gemini model (Google DeepMind Technologies Limited) , will attempt to reveal how AlphaFold 3 sets new benchmarks in the accurate modeling of protein structures and their complexes with ligands. Further, we will explore its applications in drug discovery, providing real-life case studies and examples that underscore its potential.",
            "One of the most notable advancements in AlphaFold 3 is its expanded predictive abilities. The model now accurately predicts protein-molecule complexes that include a variety of biomolecules such as DNA and RNA. This expansion is crucial for applications in genomics research and drug discovery, providing researchers with a powerful tool for faster and more accurate predictions.",
            "Machine learning, particularly through platforms like AlphaFold 3, has revolutionized the identification and optimization of lead compounds in drug discovery . By analyzing extensive chemical libraries, AlphaFold 3 identifies promising drug candidates based on their predicted biological activity and physicochemical properties, significantly accelerating the drug development process. ... AlphaFold 3's ability to predict drug-target interactions with unprecedented accuracy is a cornerstone of its application in drug discovery.",
            "Limiting the model's use to non-commercial purposes and controlling the types of molecules that can be studied may slow down the pace of discovery and application, especially in environments where commercial use could accelerate advancements . Challenges in Translating Predictions to Clinical Success \u00b7 Translating the predictive insights provided by AlphaFold 3 into successful clinical outcomes remains a significant challenge. The complexity of drug interactions and physiological responses often requires more than accurate structural predictions to achieve effective therapeutic results ."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "All the users of AlphaFold don\u2019t really care about speed, performance, latency, or any of those usual IT topics,\u201d Bangert said. \u201cWhat they really care about is accuracy. And that\u2019s why this move beyond essentially just a language model into molecular dynamics is really a good one.\u201d \u00b7 While R&D productivity rates in biopharma have declined in recent decades, blockbuster drugs still deliver substantial returns."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein.",
            "We seek outstanding applicants for full-time tenure-track/tenured faculty positions."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-023-02984-w",
          "description": "After Google Deepmind\u2019s AlphaFold proved that it could predict the 3D shapes of proteins with high accuracy in 2020, chemists became excited about the promise of using the open-source artificial-intelligence (AI) programme to discover drugs more quickly and cheaply.",
          "snippets": [
            "Nature - Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry. Questions remain about whether the AI tool for predicting protein structures can really shake up the pharmaceutical industry.",
            "Applications are sought for an Assistant Professor of Artificial Intelligence in Food Engineering within the College of Engineering and Architecture.",
            "Job Title: Associate or Senior Editor, Nature Health Location(s): New York or Shanghai \u2013 Hybrid Working Application Deadline: February 14, 2025 A..."
          ],
          "title": "AlphaFold touted as next big thing for drug discovery \u2014 but is it?",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://venturebeat.com/ai/google-deepmind-open-sources-alphafold-3-ushering-in-a-new-era-for-drug-discovery-and-molecular-biology/",
          "description": "Notably, AlphaFold 3\u2019s accuracy in predicting protein-ligand interactions exceeds traditional physics-based methods, even without structural input information. This marks an important shift in computational biology: AI methods now outperform our best physics-based models in understanding how molecules interact. The impact on drug discovery and development will be substantial. While commercial restrictions currently limit pharmaceutical applications...",
          "snippets": [
            "Notably, AlphaFold 3\u2019s accuracy in predicting protein-ligand interactions exceeds traditional physics-based methods, even without structural input information. This marks an important shift in computational biology: AI methods now outperform our best physics-based models in understanding how molecules interact. The impact on drug discovery and development will be substantial. While commercial restrictions currently limit pharmaceutical applications, the academic research enabled by this release will advance our understanding of disease mechanisms and drug interactions.",
            "The release of AlphaFold 3 represents an important step forward in AI-powered science. Its impact will extend beyond drug discovery and molecular biology. As researchers apply this tool to various challenges \u2014 from designing enzymes to developing resilient crops \u2014 we\u2019ll see new applications in computational biology.",
            "Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial interests in the wake of its creators' Nobel Prize win.",
            "While AlphaFold 2 could predict protein structures, version 3 can model the complex interactions between proteins, DNA, RNA, and small molecules \u2014 the fundamental processes of life. This matters because understanding these molecular interactions drives modern drug discovery and disease treatment."
          ],
          "title": "Google DeepMind open-sources AlphaFold 3, ushering in a new era ...",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years. Earlier versions of AlphaFold spurred a leap forward in drug development by rapidly and accurately predicting 3-D protein structures, a decades-long problem that had vexed computational biologists seeking to understand how shape affects protein function as a disease indicator.",
            "However, AlphaFold and competing programs, such as RoseTTaFold, now make the process quicker and easier. \u201cInstead of trialing a hundred options in the lab, physically, I can trial tens of thousands of options in silico,\u201d he said. \u201cWhile it still costs money, it's a small fraction and, of course, it's almost instantaneous.\u201d \u00b7 If a company typically takes ten years to get a drug across the finish line, this technology will allow them to do it in seven, he said."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "The new study is part of an effort recently launched by Collins\u2019 lab called the Antibiotics-AI Project, which has the goal of using artificial intelligence to discover and design new antibiotics. AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "\u201cBreakthroughs such as AlphaFold are expanding the possibilities for in silico drug discovery efforts, but these developments need to be coupled with additional advances in other aspects of modeling that are part of drug discovery efforts,\u201d Collins says.",
            "\u201cOur study speaks to both the current abilities and the current limitations of computational platforms for drug discovery.\u201d \u00b7 In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems.",
            "We used the raw sequence of the protein, and the SMILES representation of each ligand, without giving AlphaFold 3 any additional information about the pose, structure, or pocket. Excitingly, the predicted structures were in agreement with the published experimental structures. The pocket discovered by the study was also found by AlphaFold 3."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
          "description": "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis ...",
          "snippets": [
            "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs.",
            "Building on the foundations of its hugely successful AlphaFold2, which made a fundamental breakthrough in protein structure prediction in 2020, Google DeepMind and its sister company Isomorphic Labs launched AlphaFold3 in May. After controversially withholding the code for six months, DeepMind finally \u2013 and somewhat unexpectedly \u2013 open-sourced its platform early last week, meaning academic researchers all over the world can access both the code and training weights for the first time for non-commercial applications. This decision marks a significant advance that could massively accelerate scientific discovery and drug development.",
            "Ultimately, AlphaFold3\u2019s impact on drug discovery and development is expected to be substantial. And, while commercial restrictions currently limit pharmaceutical applications, DeepMind\u2019s decision to make the platform open-source means that academic research will inevitably be able to advance scientists\u2019 understanding of disease mechanisms and drug interactions.",
            "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery."
          ],
          "title": "AlphaFold3: Revolutionizing drug discovery and development",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "By predicting these interactions, AlphaFold 3 can: Reveal how proteins bind to DNA: This helps us understand how genes are turned on and off, crucial for regulating cellular activity. Predict how drugs interact with proteins: This is a game-changer in drug discovery. Scientists can design more effective and targeted therapies by understanding how a potential drug binds to a specific protein. One of the most exciting applications ...",
          "snippets": [
            "By predicting these interactions, AlphaFold 3 can: Reveal how proteins bind to DNA: This helps us understand how genes are turned on and off, crucial for regulating cellular activity. Predict how drugs interact with proteins: This is a game-changer in drug discovery. Scientists can design more effective and targeted therapies by understanding how a potential drug binds to a specific protein. One of the most exciting applications of AlphaFold 3 lies in drug discovery.",
            "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
            "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations. Let\u2019s delve deeper: Drug Discovery: First, as demonstrated above, AlphaFold 3 can drastically reduce drug discovery time by simulating and predicting the action of substances on proteins.",
            "Accessibility and Equity: Widespread access to AlphaFold 3 should avoid widening the gap between developed and developing nations regarding scientific progress and healthcare. Misuse in Drug Design: Faster drug discovery could lead to the development of powerful drugs that fall into the wrong hands."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 applications in drug discovery",
            "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The Pairformer module in AlphaFold 3 simplifies the processing of multiple sequence alignment data by focusing on pair and single representations, reducing reliance on MSA processing[86][87]. This streamlined approach enhances prediction efficiency and accuracy by allowing the model to focus on pairwise interactions between residues[89]. Additionally, the geometry-inspired triangular attention mechanism ensures that structural hypotheses maintain essential geometric properties, enhancing spatial relationship modeling within proteins[89]. The integration of the Pairformer with a diffusion module further improves the model's ability to predict atomic coordinates directly, eliminating the need for complex rotational adjustments and enhancing computational efficiency[87][88][90][91].",
      "raw_utterance": "AlphaFold 3 introduces several significant advancements over its predecessor, particularly through the Pairformer module. This new module replaces the EvoFormer used in AlphaFold 2 and marks a notable shift in how multiple sequence alignment (MSA) data is processed[85][86][92]. The Pairformer simplifies the architecture by focusing on pair and single representations, thereby reducing the reliance on MSA processing[86][87]. This streamlined approach is instrumental in enhancing prediction efficiency and accuracy, allowing the model to focus on pairwise interactions between residues[89].\n\nThe Pairformer operates with a geometry-inspired triangular attention mechanism, ensuring that the structural hypotheses generated during prediction maintain essential geometric properties, such as the triangle inequality[89]. This design choice is critical for accurately modeling the spatial relationships within proteins and other molecular structures.\n\nFurthermore, the integration of the Pairformer with a diffusion module represents a significant leap in AlphaFold 3's ability to predict atomic coordinates more directly. By handling raw atom coordinates, the diffusion module eliminates the need for complex rotational adjustments, which were a feature of previous architectures[87][88]. This innovation enhances the model's capability to generate accurate 3D molecular structures with greater computational efficiency[90][91].\n\nIn summary, the Pairformer module in AlphaFold 3 not only reduces the complexity associated with MSA data but also enhances the model's overall predictive performance. These architectural advancements underscore the ongoing evolution in protein structure prediction, driven by a focus on simplifying complex processes while maintaining high accuracy and reliability.",
      "role": "Research Scientist in Protein Structure Prediction",
      "role_description": " An expert in the field of protein structure prediction, this speaker will bring a scientific perspective to the discussion. They will delve into the technical aspects of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data. Additionally, they will highlight the importance of accurately modeling protein interactions for designing more effective and safer drug candidates.",
      "queries": [
        "AlphaFold 3 Pairformer module technical advancements",
        "AlphaFold 3 Pairformer multisequence alignment processing"
      ],
      "utterance_type": "Potential Answer",
      "claim_to_make": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
      "raw_retrieved_info": [
        {
          "url": "https://www.deeporigin.com/blog/alphafold-3-exciting-advance-yet-unresolved-major-issues-remain",
          "description": "The architectural changes introduced\u2014such as the replacement of the EvoFormer with the Pairformer, and the switch to a diffusion module for predicting atomic coordinates\u2014demonstrate innovative approaches to enhancing model accuracy and efficiency. However, despite these advancements, AlphaFold ...",
          "snippets": [
            "The architectural changes introduced\u2014such as the replacement of the EvoFormer with the Pairformer, and the switch to a diffusion module for predicting atomic coordinates\u2014demonstrate innovative approaches to enhancing model accuracy and efficiency. However, despite these advancements, AlphaFold 3 is not without significant limitations.",
            "We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations. Here's what we found.",
            "The EvoFormer module of AlphaFold 2 has been replaced with a simpler Pairformer module to reduce MSA processing.",
            "For protein-ligand interactions, the paper used PoseBusters benchmark set, composed of 428 protein-ligand structures released to the PDB in 2021 or later, and trained AlphaFold3 using a 2019-09-30 training cutoff. Here we have a time split without homology or ligand similarity splits. This is definitely not the hardest split to use for ML benchmarking. AF3 accuracy on the PoseBusters V1 set is 76.4%, which is 2.8% improvement over their recent technical report."
          ],
          "title": "AlphaFold 3: Exciting Advance yet Unresolved Major Issues Remain ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://zontal.io/alphafold-rises-with-version-3/",
          "description": "While building upon the foundation ... AlphaFold 2, AF3 boasts several key advancements that set it apart. At its core, the architectural changes are driven by the need to accommodate a wide range of chemical entities without excessive complexity. One of the most notable modifications lies in the replacement of the Evoformer with the simpler Pairformer Module, significantly ...",
          "snippets": [
            "While building upon the foundation laid by its predecessor, AlphaFold 2, AF3 boasts several key advancements that set it apart. At its core, the architectural changes are driven by the need to accommodate a wide range of chemical entities without excessive complexity. One of the most notable modifications lies in the replacement of the Evoformer with the simpler Pairformer Module, significantly reducing the amount of multiple sequence alignment (MSA) processing required.",
            "Explore AlphaFold 3's breakthroughs in predicting complex molecular structures with unmatched accuracy, advancing computational biology further.",
            "It\u2019s a race at an incredible pace, let\u2019s look forward to many new drugs entering the market thanks to these advancements! Luckily, using the google server you can fold proteins, multimers, and ligands at: https://alphafoldserver.com/. The main issue is that only 10 jobs token are awarded per day, to generate the thousands of structures that you want to rank from a diffusion-based model makes this server more a marketing strategy than the research tool the community is longing for.",
            "AlphaFold 3\u2019s advancements translate into remarkable performance metrics."
          ],
          "title": "AlphaFold Rises to New Heights with Version 3",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://elanapearl.github.io/blog/2024/the-illustrated-alphafold/",
          "description": "A visual walkthrough of the AlphaFold3 architecture, with more details and diagrams than you were probably looking for.",
          "snippets": [
            "MSA module first updates the MSA m, then adds it to the token-level pair representation z. In this section we spend significant time on two operations: ... MSA Row-wise Gated Self-Attention Using Only Pair Bias updates m based on z and is a simplified version of attention with pair-bias (intended for MSAs) Pairformer updates s and z with geometry-inspired (triangle) attention.",
            "Each template (Ntemplates=2 in the diagram) goes through a linear projection and is added together with a linear projection of our pair representation (z). This newly combined matrix goes through a series of operations called the Pairformer Stack (described in depth later). Finally, all of the templates are averaged together and go through - you guessed it - another linear layer. This is both called the template module and template embedder depending on where you look in the AF3 supplement, but they seem to just refer to the same thing.",
            "The last step of the MSA module is to update the pair representation through a series of steps referred to as triangle updates and attention. These triangle operations are described below with Pairformer, where they are used again.",
            "Finally, we predict a de-noising step using the Diffusion Module. We cover this module in more detail below: ... In each de-noising diffusion step, we condition our prediction on multiple representations of the input sequences: the outputs of the trunk (our post-Pairformer updated s and z, now called strunk and ztrunk)"
          ],
          "title": "The Illustrated AlphaFold | matmols",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "The introduction of novel neural network architectures in AlphaFold 3 has been pivotal in enhancing its predictive capabilities . These innovations include a scaled-down MSA processing unit and the new \"Pairformer,\" which focuses solely on pair and single representations, eliminating the need for MSA representation. This simplification allows for a more focused and efficient prediction process. Additionally, the diffusion module, a new addition to AlphaFold 3, directly handles raw atom coordinates, streamlining the prediction process by eliminating the need for complex rotational adjustments .",
            "AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field .",
            "The structure module has also been redesigned to include an explicit 3D structure for each residue, rapidly developing and refining a highly accurate protein structure . ... One of the most notable advancements in AlphaFold 3 is its expanded predictive abilities.",
            "AlphaFold 3 uses similar machine learning and deep learning models such as Gemini (Google DeepMind Technologies Limited). AlphaFold 3 has already established itself as a turning point in the field of computational biochemistry and drug development along with receptor modulation and biomolecular development."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ai4pharm.info/alphafold3",
          "description": "AlphaFold3 (June) \u2192 This post\u2019s topic! ... In AF3, atoms are grouped into tokens. ... In AF3, MSA representation is actually de-emphasized. It is first processed at the smaller and simpler MSAModule and then only the first row (single representation) is passed to the core Pairformer.",
          "snippets": [
            "Unlike in AF2, the Single rep does not (directly) influence the Pair rep within a Pairformer block with outer product mean. (the outer product mean was already used in the MSA module)",
            "Fig. 2a Pairformer module. n: number of tokens, c: number of channels.",
            "Large network trunk (Evoformer in AF2, Pairformer in AF3) evolves a pairwise representation.",
            "Authors divided Evoformer (of AF2) into MSAModule and Pairformer."
          ],
          "title": "AlphaFold3 Explained",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.blopig.com/blog/2024/08/architectural-highlights-of-alphafold3/",
          "description": "Just because a model hasn\u2019t been ... to be SE(3) equivariant. I think the biggest takeaway from AlphaFold3 is that attention is still all you need. Transformers are essentially stable, memory-efficient, fully connected GNNs. If Transformers can learn some of the benefits of GNNs such as distance encodings, then they can be an effective architecture, even for structural data. That said, AlphaFold3 still generates an explicit edge representation via the PairFormer which may ...",
          "snippets": [
            "Just because a model hasn\u2019t been designed to be SE(3) equivariant, doesn\u2019t mean the model hasn\u2019t learned to be SE(3) equivariant. I think the biggest takeaway from AlphaFold3 is that attention is still all you need. Transformers are essentially stable, memory-efficient, fully connected GNNs. If Transformers can learn some of the benefits of GNNs such as distance encodings, then they can be an effective architecture, even for structural data. That said, AlphaFold3 still generates an explicit edge representation via the PairFormer which may be important because, for instance, the pair representations are initialized with distance encodings.",
            "AlphaFold3 combines the processing of the MSA and structural templates with the generation of the pair representation. This entire module is now called the PairFormer. As in AlphaFold2, the PairFormer uses triangular attention updates to ensure its structural hypothesis at each step at least satisfies the triangle inequality.",
            "The output of the PairFormer is an NxN dimensional Pair representation which abstractly represents plausible connections in the structure as well as an N dimensional Single representation which represents each token in the sequence. These are passed to the new diffusion-based structure module to be resolved to a predicted structure. Probably the most exciting architectural development in AlphaFold3 is the completely redesigned Structure Module.",
            "In the original Transformer, these were standard dot product attention and simple feedforward layers. The AlphaFold3 structure model is a slightly different flavour. The key motivation behind most of these changes is simply that we want to be able to condition the output of the Transformer on the output of the preceding module, the PairFormer."
          ],
          "title": "Architectural highlights of AlphaFold3 | Oxford Protein Informatics ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
          "snippets": [
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "Architecture and Training Procedure: AlphaFold 3 introduces a new diffusion-based architecture, replacing the AlphaFold 2 Evoformer with the simpler Pairformer Module.",
            "Cross-Molecular Predictive Ability: The ability to accurately model interactions not just between proteins, but also including RNA, DNA, and other molecules, marks a substantial improvement over the specialized models of AlphaFold 2. Training and Inference Efficiency: The shift to a diffusion-based module reduces the complexity of the training and inference processes, potentially leading to quicker and more efficient model training and deployment. The AF3 advancement is poised to transform various aspects of biological research and drug discovery.",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far surpass its predecessor, AlphaFold 2 (AF2). I have highlighted the core advancements of AF3, illustrating its superior architecture, broadened predictive capabilities, and its implications for scientific research in this blog."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
          "snippets": [
            "Despite this, the technical achievement was widely recognized. On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024.",
            "It also used more advanced learning methods than previously to develop the inference. The 2020 version of the program (AlphaFold 2, 2020) is significantly different from the original version that won CASP 13 in 2018, according to the team at DeepMind. AlphaFold 1 used a number of separately trained modules to produce a guide potential, which was then combined with a physics-based energy potential.",
            "AlphaFold 2 scoring more than 90 in CASP's global distance test (GDT) is considered a significant achievement in computational biology and great progress towards a decades-old grand challenge of biology. Nobel Prize winner and structural biologist Venki Ramakrishnan called the result \"a stunning advance on the protein folding problem\", adding that \"It has occurred decades before many people in the field would have predicted.",
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://harrisbio.substack.com/p/alphafold3-a-foundation-model-for",
          "description": "For those seeking an in-depth technical exploration, I highly recommend a peruse of the extensive supplementary methods paper. Overview of the AlphaFold3 architecture. Sequences, ligands etc are passed through the input embedder and templates and MSA are collected. The Pairformer models interactions between atoms in a latent space before the Diffusion module builds out 3D ...",
          "snippets": [
            "For those seeking an in-depth technical exploration, I highly recommend a peruse of the extensive supplementary methods paper. Overview of the AlphaFold3 architecture. Sequences, ligands etc are passed through the input embedder and templates and MSA are collected. The Pairformer models interactions between atoms in a latent space before the Diffusion module builds out 3D coordinates.",
            "DeepMind's latest structure prediction model has many new bells and whistles - but what does it mean for the TechBio industry?",
            "On the technical side, the headline news is that AlphaFold3 operates on all-atom coordinates and also uses a diffusion model (a kind of generative model I described in my last article) to build 3D coordinates. The former means it can now generalise to more kinds of biomolecular modelling, including predicting ligands, DNAs, RNAs, modified residues and glycans.",
            "It consists of an embedding module, a Transformer-like trunk module that extracts evolutionary relationships and forms a \"structural hypothesis,\" and a final module that generates 3D coordinates. The embedding module is the simplest and transforms discrete residue and atom type information into a continuous latent space. The Pairformer architecture."
          ],
          "title": "AlphaFold3: A foundation model for biology (?)",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/kyegomez/AlphaFold3",
          "description": "Implementation of Alpha Fold 3 from the paper: \"Accurate structure prediction of biomolecular interactions with AlphaFold3\" in PyTorch - kyegomez/AlphaFold3",
          "snippets": [
            "-> pair and single representation together with the input representation are passed to the diffusion module \u00b7 -> diffusion takes in 3 tensors [pair, single representation, with new pairformer representation]",
            "-> diffusion module produces a distribution of answers \u00b7 -> for each answer the local structure will be sharply defined \u00b7 -> diffusion models are prone to hallucination where the model may hallucinate plausible looking structures \u00b7 -> to counteract hallucination, they use a novel cross distillation method where they enrich the training data with alphafold multimer v2.3 predicted strutctures.",
            "@article{Abramson2024-fj, title = \"Accurate structure prediction of biomolecular interactions with {AlphaFold} 3\", author = \"Abramson, Josh and Adler, Jonas and Dunger, Jack and Evans, Richard and Green, Tim and Pritzel, Alexander and Ronneberger, Olaf and Willmore, Lindsay and Ballard, Andrew J and Bambrick, Joshua and Bodenstein, Sebastian W and Evans, David A and Hung, Chia-Chun and O'Neill, Michael and Reiman, David and Tunyasuvunakool, Kathryn and Wu, Zachary and {\\v Z}emgulyt{\\.e}, Akvil{\\.e} and Arvaniti, Eirini and Beattie, Charles and Bertolli, Ottavia and Bridgland, Alex and Cherepan",
            "-> confidence head uses the pairwise representation to predict the lddt (pddt) and a predicted aligned error matrix as used in alphafold 2 as well as distance error matrix which is the error in the distance matrix of the predicted structure as compared to the true structure"
          ],
          "title": "GitHub - kyegomez/AlphaFold3: Implementation of Alpha Fold 3 from ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer module technical advancements",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://elanapearl.github.io/blog/2024/the-illustrated-alphafold/",
          "description": "A visual walkthrough of the AlphaFold3 architecture, with more details and diagrams than you were probably looking for.",
          "snippets": [
            "However, even though AlphaFold doesn\u2019t explicitly refer to this process as retrieval, it does quite resemble what has now been popularized as RAG. ... From our template search, we have a 3D structure for each of our templates and information about which tokens are in which chains.",
            "This careful scaling involves both the variance of our data, and the noise schedule based on our current timestep, so that our updates are smaller and smaller as we get deeper into the de-noising process. the updates from rupdate to their form with non-unit variance, xupdate, and apply the updates to xl. With that, we\u2019ve completed our tour through the main architecture of AlphaFold 3!",
            "Each individual block is repeated multiple times, and then the output of the whole section is fed back into itself again as input and the process is repeated (this is called recycling). ... Each template (Ntemplates=2 in the diagram) goes through a linear projection and is added together with a linear projection of our pair representation (z). This newly combined matrix goes through a series of operations called the Pairformer Stack (described in depth later).",
            "the outputs of the trunk (our post-Pairformer updated s and z, now called strunk and ztrunk) the initial atom and token-level representations of the sequence created in the input embedder that have not gone through the trunk (sinputs, cinputs) The AF3 paper breaks down its diffusion process into 4 steps that involve moving from tokens to atoms, back to tokens, and back to atoms:"
          ],
          "title": "The Illustrated AlphaFold | matmols",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.blopig.com/blog/2024/08/architectural-highlights-of-alphafold3/",
          "description": "AlphaFold3 combines the processing of the MSA and structural templates with the generation of the pair representation. This entire module is now called the PairFormer. As in AlphaFold2, the PairFormer uses triangular attention updates to ensure its structural hypothesis at each step at least ...",
          "snippets": [
            "AlphaFold3 combines the processing of the MSA and structural templates with the generation of the pair representation. This entire module is now called the PairFormer. As in AlphaFold2, the PairFormer uses triangular attention updates to ensure its structural hypothesis at each step at least satisfies the triangle inequality.",
            "Broadly, it can be thought of as a series of blocks which are composed of attention and processing layers. In the original Transformer, these were standard dot product attention and simple feedforward layers. The AlphaFold3 structure model is a slightly different flavour. The key motivation behind most of these changes is simply that we want to be able to condition the output of the Transformer on the output of the preceding module, the PairFormer.",
            "The output of the PairFormer is an NxN dimensional Pair representation which abstractly represents plausible connections in the structure as well as an N dimensional Single representation which represents each token in the sequence. These are passed to the new diffusion-based structure module to be resolved to a predicted structure. Probably the most exciting architectural development in AlphaFold3 is the completely redesigned Structure Module.",
            "In many cases, the PairFormer has probably learned a fairly specific hypothesis about the distance between tokens in the final structure. So how is this hypothesis communicated to the Structure module? In AlphaFold3, the pair representation for tokens i and j is linearly projected to a scalar which is then added as a bias term to the attention matrix."
          ],
          "title": "Architectural highlights of AlphaFold3 | Oxford Protein Informatics ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/kyegomez/AlphaFold3",
          "description": "Implementation of Alpha Fold 3 from the paper: \"Accurate structure prediction of biomolecular interactions with AlphaFold3\" in PyTorch - kyegomez/AlphaFold3",
          "snippets": [
            "-> confidence head uses the pairwise representation to predict the lddt (pddt) and a predicted aligned error matrix as used in alphafold 2 as well as distance error matrix which is the error in the distance matrix of the predicted structure as compared to the true structure",
            "-> within the trunk, msa processing is de emphasized with a simpler MSA block, 4 blocks ... -> pair and single representation together with the input representation are passed to the diffusion module \u00b7 -> diffusion takes in 3 tensors [pair, single representation, with new pairformer representation]",
            "@article{Abramson2024-fj, title = \"Accurate structure prediction of biomolecular interactions with {AlphaFold} 3\", author = \"Abramson, Josh and Adler, Jonas and Dunger, Jack and Evans, Richard and Green, Tim and Pritzel, Alexander and Ronneberger, Olaf and Willmore, Lindsay and Ballard, Andrew J and Bambrick, Joshua and Bodenstein, Sebastian W and Evans, David A and Hung, Chia-Chun and O'Neill, Michael and Reiman, David and Tunyasuvunakool, Kathryn and Wu, Zachary and {\\v Z}emgulyt{\\.e}, Akvil{\\.e} and Arvaniti, Eirini and Beattie, Charles and Bertolli, Ottavia and Bridgland, Alex and Cherepan",
            "-> to counteract hallucination, they use a novel cross distillation method where they enrich the training data with alphafold multimer v2.3 predicted strutctures."
          ],
          "title": "GitHub - kyegomez/AlphaFold3: Implementation of Alpha Fold 3 from ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
          "snippets": [
            "This model begins with a cloud of atoms and iteratively refines their positions, guided by the Pairformer's output, to generate a 3D representation of the molecular structure. The AlphaFold server was created to provide free access to AlphaFold 3 for non-commercial research.",
            "The overall training was conducted on processing power between 100 and 200 GPUs. AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "Some have noted that even a perfect answer to the protein prediction problem would still leave questions about the protein folding problem\u2014understanding in detail how the folding process actually occurs in nature (and how sometimes they can also misfold). In 2023, Demis Hassabis and John Jumper won the Breakthrough Prize in Life Sciences as well as the Albert Lasker Award for Basic Medical Research for their management of the AlphaFold project.",
            "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "This is achieved by a substantial evolution of the AF2 architecture and training procedure (Fig. 1d) both to accommodate more general chemical structures and to improve the data efficiency of learning. The system reduces the amount of multiple-sequence alignment (MSA) processing by replacing the AF2 evoformer with the simpler pairformer module (Fig.",
            "Note the disordered N-terminus not entirely shown. d, Predicted aligned error (PAE) per token-pair for the prediction in c with rows and columns labelled by chain id and green gradient indicating PAE. a, Accuracy on structures. containing common phosphorylation residues (SEP, TPO, PTR, NEP, HIP) from the recent PDB evaluation set. Comparison between AlphaFold 3 with phosphorylation modelled, and AlphaFold 3 without modelling phosphorylation (N = 76 clusters, paired two-sided Wilcoxon signed-rank test, p = 1.6 * 10\u22124)."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s42256-023-00721-6",
          "description": "AlphaFold2 has revolutionized bioinformatics, but its ability to predict protein structures with high accuracy comes at the price of a costly database search for multiple sequence alignments. Fang and colleagues pre-train a large-scale protein language model and use it in conjunction with ...",
          "snippets": [
            "AlphaFold2 has revolutionized bioinformatics, but its ability to predict protein structures with high accuracy comes at the price of a costly database search for multiple sequence alignments. Fang and colleagues pre-train a large-scale protein language model and use it in conjunction with AlphaFold2 as a fully trainable and efficient model for structure prediction.",
            "Protein structure prediction pipelines based on artificial intelligence, such as AlphaFold2, have achieved near-experimental accuracy. These advanced pipelines mainly rely on multiple sequence alignments (MSAs) as inputs to learn the co-evolution information from the homologous sequences.",
            "Nature Machine Intelligence - AlphaFold2 has revolutionized bioinformatics, but its ability to predict protein structures with high accuracy comes at the price of a costly database search for...",
            "The MSA-free HelixFold-Single has a tremendous advantage in inference efficiency by avoiding MSA searching. Figure 5 exhibits the computation time cost of (1) MSA searching, (2) the whole inference pipeline of AlphaFold2 and (3) the inference of HelixFold-Single. All the tests are executed on a single NVIDIA A100(40G) graphics processing unit."
          ],
          "title": "A method for multiple-sequence-alignment-free protein structure ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ebi.ac.uk/training/online/courses/alphafold/inputs-and-outputs/a-high-level-overview/",
          "description": "Users wishing to predict the 3D structure of a protein only need to supply its amino acid sequence. To analyse this, AlphaFold2 uses a multiple sequence alignment (MSA) combining the sequences of multiple related proteins. The software generates a set of pair representations modelling the ...",
          "snippets": [
            "Users wishing to predict the 3D structure of a protein only need to supply its amino acid sequence. To analyse this, AlphaFold2 uses a multiple sequence alignment (MSA) combining the sequences of multiple related proteins. The software generates a set of pair representations modelling the relationships between every pair of amino acid residues.",
            "The software uses the MSA to predict all the pair representations and thus the 3D structure of the protein. Figure 13. High-level overview of how AlphaFold2 predicts a protein\u2019s structure from its amino acid sequence. From the user\u2019s perspective, the only input AlphaFold2 needs is protein sequence(s). However, AlphaFold2 works by building a multiple sequence alignment (MSA), in which multiple similar protein sequences are set alongside each other.",
            "A high-quality MSA is essential for AlphaFold2 to produce an accurate prediction of protein structure. A diverse and deep MSA, with hundreds or thousands of sequences in the alignment, will help AlphaFold2 to identify co-evolutionary signals and use them to figure out the protein\u2019s 3D structure.",
            "The structure module first turns this into a backbone of the 3D structure. It then finishes the modelling by placing the amino acid side chains and refining their positions. AlphaFold2 then performs an iterative process called \u201crecycling\u201d. It feeds the MSA, the pair representations and the 3D structure back to the neural network, and generates a new 3D structure."
          ],
          "title": "AlphaFold2: A high-level overview | AlphaFold",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://zontal.io/alphafold-rises-with-version-3/",
          "description": "Explore AlphaFold 3's breakthroughs in predicting complex molecular structures with unmatched accuracy, advancing computational biology further.",
          "snippets": [
            "While building upon the foundation laid by its predecessor, AlphaFold 2, AF3 boasts several key advancements that set it apart. At its core, the architectural changes are driven by the need to accommodate a wide range of chemical entities without excessive complexity. One of the most notable modifications lies in the replacement of the Evoformer with the simpler Pairformer Module, significantly reducing the amount of multiple sequence alignment (MSA) processing required.",
            "One of the key challenges in generative models is the tendency to hallucinate plausible-looking structures in unstructured regions. To counteract this effect, the researchers employed a novel cross-distillation method, enriching the training data with AlphaFold-Multimer v2 predicted structures.",
            "Luckily, using the google server you can fold proteins, multimers, and ligands at: https://alphafoldserver.com/. The main issue is that only 10 jobs token are awarded per day, to generate the thousands of structures that you want to rank from a diffusion-based model makes this server more a marketing strategy than the research tool the community is longing for.",
            "In the ever-evolving landscape of computational biology, the AlphaFold team at DeepMind has once again pushed the boundaries with the introduction of AlphaFold 3 (AF3)."
          ],
          "title": "AlphaFold Rises to New Heights with Version 3",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0959440X23000131",
          "description": "Sequence alignment is fundamental for analyzing protein structure and function. For all but closely-related proteins, alignments based on structures a\u2026",
          "snippets": [
            "Based on the success of AlphaFold (and its likes) in producing high-quality structure predictions, we suggest that when aligning homologous proteins, lacking experimental structures, better results can be obtained by a structural alignment of predicted structures than by an alignment based only on amino-acid sequences.",
            "The most obvious generalization is that, unlike the results presented here, there is no limitation to pairwise alignment. A family of proteins containing some (or no) experimentally-determined structures and AlphaFold-based predictions of the rest, could be treated by multiple structure alignment programs such as MUSTANG .",
            "We report several metrics for each annotated pocket, and we also include binding pockets that form at the interface of multiple chains. Analysis of the database shows that about 24% of the binding sites occur at the interface of two or more chains and that less than 50% of the total binding sites processed have an apo form in the PDB.",
            "Models of millions of protein structures are now available3,4 while the most widely used method in computational biology, similarity search, has been reinvented to enable ultra-fast searches in the new and vast 3D structure space.5 In line with the paradigm that structure is better conserved than sequence,6,7 the newly acquired ability to perform fast and accurate structure searches, \u201calready outperforms sequence-based alignment methods in many ways\u201d, even when using moderately accurate models.8,9 At the same time, other areas of structural biology, such as protein\u2013ligand binding site prediction or the study of intrinsically disordered proteins, have seen less improvement."
          ],
          "title": "Sequence and structure alignments in post-AlphaFold era - ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data."
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.deeporigin.com/blog/alphafold-3-exciting-advance-yet-unresolved-major-issues-remain",
          "description": "We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations. Here's what we found.",
          "snippets": [
            "The EvoFormer module of AlphaFold 2 has been replaced with a simpler Pairformer module to reduce MSA processing.",
            "The architectural changes introduced\u2014such as the replacement of the EvoFormer with the Pairformer, and the switch to a diffusion module for predicting atomic coordinates\u2014demonstrate innovative approaches to enhancing model accuracy and efficiency. However, despite these advancements, AlphaFold 3 is not without significant limitations.",
            "AlphaFold 3 is a large system and uses diffusion iterations. Since the system mainly consists of neural networks, its inference is done on GPUs. It is not a fast method. The GPU wall clock time without MSA construction, data processing and post-processing is given in Supplementary information 5.10 Table 8.",
            "AlphaFold 3, which is the next step of AlphaFold 2, models proteins with possibly modified residues, nucleic acids, small molecules and ions. It uses a single ML model for predictions from input of biopolymer sequences, residue modifications, and ligand SMILES, claiming improved accuracy over specialized tools."
          ],
          "title": "AlphaFold 3: Exciting Advance yet Unresolved Major Issues Remain ...",
          "meta": {
            "query": "AlphaFold 3 Pairformer multisequence alignment processing",
            "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "What specific mechanisms within the diffusion module work together with the Pairformer to improve the prediction of atomic coordinates directly in AlphaFold 3, ultimately enhancing computational efficiency? [93]",
      "raw_utterance": "How does the integration of the Pairformer module with the diffusion module in AlphaFold 3 enhance the model's ability to predict atomic coordinates directly and improve computational efficiency?",
      "role": "Moderator",
      "role_description": "",
      "queries": [],
      "utterance_type": "Original Question",
      "claim_to_make": "",
      "raw_retrieved_info": [],
      "cited_info": null
    }
  ],
  "warmstart_conv_archive": [
    {
      "utterance": "AlphaFold 3 is the latest iteration of the innovative biomolecular structure prediction AI developed by Google DeepMind Technologies Limited, taking a significant leap forward from its predecessors in terms of accuracy and capabilities[1][7]. It builds upon the groundbreaking achievements of AlphaFold 2, which revolutionized the prediction of protein 3D structures, solving complex protein structures in mere minutes compared to the years and high costs previously required[3]. The development of AlphaFold 3 has been recognized with prestigious awards like the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023, highlighting the project's substantial impact on the scientific community[2][10].\n\nAlphaFold 3 not only retains the ability to predict protein folding structures but also expands its scope to predict the structure and interactions of all biomolecules, including DNA, RNA, and small molecules[7][8]. This is achieved through a significantly updated diffusion-based architecture capable of predicting joint structures of complexes, marking a major advancement in the field of computational structural biology[6][12]. However, unlike some models like RoseTTAFold, AlphaFold 3 does not design new proteins, but it offers a user-friendly web server interface that simplifies access without requiring coding skills[4].\n\nThe AI model's transformative potential extends into drug discovery, as it provides free access to a majority of its capabilities via the newly launched AlphaFold Server, empowering researchers to better understand biological processes and design drugs more effectively[5][9]. Despite its potential, AlphaFold 3's release was met with some criticism due to the decision to withhold the full code, reflecting the ongoing challenge of balancing open science with commercial interests[11]. Nevertheless, AlphaFold 3 continues to lead in predicting biomolecular complexes, marking a pivotal advancement in the understanding of the biological world and the future of medical research[12].",
      "raw_utterance": "AlphaFold 3 is the latest iteration of the innovative biomolecular structure prediction AI developed by Google DeepMind Technologies Limited, taking a significant leap forward from its predecessors in terms of accuracy and capabilities[1][7]. It builds upon the groundbreaking achievements of AlphaFold 2, which revolutionized the prediction of protein 3D structures, solving complex protein structures in mere minutes compared to the years and high costs previously required[3]. The development of AlphaFold 3 has been recognized with prestigious awards like the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023, highlighting the project's substantial impact on the scientific community[2][10].\n\nAlphaFold 3 not only retains the ability to predict protein folding structures but also expands its scope to predict the structure and interactions of all biomolecules, including DNA, RNA, and small molecules[7][8]. This is achieved through a significantly updated diffusion-based architecture capable of predicting joint structures of complexes, marking a major advancement in the field of computational structural biology[6][12]. However, unlike some models like RoseTTAFold, AlphaFold 3 does not design new proteins, but it offers a user-friendly web server interface that simplifies access without requiring coding skills[4].\n\nThe AI model's transformative potential extends into drug discovery, as it provides free access to a majority of its capabilities via the newly launched AlphaFold Server, empowering researchers to better understand biological processes and design drugs more effectively[5][9]. Despite its potential, AlphaFold 3's release was met with some criticism due to the decision to withhold the full code, reflecting the ongoing challenge of balancing open science with commercial interests[11]. Nevertheless, AlphaFold 3 continues to lead in predicting biomolecular complexes, marking a pivotal advancement in the understanding of the biological world and the future of medical research[12].",
      "role": "Default Background Researcher",
      "role_description": "",
      "queries": [
        "AlphaFold 3 overview",
        "What is AlphaFold 3"
      ],
      "utterance_type": "Questioning",
      "claim_to_make": "Background information about AlphaFold 3\\",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "It takes humans years to determine the structure of various proteins and how the shape works with the receptors but AlphaFold 3 predicts the same structure in seconds. The version's utility is unimaginable in the field of drug discoveries, vaccines, enzymatic processes, and determining the rate and effect of different biological processes.",
            "AlphaFold 3 uses similar machine learning and deep learning models such as Gemini (Google DeepMind Technologies Limited). AlphaFold 3 has already established itself as a turning point in the field of computational biochemistry and drug development along with receptor modulation and biomolecular development.",
            "With the help of AlphaFold 3 and models similar to this, researchers will gain unparalleled insights into the structural dynamics of proteins and their interactions, opening up new avenues for scientists and doctors to exploit for the benefit of the patient."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
          "snippets": [
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins.",
            "AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
            "This model begins with a cloud of atoms and iteratively refines their positions, guided by the Pairformer's output, to generate a 3D representation of the molecular structure. The AlphaFold server was created to provide free access to AlphaFold 3 for non-commercial research.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/technologies/alphafold/",
          "description": "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree ...",
          "snippets": [
            "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree of accuracy.",
            "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how life\u2019s molecules interact.",
            "Access the AlphaFold 3 model code and weights for academic use.",
            "AlphaFold has revealed millions of intricate 3D protein structures, and is helping scientists understand how all of life\u2019s molecules interact."
          ],
          "title": "AlphaFold - Google DeepMind",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://cen.acs.org/analytical-chemistry/structural-biology/AlphaFold-3-offer-structure-prediction/102/i15",
          "description": "Could you just tell me how it binds the DNA?\u201d John Jumper, a director at Google DeepMind, said during a press conference. Unlike past versions, AlphaFold 3, which was codeveloped with drug company Isomorphic Labs and first announced in October, can tackle such interactions.",
          "snippets": [
            "AlphaFold 3 shares many capabilities with the recently published RoseTTAFold All-Atom model. Though it lacks RoseTTAFold\u2019s ability to design new proteins, AlphaFold 3 has one big advantage: a new web server with a simple interface that requires no coding by the user.",
            "Casual users beware: AlphaFold 3 will predict the most likely structure of any combination of input molecules, whether or not they genuinely interact. According to Jaderberg, the model assigns low confidence scores to complexes that are not thought to occur in the real world.",
            "This article was updated on May 16, 2024, to add information about a letter to Nature by structural and computational biologists as well as a paper on an open-source program called OpenFold. The update also added a space to correct the name of AlphaFold 3.",
            "Methods 2024, DOI: 10.1038/s41592-024-02272-z). In principle, a laboratory at a company or university could train its own variant of OpenFold\u2014for example, using proprietary structure data\u2014and generate predictions that resemble what AlphaFold 2 might predict, without using Google\u2019s servers. A lab might also optimize the model to solve a different type of problem. In an email to C&EN, AlQuraishi writes that his team has already started an effort to reproduce AlphaFold 3."
          ],
          "title": "AlphaFold 3 to offer structure prediction via web browser",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped ...",
          "snippets": [
            "In order to get AlphaFold 3 to work with this much wider range of biomolecules, the team vastly expanded the data that the newer model was trained on to include DNA, RNA, small molecules and more. \u201cWe were able to say, \u2018Let's just train on everything that exists in this dataset that helped us so much with proteins and let\u2019s see how far we can get,\u2019\u201d Lindsay says.",
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types.",
            "So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not. \u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says.",
            "Instead, they got started on AlphaFold 3."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments and enzyme design. AlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences. AlphaFold 3 takes us beyond proteins to a broad spectrum of biomolecules.",
            "Given an input list of molecules, AlphaFold 3 generates their joint 3D structure, revealing how they all fit together. It models large biomolecules such as proteins, DNA and RNA, as well as small molecules, also known as ligands \u2014 a category encompassing many drugs."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://310.ai/blog/alphafold2-alphafold-multimer-alphafold3",
          "description": "To learn the difference between ... 2/AlphaFold2-Multimer: A Summary\u201d. There, you can find a short summary of the main differences and similarities between these 3 models that covers the main computer science/machine learning aspects of the model. To get an overview of AlphaFold3, ...",
          "snippets": [
            "To learn the difference between AlphaFold2, AlphaFold3, and AlphaFold-Multimer, look at \u201cAlphaFold 3 vs AlphaFold 2/AlphaFold2-Multimer: A Summary\u201d. There, you can find a short summary of the main differences and similarities between these 3 models that covers the main computer science/machine learning aspects of the model. To get an overview of AlphaFold3, its advantages, and disadvantages in a concise form, look at \u201cAlphaFold 3: A Leap Forward in Biomolecular Structure Prediction \u2014 Opportunities and Limitations\u201d.",
            "To find out more about other tools available as open source that can be compared to AlphaFold3, look at \u201cAlternatives to AlphaFold 3\u2014 how they work and when to use them\u201d. To get an overview of 3 weeks of observations on AlphaFold3's performance, look at \u201cSparks of Chemical Intuition\u201d\u2014and Gross Limitations!\u2014in AlphaFold 3\u201d",
            "Here we cover practical considerations for people with a biological background: strong and weak sides of all AlphaFold models, types of structures AlphaFold3 fails to predict, things to be cautious about, and why we still need experimental structures even with all AlphaFold models. Structure prediction is often used in the context of protein structure prediction in particular (even though you can also predict structure of RNA or DNA or small molecules). It\u2019s a computational method used to determine the 3D structure of a protein based on its amino acid sequence.",
            "It mainly relies on multiple sequence alignments (MSAs), pairwise features, specific output representation and associated loss, and transformer-based equivariant attention architecture. AlphaFold was designed to predict the 3D coordinates of amino acid residues in a protein monomer, providing accurate and reliable structural models."
          ],
          "title": "AlphaFold2, AlphaFold-Multimer, AlphaFold3",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://elanapearl.github.io/blog/2024/the-illustrated-alphafold/",
          "description": "However, even though AlphaFold doesn\u2019t explicitly refer to this process as retrieval, it does quite resemble what has now been popularized as RAG. ... From our template search, we have a 3D structure for each of our templates and information about which tokens are in which chains.",
          "snippets": [
            "Specifically, the values are binned into 38 bins between 3.15A and 50.75A and there's 1 additional bin for any distances bigger than that. To each distogram, we then append metadata about which chain \u00b7 In molecular complexes, a chain refers to a distinct molecule or part of a molecule. This can be a protein chain (a sequence of amino acids), a DNA or RNA chain (a sequence of nucleotides), or other biomolecules. AlphaFold uses chain information to differentiate between parts of a complex, helping it predict how these parts interact to form the overall structure each token belongs to, whether this token was resolved in the crystal structure, and information about local distances within each amino acid.",
            "So for zi,j, we also want to encourage consistency with zk,i and zk,j for all atoms k. If we think of the atoms as a graph, with z as a directed adjacency matrix, it makes sense that AlphaFold calls these \u201coutgoing edges\u201d and \u201cincoming edges\u201d. Consider row i=0 of this adjacency matrix, and let\u2019s say we want to update z0,2, which has been highlighted in purple. The idea behind the update is that if we know the distances between 0\u21921 and 2\u21921, that gives us some constraints on what 0\u21922 can be. Similarly, if we know the distances between 0\u21923 and 2\u21923, this also gives us a constraint on 0\u21922.",
            "With that, we\u2019ve completed our tour through the main architecture of AlphaFold 3!",
            "A visual walkthrough of the AlphaFold3 architecture, with more details and diagrams than you were probably looking for."
          ],
          "title": "The Illustrated AlphaFold | matmols",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9.",
            "Here we present AlphaFold 3 (AF3)\u2014a model that is capable of high-accuracy prediction of complexes containing nearly all molecular types present in the Protein Data Bank32 (PDB) (Fig. 1a,b). In all but one category, it achieves a substantially higher performance than strong methods that specialize in just the given task (Fig."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2022.875587/full",
          "description": "Alpha Fold achieved a summed z-score of 52.8 compared with 36.6 for the next closest group. Furthermore combining FM and TBM/FM categories, AlphaFold scored 68.3 compared with 48.2 despite using only FM techniques (Senior et al., 2020).",
          "snippets": [
            "Choosing the distogram as a final output of the network instead of an actual 3D structure can also be considered a bottleneck as some of the more complex and subtle interactions that the model might have learned could not be expressed using this representation, this is worsened by the fitting of a spline over the predicted distances, discarding most of the subtleties of the model. AlphaFold2 is the second iteration of the AlphaFold system.",
            "AlphaFold 2 is an end to end solution (Jumper et al., 2020). This not only allows the network to better fine tune by evaluating on the actual structure instead of an intermediary step. It also frees the network to explore different avenues by not having to restrain itself to an imposed strategy. An important component of the model is a version of the iterative SE(3)-Transformer (Jumper et al., 2020).",
            "This makes the SE(3)-Transformer a good contender as a model architecture. AlphaFold 2 uses an embedding that contains the full sequences found by MSA and potential templates (Flower and Hurley, 2021), while the previous solution was receiving only MSA statistics.",
            "Applying the model in an iterative manor using the Iterative SE(3)-Transformer allows the gradients to propagate through the whole architecture eliminating the disconnect between pairwise distance predictions and the 3D structure encountered in the initial AlphaFold model."
          ],
          "title": "Frontiers | An Overview of Alphafold's Breakthrough",
          "meta": {
            "query": "AlphaFold 3 overview",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
          "description": "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including ...",
          "snippets": [
            "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins).",
            "Where AlphaFold 2 used a complex custom geometry-based module, AlphaFold 3 uses a generative model that\u2019s based on diffusion \u2014 similar to our other cutting-edge image generation models, like Imagen \u2014 which greatly simplified how the model handles all the new molecule types. That shift led to a new issue, though: Since so-called \u201cdisordered regions\u201d of proteins weren\u2019t included in the training data, the diffusion model would try to create an inaccurate \u201cordered\u201d structure with a defined spiral shape, instead of predicting disordered regions.",
            "So the team turned to AlphaFold 2, which is already extremely good at predicting which interactions would be disordered \u2014 which look like a pile of chaotic spaghetti \u2014 and which ones were not. \u201cWe were able to use those predicted structures from AlphaFold 2 as distillation training for AlphaFold 3, so that AlphaFold 3 could learn to predict disorder,\u201d Lindsay says.",
            "An example of a prediction from AlphaFold 3 with ordered \u201cfusilli\u201d regions in blue and disordered \u201cspaghetti\u201d regions in orange. The colors represent the model\u2019s confidence of predicted accuracy. The team is looking forward to seeing how researchers will use AlphaFold 3 to advance fields like genomics research, drug design and more."
          ],
          "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01385-x",
          "description": "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule ...",
          "snippets": [
            "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule complexes containing DNA, RNA and more.",
            "When exposed to an external magnetic field these particles self-assemble into an intricate 3D network that remains intact even after the field is removed. The team used their substance to make liquid bioelectronics that could be injected into the body and convert biomechanical motion into detectable electrical signals. These kinds of devices could be used for self-powered and wireless monitoring of the cardiovascular system. If you are magnetically attracted to that research, you can read it in Nature Materials. ... AlphaFold and its successor AlphaFold 2 have been game changers in biology, as the AIs have made it easier than ever to predict the structures of proteins \u2013 the molecules that make up so much of life.",
            "Yeah, I like to see AlphaFold 3 as \u201cThe Return of the Jedi\u201d of AlphaFold kind of completing the trilogy. Or \u201cThe Godfather III\u201d. I don\u2019t know which was deemed better. ... Hopefully it's not Godfather III because that one was not the best one in my opinion. But let's start off by talking about what this version can do. So, what is it that AlphaFold 3 promises that maybe the other versions lacked?",
            "The only problem \u2014 I wouldn't say a problem \u2014 was that it just predicted protein structures, it didn't predict proteins alongside all the other, you know, players of the cellular ecosystem. That was just not part of AlphaFold 2\u2019s language, part of its abilities. And so AlphaFold 3, this latest update, is exactly that it brings in the rest of the ecosystem, all these other players and you know, predicts proteins alongside of them."
          ],
          "title": "Alphafold 3.0: the AI protein predictor gets an upgrade",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "The hype is warranted, said Patrick Bangert, senior vice president of data, analytics, and AI at Searce, a cloud services company. \u201cIt's a Nobel Prize-worthy invention,\u201d he said. AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said.",
            "Given its potential in life science research, DeepMind and Isomorphic\u2019s CEO said this month the platform could eventually be a \u201cmulti-hundred billion\u201d dollar business. And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "Hassabis and Jumper had previously ... 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins. The 3-D structure is crucial to understanding the biological ...",
          "snippets": [
            "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins. The 3-D structure is crucial to understanding the biological function of the protein.",
            "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
            "The model's ability to predict multiple native conformations of proteins is limited. AlphaFold 3 version can predict structures of protein complexes with a very limited set of selected cofactors and co- and post-translational modifications. Between 50% and 70% of the structures of the human proteome are incomplete without covalently-attached glycans.",
            "Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "AlphaFold 3 is not limited to single-chain proteins, as it can also predict the structures of protein complexes with DNA, RNA, post-translational modifications and selected ligands and ions."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "We\u2019ve all heard about the potential of artificial intelligence in the life sciences field. In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again.",
          "snippets": [
            "The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition. Having gone through multiple major iterations, the most recent release, AlphaFold 3, is set to further transform the protein space.",
            "But what about AlphaFold 3? DeepMind state that the Evoformer model has been updated in this iteration of the technology. The model is now \u2018simpler\u2019, and focuses more on the pair representation. In addition, after processing inputs, AlphaFold 3 uses a \u2018diffusion network\u2019, described by DeepMind as being similar to the tools used in AI image generation.",
            "Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own.",
            "These interactions are crucial in understanding the underpinnings of life, and in identifying potential drug candidates. This is reflected in AlphaFold 3\u2019s large training set, which includes a wider range of molecules."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://venturebeat.com/ai/google-deepmind-open-sources-alphafold-3-ushering-in-a-new-era-for-drug-discovery-and-molecular-biology/",
          "description": "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic ...",
          "snippets": [
            "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic Labs work to develop new drugs using these advances.",
            "While the code is freely available under a Creative Commons license, access to the crucial model weights requires Google\u2019s explicit permission for academic use. This approach attempts to satisfy both scientific and commercial needs \u2014 though some researchers argue it should go further. The technical advances in AlphaFold 3 set it apart.",
            "Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial interests in the wake of its creators' Nobel Prize win.",
            "AlphaFold 3 represents a quantum leap beyond its predecessors. While AlphaFold 2 could predict protein structures, version 3 can model the complex interactions between proteins, DNA, RNA, and small molecules \u2014 the fundamental processes of life. This matters because understanding these molecular interactions drives modern drug discovery and disease treatment."
          ],
          "title": "Google DeepMind open-sources AlphaFold 3, ushering in a new era ...",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/pii/S0969212624003356",
          "description": "Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field. However, challenges loom f\u2026",
          "snippets": [
            "Author links open overlay panelToni K. Tr\u00e4ger 1 2, Christian T\u00fcting 1 2, Panagiotis L. Kastritis 1 2 3 4Show more ... Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field.",
            "Supervised modeling, i.e., integrative structural biology, will continue to play a role in fine-tuning this type of prediction (e.g., removing clashes, rebuilding loops/disordered regions, and redocking interfaces). 3D analysis of endogenous metabolic complexes continues to require, in addition to AI, precise and multi-faceted interrogation methods."
          ],
          "title": "The human touch: Utilizing AlphaFold 3 to analyze structures of ...",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\",
            "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deeperinsights.com/ai-blog/alphafold-3-the-key-to-understanding-lifes-building-blocks",
          "description": "AlphaFold 3 is a monumental leap that is revolutionising our understanding of life's most fundamental structures [source]. Building on the astounding successes of AlphaFold 2, which already set a new benchmark by predicting protein structures with near-experimental accuracy, AlphaFold 3 takes ...",
          "snippets": [
            "AlphaFold 3 is a monumental leap that is revolutionising our understanding of life's most fundamental structures [source]. Building on the astounding successes of AlphaFold 2, which already set a new benchmark by predicting protein structures with near-experimental accuracy, AlphaFold 3 takes innovation to an entirely new level.",
            "AlphaFold 2 succeeded through innovative techniques, using neural networks and deep learning. It trained on a vast database of known protein structures, predicting how a protein\u2019s amino acid sequence would fold into its 3D structure. This approach dramatically outperformed previous methods, achieving near-experimental accuracy. [source] In 2024, DeepMind, in collaboration with Isomorphic Labs, introduced AlphaFold 3.",
            "The primary input to AlphaFold 3 is the amino acid sequence of the protein. Proteins are made up of chains of amino acids, and the specific order of these amino acids (the sequence) determines how the protein will fold into its three-dimensional shape.",
            "The output of the diffusion network is a highly accurate 3D structure of the protein. This structure includes detailed atomic positions, which are essential for understanding the protein's function and interactions. Accurate 3D structures are critical for numerous applications in biology and medicine, including drug design, understanding disease mechanisms, and exploring protein functions. After generating the initial 3D structure, AlphaFold 3 applies post-processing techniques such as energy minimization and conformational validation."
          ],
          "title": "AlphaFold 3: The Key to Understanding Life's Building Blocks - ...",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more. The publication, which is a collaboration between DeepMind and Isomorphic Labs, ...",
          "snippets": [
            "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more. The publication, which is a collaboration between DeepMind and Isomorphic Labs, a London-based company launched in 2021 to build upon DeepMind\u2019s AI research to tackle biological problems, emphasizes AlphaFold 3\u2019s potential to advance therapeutic applications, including drug discovery.",
            "Biology is a complex dynamical system so modeling interactions is crucial.\u201d \u00b7 But his enthusiasm was not universally shared. In contrast to the launch of AlphaFold 2 in 2021, Nature\u2019s publication of AlphaFold 3 lacked the open source code.",
            "In lieu of code, AlphaFold 3 was released to the community as a web server, accessible to individuals without a computational background. While a recent blog post from DeepMind and Isomorphic Labs described the new AlphaFold Server as a facilitator of \u201cnovel hypotheses to test in the lab, speeding up workflows and enabling further innovation,\u201d researchers were quick to note the web server\u2019s limitations.",
            "Scientists took to social media to complain how ligand inputs to the web server were limited to a finite list of biological molecules and did not allow custom inputs, such as small molecule drugs. In that vein, while Isomorphic Labs has reported applying AlphaFold 3 to drug design for internal projects as well as with pharmaceutical partners, the public web server is under a license that is limited to non-commercial use."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@CompXBio/alphafold-3-a-real-game-changer-ef0add53f364",
          "description": "Building on the successes of AlphaFold ... 3, on May 8, 2024. Demonstrating the prediction of protein-DNA complex. Source: AlphaFold \u00b7 Proteins, the fundamental building blocks of all living organisms, are key to understanding the complex mechanisms that govern life. Elucidating protein structures is crucial for ...",
          "snippets": [
            "Building on the successes of AlphaFold 2 and AlphaFold-Multimer, Google DeepMind released its state-of-the-art protein structure and interaction predictor, AlphaFold 3, on May 8, 2024. Demonstrating the prediction of protein-DNA complex. Source: AlphaFold \u00b7 Proteins, the fundamental building blocks of all living organisms, are key to understanding the complex mechanisms that govern life. Elucidating protein structures is crucial for comprehending biological processes.",
            "While 200,000 structures may sound substantial, it is a mere drop in the ocean compared to the total number of proteins in humans and other organisms. ... This context underscores the significance of AlphaFold\u2019s debut, leveraging decades of data from one of the most informative datasets in life sciences. AlphaFold 3 (AF3) goes beyond previous versions by focusing on protein-ligand binding, antibody-antigen binding, protein-nucleic acid interactions, ion binding, and post-translational modifications (PTMs).",
            "AF3 can handle multiple protein sequences with PTMs and small molecules in the Simplified Molecular Input Line Entry System (SMILES) format, predicting structures with the atoms' 3D coordinates. Unlike the relationship between AlphaFold 2 (AF2) and AlphaFold-Multimer (AFM), AF3 fundamentally differs from AF2. AF3 introduces several significant changes/issues:",
            "Building on the successes of AlphaFold 2 and AlphaFold-Multimer, Google DeepMind released its state-of-the-art protein structure and interaction predictor, AlphaFold 3, on May 8, 2024. Proteins, the\u2026"
          ],
          "title": "AlphaFold 3: A Real Game Changer? | by Ian Lee | Medium",
          "meta": {
            "query": "What is AlphaFold 3",
            "question": "Background information about AlphaFold 3\\"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3 represents a significant step forward in the field of protein structure prediction, building on the successes of its predecessors, particularly AlphaFold 2, which had already revolutionized the domain when it won the CASP14 competition in 2020[13][19]. When comparing AlphaFold 3 to earlier versions like AlphaFold 2, there are clear advancements in both accuracy and speed that underscore its superiority.\n\nIn terms of accuracy, AlphaFold 3 demonstrates substantial improvements across various tasks. It achieves far greater precision in predicting protein\u2013ligand and protein\u2013nucleic acid interactions, surpassing state-of-the-art tools that were specifically designed for these purposes[17][18]. For instance, it delivers a minimum 50% improvement in accuracy for protein interactions with other molecules, such as DNA, RNA, and ligands, compared to existing methods[21]. This is a major leap forward, particularly for fields like drug discovery and structural biology, where precise molecular interaction models are critical[20]. AlphaFold 3 also shows better performance for antibody\u2013antigen predictions than AlphaFold-Multimer v2.3, a specialized tool for these tasks[17].\n\nAnother factor contributing to its improved accuracy is the redesigned architecture. Unlike AlphaFold 2, which relied heavily on the \"Invariant Point Attention\" mechanism, AlphaFold 3 adopts a diffusion-based model wrapped around a Transformer architecture. This new approach processes atomic positions in R3 space, simplifying the model while enhancing its capacity to converge on highly accurate molecular structures[16][18]. The use of a diffusion network, reminiscent of those in AI image generators, allows AlphaFold 3 to assemble predictions with remarkable precision by iteratively refining a starting \"cloud of atoms\" into its final structure[18].\n\nSpeed is another domain where AlphaFold 3 outshines its predecessors. While AlphaFold 2 required considerable computational resources and time, AlphaFold 3 introduces optimizations that enable faster processing. For example, when run on high-throughput configurations, such as those using NVIDIA A100 GPUs, AlphaFold 3 exhibits at least a 2\u00d7 improvement in efficiency across various tasks, making it more suitable for large-scale applications[15]. Additionally, its ability to operate on a single NVIDIA A100 with 80 GB of memory enhances accessibility for researchers who may lack extensive computational infrastructure[15].\n\nHowever, it is important to note that AlphaFold 3, like its predecessors, still shows dependence on the quality of input data, particularly Multiple Sequence Alignments (MSAs). Proteins with shallow MSAs are predicted with lower accuracy, highlighting an area that could benefit from further refinement in future iterations[14].\n\nIn summary, AlphaFold 3 significantly surpasses earlier versions in both accuracy and speed. Its ability to predict molecular interactions with high precision, coupled with a more efficient architecture, positions it as a transformative tool in computational biology. However, certain limitations, such as its dependence on MSA quality, remain areas for potential improvement[14][17][18].",
      "raw_utterance": "AlphaFold 3 represents a significant step forward in the field of protein structure prediction, building on the successes of its predecessors, particularly AlphaFold 2, which had already revolutionized the domain when it won the CASP14 competition in 2020[13][19]. When comparing AlphaFold 3 to earlier versions like AlphaFold 2, there are clear advancements in both accuracy and speed that underscore its superiority.\n\nIn terms of accuracy, AlphaFold 3 demonstrates substantial improvements across various tasks. It achieves far greater precision in predicting protein\u2013ligand and protein\u2013nucleic acid interactions, surpassing state-of-the-art tools that were specifically designed for these purposes[17][18]. For instance, it delivers a minimum 50% improvement in accuracy for protein interactions with other molecules, such as DNA, RNA, and ligands, compared to existing methods[21]. This is a major leap forward, particularly for fields like drug discovery and structural biology, where precise molecular interaction models are critical[20]. AlphaFold 3 also shows better performance for antibody\u2013antigen predictions than AlphaFold-Multimer v2.3, a specialized tool for these tasks[17].\n\nAnother factor contributing to its improved accuracy is the redesigned architecture. Unlike AlphaFold 2, which relied heavily on the \"Invariant Point Attention\" mechanism, AlphaFold 3 adopts a diffusion-based model wrapped around a Transformer architecture. This new approach processes atomic positions in R3 space, simplifying the model while enhancing its capacity to converge on highly accurate molecular structures[16][18]. The use of a diffusion network, reminiscent of those in AI image generators, allows AlphaFold 3 to assemble predictions with remarkable precision by iteratively refining a starting \"cloud of atoms\" into its final structure[18].\n\nSpeed is another domain where AlphaFold 3 outshines its predecessors. While AlphaFold 2 required considerable computational resources and time, AlphaFold 3 introduces optimizations that enable faster processing. For example, when run on high-throughput configurations, such as those using NVIDIA A100 GPUs, AlphaFold 3 exhibits at least a 2\u00d7 improvement in efficiency across various tasks, making it more suitable for large-scale applications[15]. Additionally, its ability to operate on a single NVIDIA A100 with 80 GB of memory enhances accessibility for researchers who may lack extensive computational infrastructure[15].\n\nHowever, it is important to note that AlphaFold 3, like its predecessors, still shows dependence on the quality of input data, particularly Multiple Sequence Alignments (MSAs). Proteins with shallow MSAs are predicted with lower accuracy, highlighting an area that could benefit from further refinement in future iterations[14].\n\nIn summary, AlphaFold 3 significantly surpasses earlier versions in both accuracy and speed. Its ability to predict molecular interactions with high precision, coupled with a more efficient architecture, positions it as a transformative tool in computational biology. However, certain limitations, such as its dependence on MSA quality, remain areas for potential improvement[14][17][18].",
      "role": "Computational Biologist",
      "role_description": " This expert specializes in using computational methods to analyze biological data, including protein structures. They will focus on the technical aspects of AlphaFold 3, discussing how the AI model works and its implications for protein structure prediction.",
      "queries": [
        "AlphaFold 3 accuracy vs AlphaFold 2",
        "AlphaFold 3 speed comparison with AlphaFold 2"
      ],
      "utterance_type": "Support",
      "claim_to_make": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
      "raw_retrieved_info": [
        {
          "url": "https://www.linkedin.com/pulse/alphafold-3-vs-2alphafold2-multimer-summary-genophore-inc-vuqqe",
          "description": "",
          "snippets": [],
          "title": "AlphaFold 3 vs AlphaFold 2/AlphaFold2-Multimer",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.scilifelab.se/news/alphafold3-early-pain-points-overshadow-potential-promise/",
          "description": "The scientific community has long awaited the release of AlphaFold3 (AF3), the latest version of DeepMind\u2019s groundbreaking protein structure prediction tool. AlphaFold2 (AF2) set a high bar by revolutionizing our [\u2026]",
          "snippets": [
            "AlphaFold3 is a testament to the continuous advancements in computational biology. Its improvements in accuracy, usability, and speed are noteworthy. However, the concerns regarding its closed nature cannot be ignored.",
            "\u201cI\u2019ve tried using AlphaFold3 for my protein complexes, but they are too large for the program to handle. I\u2019ve seen some colleagues successfully use it for antibody-protein complexes, where it seems to provide likely correct interactions that align with other observations. However, others were disappointed with its predictions for sugars. While the tool\u2019s speed is extremely useful, its lack of openness has generated significant criticism in the community\u201d Marta Carroni, platform director at SciLifeLab Cellular and Molecular Imaging and head of unit at Cryo-EM Stockholm.",
            "AlphaFold is perhaps the most important data-driven example of how AI has transformed the life science landscape. Initially, many were skeptical about the utility of AF2.",
            "AlphaFold2 (AF2) set a high bar by revolutionizing our understanding of protein folding, but how does AF3 compare?"
          ],
          "title": "AlphaFold3: Early pain points overshadow potential promise - ...",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@CompXBio/alphafold-3-a-real-game-changer-ef0add53f364",
          "description": "Building on the successes of AlphaFold 2 and AlphaFold-Multimer, Google DeepMind released its state-of-the-art protein structure and interaction predictor, AlphaFold 3, on May 8, 2024. Proteins, the\u2026",
          "snippets": [
            "Building on the successes of AlphaFold 2 and AlphaFold-Multimer, Google DeepMind released its state-of-the-art protein structure and\u2026",
            "These steps involve (1) extracting co-evolutionary information through MSA and (2) predicting structures based on that information. AF3 can handle multiple protein sequences with PTMs and small molecules in the Simplified Molecular Input Line Entry System (SMILES) format, predicting structures with the atoms' 3D coordinates. Unlike the relationship between AlphaFold 2 (AF2) and AlphaFold-Multimer (AFM), AF3 fundamentally differs from AF2.",
            "While developing this version, DeepMind might aim to speed up large-scale drug discovery and screening. Unfortunately, unlike AF2 and AFM, AF3 is not open-sourced. Following criticism on X, DeepMind announced plans to release code and weights within the next six months. However, it remains uncertain if protein-ligand predictions will be included in that version. At this point, you could run 20 jobs daily on the AlphaFold server, and here is an example of how to submit jobs in batch.",
            "This context underscores the significance of AlphaFold\u2019s debut, leveraging decades of data from one of the most informative datasets in life sciences."
          ],
          "title": "AlphaFold 3: A Real Game Changer? | by Ian Lee | Medium",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
          "snippets": [
            "For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition.",
            "Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own.",
            "We\u2019ve all heard about the potential of artificial intelligence in the life sciences field. In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again.",
            "AlphaFold 2 utilised a deep learning architecture called Evoformer. This model has been instrumental in advancing research into protein structures and folding mechanisms, leading to breakthroughs in subsequent areas such as drug discovery and vaccine development."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Increased speed"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "Protein monomer LDDT improvement is also significant (paired Wilcoxon signed-rank test, P = 1.7 \u00d7 10\u221234). AF3 has a very similar dependence on MSA depth to AlphaFold-Multimer v.2.3; proteins with shallow MSAs are predicted with lower accuracy (a comparison of the dependence of single-chain ...",
          "snippets": [
            "Protein monomer LDDT improvement is also significant (paired Wilcoxon signed-rank test, P = 1.7 \u00d7 10\u221234). AF3 has a very similar dependence on MSA depth to AlphaFold-Multimer v.2.3; proteins with shallow MSAs are predicted with lower accuracy (a comparison of the dependence of single-chain LDDT on MSA depth is shown in Extended Data Fig.",
            "To study antibody-antigen interface prediction, we filter the low homology recent PDB set to complexes that contain at least one protein\u2013protein interface where one of the protein chains is in one of the two largest PDB chain clusters (these clusters are representative of antibodies). We further filter to complexes with at most 2,560 tokens and with no unknown amino acids in the PDB to allow extensive comparison against relaxed predictions of AlphaFold-Multimer v2.3.",
            "Light hashed bar indicates RMSD < 2 \u00c5 but not PB valid. f, PoseBusters V2 detailed validity check comparison. Error bars indicate exact binomial distribution 95% confidence intervals. N = 427 targets for RoseTTAFold All-Atom and 428 targets for all others in Version 1; 308 targets in Version 2. a, CASP15 RNA prediction accuracy from AIChemy_RNA (the top AI-based submission), RoseTTAFold2NA (the AI-based method capable of predicting proteinRNA complexes), and AlphaFold 3.",
            "Predictions are downloaded from the CASP website for external models. b, Accuracy on structures containing low homology RNA-only or DNA-only complexes from the recent PDB evaluation set. Comparison between AlphaFold 3 and RoseTTAFold2NA (RF2NA) (RNA: N = 29 structures, paired Wilcoxon signed-rank test, p = 1.6 * 10\u22127; DNA: N = 63 structures, paired two-sided Wilcoxon signed-rank test, p = 5.2 * 10\u221212)."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Increased speed"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.rbvi.ucsf.edu/chimerax/data/alphafold-jan2022/afspeed.html",
          "description": "Times below are for 2.1.1 unless stated otherwise. How many amino acids can a protein or complex contain before AlphaFold runs out of memory? And how often does it make wrong predictions of large complexes? Here are examples of runs on large structures. UCSF cluster: Wynton cluster, using Nvidia A40 GPUs with 48 GB video memory, CPU info N/A, Alphafold databases on parallel BeeGFS file system. Desktop PC: Intel Core i9-10850K CPU @ 3...",
          "snippets": [
            "Times below are for 2.1.1 unless stated otherwise. How many amino acids can a protein or complex contain before AlphaFold runs out of memory? And how often does it make wrong predictions of large complexes? Here are examples of runs on large structures. UCSF cluster: Wynton cluster, using Nvidia A40 GPUs with 48 GB video memory, CPU info N/A, Alphafold databases on parallel BeeGFS file system. Desktop PC: Intel Core i9-10850K CPU @ 3.60GHz, 64 GBytes memory, Nvidia RTX 3090 / 24 GBytes, AlphaFold databases on 4 TB Samsung 870 QVO SATA 3 SSD drive.",
            "The table shows ColabFold 1.5.5 is about 2 to 10 times faster than AlphaFold 2.3.2."
          ],
          "title": "AlphaFold Performance",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "AlphaFold Server helps scientists make novel hypotheses to test in the lab, speeding up workflows and enabling further innovation. Our platform gives researchers an accessible way to generate predictions, regardless of their access to computational resources or their expertise in machine learning. Experimental protein-structure prediction can take about the length of a PhD and cost hundreds of thousands of dollars. Our previous model, AlphaFold 2, has been used to predict hundreds of millions of structures, which would have taken hundreds of millions of researcher-years at the current rate of experimental structural biology.",
            "Our new model builds on the foundations of AlphaFold 2, which in 2020 made a fundamental breakthrough in protein structure prediction. So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments and enzyme design.",
            "AlphaFold 3\u2019s capabilities come from its next-generation architecture and training that now covers all of life\u2019s molecules. At the core of the model is an improved version of our Evoformer module \u2014 a deep learning architecture that underpinned AlphaFold 2\u2019s incredible performance.",
            "Building on the external consultations we carried out for AlphaFold 2, we\u2019ve now engaged with more than 50 domain experts, in addition to specialist third parties, across biosecurity, research and industry, to understand the capabilities of successive AlphaFold models and any potential risks."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@falk_hoffmann/promising-alternatives-to-alphafold-3-how-they-work-and-when-to-use-them-ccbcde490b14",
          "description": "As mentioned in my last text, AlphaFold 3 (AF3) sets the new standard for protein-ligand structure prediction. However, AlphaFold 3 has several limitations. Those include: Those limitations show a\u2026",
          "snippets": [
            "Are you curious about what this text holds for you?",
            "Changes include hardware and memory-optimized geometrical attention building blocks for higher inference throughput, an expansion of the training data to protein-nucleic acid complexes and the presence of post-translational modifications (PTM) and cofactors for more applications (see also the comparison to AF3) and better scaling of the model. Based on the reported values in the press release on the PostBusters dataset, it reaches a success rate, measured as correctly predicted protein structure with an RMSD of less than 2 A, of 54.9% and 76.8% if pocket residues are not specified or are specified, respectively. This beats all non-AlphaFold docking methods like Vina, DiffDock and TankBind but is inferior to the new AF3.",
            "Second, if template structures should be used, they are generated with AlphaFold2 or \u2014 if available \u2014 extracted from alternative experimental structures and template features are computed from those structures (Lines 2\u20134).",
            "A significant leap forward occurred in the 2010s through the integration of machine learning and statistical methods. Techniques like Rosetta and the use of co-evolutionary data significantly improved the accuracy of predictions. The introduction of deep learning models, particularly with the release of AlphaFold by DeepMind, marked a revolutionary change."
          ],
          "title": "Alternatives to AlphaFold 3\u2014 how they work and when to use them ...",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/google-deepmind/alphafold3/blob/main/docs/performance.md",
          "description": "AlphaFold 3 inference pipeline. Contribute to google-deepmind/alphafold3 development by creating an account on GitHub.",
          "snippets": [
            "In contrast, this repository supports running AlphaFold 3 on a single NVIDIA A100 with 80 GB of memory in a configuration optimised to maximise throughput. We compare compile-free inference timings of these two setups in the table below using GPU seconds (i.e. multiplying by 16 when using 16 A100s). The setup in this repository is more efficient (by at least 2\u00d7) across all token sizes, indicating its suitability for high-throughput applications.",
            "ENV XLA_PYTHON_CLIENT_PREALLOCATE=false ENV TF_FORCE_UNIFIED_MEMORY=true ENV XLA_CLIENT_MEM_FRACTION=3.2 \u00b7 You may also want to make use of the JAX persistent compilation cache, to avoid unnecessary recompilation of the model between runs. You can enable the compilation cache with the --jax_compilation_cache_dir <YOUR_DIRECTORY> flag in run_alphafold.py.",
            "If you would like to improve performance, it\u2019s recommended to increase the disk speed (e.g. by leveraging a RAM-backed filesystem), or increase the available CPU cores and add more parallelisation. Also note that for sequences with deep MSAs, Jackhmmer or Nhmmer may need a substantial amount of RAM beyond the recommended 64 GB of RAM. Table 8 in the Supplementary Information of the AlphaFold 3 paper provides compile-free inference timings for AlphaFold 3 when configured to run on 16 NVIDIA A100s, with 40 GB of memory per device.",
            "If you would like to run AlphaFold 3 on inputs larger than 5,120 tokens, or on a GPU with less memory (an A100 with 40 GB of memory, for instance), we recommend enabling unified memory. Enabling unified memory allows the program to spill GPU memory to host memory if there isn't enough space."
          ],
          "title": "alphafold3/docs/performance.md at main \u00b7 google-deepmind/alphafold3",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Increased speed"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.blopig.com/blog/2024/08/architectural-highlights-of-alphafold3/",
          "description": "Probably the most exciting architectural development in AlphaFold3 is the completely redesigned Structure Module. The old \u201cInvariant Point Attention\u201d is gone, in favour of a diffusion model wrapped around a Transformer. In some ways, this is a simplification: positions are now only represented as coordinates in R3 and the model, conspicuously, no longer explicitly guarantees SE(3...",
          "snippets": [
            "Probably the most exciting architectural development in AlphaFold3 is the completely redesigned Structure Module. The old \u201cInvariant Point Attention\u201d is gone, in favour of a diffusion model wrapped around a Transformer. In some ways, this is a simplification: positions are now only represented as coordinates in R3 and the model, conspicuously, no longer explicitly guarantees SE(3) equivariance.",
            "In AlphaFold2, the structure module takes great care to ensure that SE(3) (relative distance) is preserved. AlphaFold3 scraps this, instead simply linearly embedding the coordinates and passing them into the token embeddings to be processed like any other token feature.",
            "In this way the model must learn to use positional information which has been subject to arbitrary SE(3) transformations. Just because a model hasn\u2019t been designed to be SE(3) equivariant, doesn\u2019t mean the model hasn\u2019t learned to be SE(3) equivariant. I think the biggest takeaway from AlphaFold3 is that attention is still all you need.",
            "The AlphaFold2 Method Paper: A Fount of Good Ideas \u00ab Some Thoughts on a Mysterious Universe on AlphaFold 2 is here: what\u2019s behind the structure prediction miracle"
          ],
          "title": "Architectural highlights of AlphaFold3 | Oxford Protein Informatics ...",
          "meta": {
            "query": "AlphaFold 3 speed comparison with AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Increased speed"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "The new AlphaFold model demonstrates ... with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4...",
          "snippets": [
            "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9.",
            "Protein monomer LDDT improvement is also significant (paired Wilcoxon signed-rank test, P = 1.7 \u00d7 10\u221234). AF3 has a very similar dependence on MSA depth to AlphaFold-Multimer v.2.3; proteins with shallow MSAs are predicted with lower accuracy (a comparison of the dependence of single-chain LDDT on MSA depth is shown in Extended Data Fig.",
            "N = 427 targets for RoseTTAFold All-Atom and 428 targets for all others in Version 1; 308 targets in Version 2. a, CASP15 RNA prediction accuracy from AIChemy_RNA (the top AI-based submission), RoseTTAFold2NA (the AI-based method capable of predicting proteinRNA complexes), and AlphaFold 3.",
            "Predictions are downloaded from the CASP website for external models. b, Accuracy on structures containing low homology RNA-only or DNA-only complexes from the recent PDB evaluation set. Comparison between AlphaFold 3 and RoseTTAFold2NA (RF2NA) (RNA: N = 29 structures, paired Wilcoxon signed-rank test, p = 1.6 * 10\u22127; DNA: N = 63 structures, paired two-sided Wilcoxon signed-rank test, p = 5.2 * 10\u221212)."
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines .",
            "AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field .",
            "AlphaFold's impact is notable in drug discovery, particularly for viral diseases. The platform has been used to identify potential inhibitors for the non-structural protein 6 (NSP6) of SARS-CoV-2, with candidates recommended for biological testing. This approach not only accelerates the identification of viable drug candidates but also refines the drug development process by focusing on the most promising targets . ... The accuracy of AlphaFold in predicting complex viral protein structures is revolutionary."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.linkedin.com/pulse/hype-around-alphafold-3-results-vs-limitations-andrii-buvailo-ph-d--jqewc",
          "description": "",
          "snippets": [],
          "title": "Hype Around AlphaFold 3: Results vs Limitations",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "At the core of the model is an ... 2\u2019s incredible performance. After processing the inputs, AlphaFold 3 assembles its predictions using a diffusion network, akin to those found in AI image generators. The diffusion process starts with a cloud of atoms, and over many steps converges on its final, most accurate molecular structure. AlphaFold 3\u2019s predictions of molecular interactions surpass the accuracy of all existing ...",
          "snippets": [
            "At the core of the model is an improved version of our Evoformer module \u2014 a deep learning architecture that underpinned AlphaFold 2\u2019s incredible performance. After processing the inputs, AlphaFold 3 assembles its predictions using a diffusion network, akin to those found in AI image generators. The diffusion process starts with a cloud of atoms, and over many steps converges on its final, most accurate molecular structure. AlphaFold 3\u2019s predictions of molecular interactions surpass the accuracy of all existing systems.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery.",
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@falk_hoffmann/alphafold3-and-its-improvements-in-comparison-to-alphafold2-96815ffbb044",
          "description": "AlphaFold uses a neural network approach that directly predicts the 3D coordinates of all non-hydrogen atoms for a given protein using the protein sequence and sequence homology. While immediately being the best prediction method in CASP13, it was still not good enough to call the protein structure prediction task successful. A successful in silico prediction method reaches experimental accuracy...",
          "snippets": [
            "It is interesting to see how open-source models like OpenFold will use those models to improve their accuracy. We can expect several new complex prediction tools soon, most of which will use approaches implemented in AlphaFold3. ... Abramson, J., Adler, J., Dunger, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3.",
            "The number of good predictions, measured by a pocket RMSD of less than 2\u00c5 on high-quality experimental datasets, varies between 40% for RNA-modified residues and nearly 80% for bonded ligands. The limited number of examples in the datasets generates a relatively high statistical error on those values. AlphaFold3 also improves the prediction of protein-protein complexes, with a significant improvement in antibody-protein interfaces compared to AlphaFold-Multimer v2.3.",
            "Algorithm of relative position encoding extracted from the Supporting Information of the AlphaFold3 paper. Steps 1, 2 and 3 identify token pairs i and j from the same chain, with the same residue index and even with the same entity, respectively.",
            "Predicting protein structures is one of the most important challenges in biochemistry. Highly accurate protein structures are essential for drug discovery purposes. Here, you can find more about the\u2026"
          ],
          "title": "AlphaFold3 and its improvements in comparison to AlphaFold2 | by ...",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.ebi.ac.uk/training/online/courses/alphafold/validation-and-impact/how-accurate-are-alphafold-structure-predictions/",
          "description": "Two identical structures would have an RMSD of 0 \u00c5ngstr\u00f6ms (\u00c5). An RMSD bigger than 2-3 \u00c5 suggests that the structures are substantially different. The median RMSD between different experimental structures of the same protein is 0.6 \u00c5, while it is 1 \u00c5 for the AlphaFold models and experimental ...",
          "snippets": [
            "Two identical structures would have an RMSD of 0 \u00c5ngstr\u00f6ms (\u00c5). An RMSD bigger than 2-3 \u00c5 suggests that the structures are substantially different. The median RMSD between different experimental structures of the same protein is 0.6 \u00c5, while it is 1 \u00c5 for the AlphaFold models and experimental structures.",
            "Furthermore, for high-confidence parts of the AlphaFold structure predictions (explained later in \u201cInputs and Outputs\u201d), the median RMSD is 0.6 \u00c5: on par with the experimental structures. However, for low-confidence parts it may go up to 2 \u00c5 and higher.",
            "High-confidence regions of AlphaFold2 structure predictions are usually very close to the experimental structures, and therefore very useful in designing downstream experiments. However, low-confidence regions may deviate substantially.",
            "AlphaFold2 gets the fold and majority of the side chain positions right, but if you are interested in the features that require atomic precision, like understanding the fine details of catalysis, AlphaFold2 may not be able to match such requirements."
          ],
          "title": "How accurate are AlphaFold2 structure predictions? | AlphaFold",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "For years, scientists have been ... improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition. Having gone through multiple major iterations, the most recent release, AlphaFold 3, is set to ...",
          "snippets": [
            "For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition. Having gone through multiple major iterations, the most recent release, AlphaFold 3, is set to further transform the protein space.",
            "These improvements to the model have led the company to claim that AlphaFold 3 has the highest accuracy yet. Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own.",
            "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
            "We\u2019ve all heard about the potential of artificial intelligence in the life sciences field. In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/meet-alphafold-3-which-can-accurately-model-more-than-99-of-molecular-types-in-the-protein-data-bank/",
          "description": "Unlike its predecessor, AlphaFold 2, which relied on an architecture optimized for predicting the structure of individual proteins, AlphaFold 3 (AF3) uses a diffusion model that predicts raw atom coordinates. This shift towards a diffusion-based architecture allows AF3 to model an array of biomolecular interactions, including proteins, nucleic acids, small molecules, ions and modified residues with high accuracy...",
          "snippets": [
            "AlphaFold 3 by DeepMind accurately predicts protein structures and interactions, transforming drug discovery and structural biology.",
            "AlphaFold 3\u2019s remarkable ability to predict the interactions between proteins and small molecules holds immense promise for revolutionizing drug discovery. The paper highlights that \u201cAF3 shows far greater accuracy on protein-ligand interactions than state-of-the-art docking tools,\u201d suggesting that the model can reliably predict the binding sites and optimal shapes for potential drug molecules.",
            "In a press briefing, Demis Hassabis, CEO of DeepMind Technologies, explained the evolution of AlphaFold over the years and the significance of AlphaFold 3: \u201cWith AlphaFold 2, the big milestone moment in structural biology was in essence you can think of it as our solution to the static picture of proteins, going from predicting the amino acid sequence to the 3D structure of the protein,\u201d he said.",
            "AlphaFold 2 has \u201cunlocked all kinds of amazing research,\u201d Hassabis said. \u201cIt has been cited over 20,000 times now and is being used by thousands of researchers around the world. AlphaFold 3 represents the \u201cnext step\u201d toward using AI to understand and model biology."
          ],
          "title": "AlphaFold 3 offers even more accurate protein structure prediction",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy ...",
          "snippets": [
            "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
            "Measured by the root-mean-square deviation (RMS-D) of the placement of the alpha-carbon atoms of the protein backbone chain, which tends to be dominated by the performance of the worst-fitted outliers, 88% of AlphaFold 2's predictions had an RMS deviation of less than 4 \u00c5 for the set of overlapped C-alpha atoms. 76% of predictions achieved better than 3 \u00c5, and 46% had a C-alpha atom RMS accuracy better than 2 \u00c5, with a median RMS deviation in its predictions of 2.1 \u00c5 for a set of overlapped CA atoms.",
            "AlphaFold 2's results at CASP14 were described as \"astounding\" and \"transformational\". However, some researchers noted that the accuracy was insufficient for a third of its predictions, and that it did not reveal the underlying mechanism or rules of protein folding for the protein folding problem remains unsolved.",
            "Overall, AlphaFold 2 made the best prediction for 88 out of the 97 targets. On the competition's preferred global distance test (GDT) measure of accuracy, the program achieved a median score of 92.4 (out of 100), meaning that more than half of its predictions were scored at better than 92.4% for having their atoms in more-or-less the right place, a level of accuracy reported to be comparable to experimental techniques like X-ray crystallography.",
            "In 2018 AlphaFold 1 had only reached this level of accuracy in two of all of its predictions. 88% of predictions in the 2020 competition had a GDT_TS score of more than 80. On the group of targets classed as the most difficult, AlphaFold 2 achieved a median score of 87."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far surpass its predecessor, AlphaFold 2 (AF2).",
          "snippets": [
            "Handling of Arbitrary Chemical Components: AlphaFold 3 eliminates the need for specific handling of stereochemistry and bonding patterns, which was a limitation in AlphaFold 2. This makes it versatile in dealing with various types of biomolecular interactions. Predictive Accuracy: There\u2019s a significant leap in the accuracy of predicting complex biomolecular structures.",
            "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "Accuracy and Performance: AlphaFold 3 exhibits enhanced accuracy in predicting protein-ligand interactions, protein-nucleic acid interactions, and antibody-antigen interactions."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "AlphaFold 3 accuracy vs AlphaFold 2",
            "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The commercialization of AlphaFold 3, while representing a groundbreaking advancement in molecular biology, raises several key ethical considerations that must be carefully addressed to ensure its responsible and equitable use. Below, I\u2019ll walk you through some of the major points, based on the gathered information.\n\n### 1. **Access and Inclusivity**  \nOne of the primary concerns revolves around access to AlphaFold 3. Unlike its predecessor, AlphaFold 2, the full code for AlphaFold 3 is not publicly available. Access is limited to the AlphaFold Server, which is restricted to non-commercial use and imposes limits on the types of molecules that can be studied[22]. This creates a disparity in access between academic researchers and commercial entities, potentially widening the gap in who benefits from this revolutionary technology. Ensuring fairness and inclusivity in who gets to use AlphaFold 3\u2014especially for scientists in resource-limited settings\u2014is critical[28].\n\n### 2. **Bias in Data and Predictions**  \nAlphaFold 3 relies on large datasets for training, but as with any AI system, the quality of its predictions depends heavily on the quality of the data. If the training datasets are biased or incomplete, the system could produce skewed or less accurate predictions for certain types of proteins or molecular interactions[28]. This issue underscores the importance of rigorous scrutiny of the data used to train AlphaFold 3, to prevent unintended biases that could disproportionately impact certain fields or communities.\n\n### 3. **Commercialization and Ethical Use**  \nThe use of AlphaFold 3 in commercial applications such as drug discovery and protein design introduces both opportunities and risks[24]. While the technology has the potential to accelerate innovation in pharmaceuticals, its commercialization could lead to monopolization by large corporations, making life-saving drugs or therapies prohibitively expensive for many[26]. Companies adopting this technology must balance profit motives with ethical obligations to ensure the fruits of these advancements are broadly accessible.\n\n### 4. **Biosecurity Concerns**  \nAnother important ethical dimension is biosecurity. Advanced AI models like AlphaFold 3 can predict molecular structures with incredible accuracy[29][30], raising concerns about the potential misuse of the technology. For instance, it could theoretically be exploited to design harmful biological agents. DeepMind and Isomorphic Labs have consulted extensively with experts in biosecurity, bioethics, and AI safety to assess these risks. According to John Jumper, the marginal biosecurity risks were deemed far outweighed by the immense scientific benefits AlphaFold 3 offers[27]. However, vigilance in monitoring its applications remains essential.\n\n### 5. **Transparency and Reproducibility**  \nThe decision not to release the full code for AlphaFold 3 also raises ethical questions about transparency in scientific research. Nature\u2019s editor-in-chief, Magdalena Skipper, has highlighted the importance of balancing open science with biosecurity concerns. Alternatives like pseudocode have been suggested to support reproducibility without compromising safety[27]. Nevertheless, striking this balance is challenging and has significant implications for the scientific community.\n\n### 6. **Regulation and Guidance**  \nWith the immense power of AlphaFold 3 comes a responsibility to ensure it is used ethically and for the greater good. Strong regulatory frameworks and guidance will be required to prevent misuse and to ensure the technology\u2019s benefits are distributed equitably[25]. Governments, academic institutions, and private companies will need to collaborate to establish policies that promote responsible innovation while safeguarding against unintended consequences.\n\n### Final Thoughts  \nAlphaFold 3 is undeniably transformative, pushing the boundaries of molecular biology and offering solutions to age-old scientific challenges like the protein-folding problem[23]. However, its commercialization and the sharing of its data must be approached thoughtfully. Issues of access, inclusivity, bias, biosecurity, transparency, and regulation are central to ensuring that this powerful tool is used ethically and responsibly. While DeepMind and its collaborators have taken steps to address some of these concerns, ongoing efforts will be needed to navigate the complex ethical landscape surrounding AlphaFold 3.",
      "raw_utterance": "The commercialization of AlphaFold 3, while representing a groundbreaking advancement in molecular biology, raises several key ethical considerations that must be carefully addressed to ensure its responsible and equitable use. Below, I\u2019ll walk you through some of the major points, based on the gathered information.\n\n### 1. **Access and Inclusivity**  \nOne of the primary concerns revolves around access to AlphaFold 3. Unlike its predecessor, AlphaFold 2, the full code for AlphaFold 3 is not publicly available. Access is limited to the AlphaFold Server, which is restricted to non-commercial use and imposes limits on the types of molecules that can be studied[22]. This creates a disparity in access between academic researchers and commercial entities, potentially widening the gap in who benefits from this revolutionary technology. Ensuring fairness and inclusivity in who gets to use AlphaFold 3\u2014especially for scientists in resource-limited settings\u2014is critical[28].\n\n### 2. **Bias in Data and Predictions**  \nAlphaFold 3 relies on large datasets for training, but as with any AI system, the quality of its predictions depends heavily on the quality of the data. If the training datasets are biased or incomplete, the system could produce skewed or less accurate predictions for certain types of proteins or molecular interactions[28]. This issue underscores the importance of rigorous scrutiny of the data used to train AlphaFold 3, to prevent unintended biases that could disproportionately impact certain fields or communities.\n\n### 3. **Commercialization and Ethical Use**  \nThe use of AlphaFold 3 in commercial applications such as drug discovery and protein design introduces both opportunities and risks[24]. While the technology has the potential to accelerate innovation in pharmaceuticals, its commercialization could lead to monopolization by large corporations, making life-saving drugs or therapies prohibitively expensive for many[26]. Companies adopting this technology must balance profit motives with ethical obligations to ensure the fruits of these advancements are broadly accessible.\n\n### 4. **Biosecurity Concerns**  \nAnother important ethical dimension is biosecurity. Advanced AI models like AlphaFold 3 can predict molecular structures with incredible accuracy[29][30], raising concerns about the potential misuse of the technology. For instance, it could theoretically be exploited to design harmful biological agents. DeepMind and Isomorphic Labs have consulted extensively with experts in biosecurity, bioethics, and AI safety to assess these risks. According to John Jumper, the marginal biosecurity risks were deemed far outweighed by the immense scientific benefits AlphaFold 3 offers[27]. However, vigilance in monitoring its applications remains essential.\n\n### 5. **Transparency and Reproducibility**  \nThe decision not to release the full code for AlphaFold 3 also raises ethical questions about transparency in scientific research. Nature\u2019s editor-in-chief, Magdalena Skipper, has highlighted the importance of balancing open science with biosecurity concerns. Alternatives like pseudocode have been suggested to support reproducibility without compromising safety[27]. Nevertheless, striking this balance is challenging and has significant implications for the scientific community.\n\n### 6. **Regulation and Guidance**  \nWith the immense power of AlphaFold 3 comes a responsibility to ensure it is used ethically and for the greater good. Strong regulatory frameworks and guidance will be required to prevent misuse and to ensure the technology\u2019s benefits are distributed equitably[25]. Governments, academic institutions, and private companies will need to collaborate to establish policies that promote responsible innovation while safeguarding against unintended consequences.\n\n### Final Thoughts  \nAlphaFold 3 is undeniably transformative, pushing the boundaries of molecular biology and offering solutions to age-old scientific challenges like the protein-folding problem[23]. However, its commercialization and the sharing of its data must be approached thoughtfully. Issues of access, inclusivity, bias, biosecurity, transparency, and regulation are central to ensuring that this powerful tool is used ethically and responsibly. While DeepMind and its collaborators have taken steps to address some of these concerns, ongoing efforts will be needed to navigate the complex ethical landscape surrounding AlphaFold 3.",
      "role": "Bioethicist",
      "role_description": " This expert specializes in the ethical implications of new technologies in the field of biology and medicine. They will bring a critical perspective to the discussion, addressing concerns around the commercialization of AlphaFold 3, data sharing practices, and the broader ethical considerations of using AI in biomolecular structure prediction.",
      "queries": [
        "AlphaFold 3 ethical considerations",
        "commercialization challenges of AlphaFold technology"
      ],
      "utterance_type": "Support",
      "claim_to_make": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Efforts to add more training data ... posing a challenge in relying solely on AI predictions without further empirical verification [1]. ... Unlike its predecessor, AlphaFold 2, the full code of AlphaFold 3 is not publicly available. Access is provided through the AlphaFold Server, which is limited to non-commercial use and restricts ...",
          "snippets": [
            "Efforts to add more training data have been made, yet this issue has not been fully resolved, posing a challenge in relying solely on AI predictions without further empirical verification . ... Unlike its predecessor, AlphaFold 2, the full code of AlphaFold 3 is not publicly available. Access is provided through the AlphaFold Server, which is limited to non-commercial use and restricts the types of molecules that can be studied.",
            "The decision to restrict access to AlphaFold 3's full capabilities could potentially stifle innovation and broader application within the scientific community. Limiting the model's use to non-commercial purposes and controlling the types of molecules that can be studied may slow down the pace of discovery and application, especially in environments where commercial use could accelerate advancements . Challenges in Translating Predictions to Clinical Success",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines . This review, by exploring advancements in machine learning and deep learning technologies such as the the innovative use of AI by Bileschi and Colwell  to harness molecular structure predictions and the Gemini model (Google DeepMind Technologies Limited) , will attempt to reveal how AlphaFold 3 sets new benchmarks in the accurate modeling of protein structures and their complexes with ligands."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/discover/blog/alphafold-a-solution-to-a-50-year-old-grand-challenge-in-biology/",
          "description": "Proteins are essential to life, supporting practically all its functions. They are large complex molecules, made up of chains of amino acids, and what a protein does largely depends on its unique...",
          "snippets": [
            "Figuring out what shapes proteins fold into is known as the \u201cprotein folding problem\u201d, and has stood as a grand challenge in biology for the past 50 years. In a major scientific advance, the latest version of our AI system AlphaFold has been recognised as a solution to this grand challenge by the organisers of the biennial Critical Assessment of protein Structure Prediction (CASP).",
            "In the results from the 14th CASP assessment, released today, our latest AlphaFold system achieves a median score of 92.4 GDT overall across all targets. This means that our predictions have an average error (RMSD) of approximately 1.6 Angstroms, which is comparable to the width of an atom (or 0.1 of a nanometer). Even for the very hardest protein targets, those in the most challenging free-modelling category, AlphaFold achieves a median score of 87.0 GDT (data available here).",
            "AlphaFold predicts highly accurate structures measured against experimental result. These exciting results open up the potential for biologists to use computational structure prediction as a core tool in scientific research. Our methods may prove especially helpful for important classes of proteins, such as membrane proteins, that are very difficult to crystallise and therefore challenging to experimentally determine.",
            "This computational work represents a stunning advance on the protein-folding problem, a 50-year-old grand challenge in biology. It has occurred decades before many people in the field would have predicted. It will be exciting to see the many ways in which it will fundamentally change biological research. Professor Venki Ramakrishnan, Nobel Laureate and President of The Royal Society \u00b7 We first entered CASP13 in 2018 with our initial version of AlphaFold, which achieved the highest accuracy among participants."
          ],
          "title": "AlphaFold: a solution to a 50-year-old grand challenge in biology ...",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.forbes.com/sites/robtoews/2021/10/03/alphafold-is-the-most-important-achievement-in-ai-ever/",
          "description": "Machine learning will transform the life sciences in the years ahead.",
          "snippets": [
            "The Boulder team had spent years unsuccessfully trying to determine this protein\u2019s structure; with AlphaFold, they learned it in 15 minutes. When it comes to commercial opportunity and startup activity, there are two applications in particular for which AlphaFold attracts a lot of attention: drug discovery and protein design.",
            "Finding a solution to this puzzle, known as the \u201cprotein folding problem,\u201d has stood as a grand challenge in the field of biology for half a century. It has stumped generations of scientists. One commentator in 2007 described it as \u201cone of the most important yet unsolved issues of modern science.\u201d ... AI just solved it. (While use of the word \u201csolved\u201d has generated some disagreement in the community, sometimes devolving into semantics, most experts closest to the topic agree that AlphaFold can indeed be considered a solution to the protein folding problem.)",
            "And because (like any AI system) AlphaFold has learned to make predictions based on its training data, it may struggle to accurately predict the shapes of unusual new proteins, including de novo protein designs not found in nature. Yet there is a broader point to keep in mind here: when the challenges that today remain beyond AlphaFold\u2019s grasp get solved, those solutions will themselves almost certainly be powered by deep learning.",
            "At the same time, AlphaFold is no silver bullet for real-world challenges like drug discovery."
          ],
          "title": "AlphaFold Is The Most Important Achievement In AI\u2014Ever",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sterlitech.com/blog/post/alphafold-ai-system-can-change-the-world",
          "description": "While 2020 was a difficult time across many metrics, it was an exciting year for protein science!",
          "snippets": [
            "But with great power comes great responsibility, and strong guidance will be needed to ensure that the advantages of this powerful new technology are not overshadowed by the costs. The next and final installment of our three-part series will follow the story of Team AlphaFold as they eagerly joined the fight against COVID-19. ... AlphaFold Team. (2020). AlphaFold: a solution to a 50-year-old grand challenge in biology.",
            "In the near future, AlphaFold can also be used to improve environmental sustainability and address the challenges of climate change. For example, finding new proteins that can degrade plastic or capture carbon may help to lessen the effects of industrial pollution and global warming (1).",
            "AlphaFold gained international acclaim for advancing protein structure prediction after blowing the competition out of the water at CASP in both the 2018 and 2020 competitions (1). The AlphaFold system uses AI to decipher an unknown protein structure by predicting the distance and bond angle between pairs of amino acids. Now that the technology exists, leaders in research and industry are brainstorming new ways to use protein structure prediction.",
            "Protein structure prediction could also be of great economic value for designing genetically modified crops that are drought and pest resistant, new synthetic materials, cosmetics, and natural products. DeepMind\u2019s commitment to keeping AlphaFold code open source means that more people will have access to use the technology in new and innovative ways."
          ],
          "title": "AlphaFold AI System can Change the World",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.reddit.com/r/Biochemistry/comments/1gui8n8/what_can_alphafold_teach_us_about_the_impact_of/",
          "description": "Alpha-fold has had a tremendous impact on the field of protein-structure prediction. Previously, problems that took years and hundreds of thousands\u2026",
          "snippets": [
            "Posted by u/North_Atmosphere1566 - 9 votes and 15 comments",
            "I don\u2019t think it\u2019s really worthwhile to call this \u2018AI\u2019. Right now, AI refers to large language models which are extremely wasteful and bad, whereas alphafold, despite its many flaws, is actually a sensible use of the neural network technology",
            "Alphafold has been incapable of accurately predicting the majority of structures I have been working on, and in fact has been incapable of predicting the structures and complexes I have deposited in the PDB (on which I assumed it trained).",
            "Alphafold is revolutionary, in that I believe in many scenarios will remove the need for structure determination using standard methods, at least in scenarios where testing the proposed answers that are created by using AF are more effective than obtaining a structure de novo."
          ],
          "title": "r/Biochemistry on Reddit: What can Alpha-fold teach us about the ...",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds. Credits: Image: MIT News, with images from iStockphoto \u00b7 Images for download on the MIT News office website are made available to non-commercial entities, press and the general public under a Creative Commons Attribution Non-Commercial No Derivatives license.",
            "AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "A new study from MIT reveals the potential and limitations of one such computational approach. Using protein structures generated by an artificial intelligence program called AlphaFold, the researchers explored whether existing models could accurately predict the interactions between bacterial proteins and antibacterial compounds.",
            "In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company ...",
          "snippets": [
            "Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed.",
            "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "Google DeepMind has debuted AlphaFold Server, an easy-to-use platform available for non-commercial research use, that enables users to quickly model structures composed of proteins, DNA, RNA and a selection of ligands, ions and chemical modifications"
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2022.875587/full",
          "description": "This paper presents a short summary of the protein folding problem, what it is and why it is significant. Introduces the CASP competition and how accuracy is...",
          "snippets": [
            "This paper presents a short summary of the protein folding problem, what it is and why it is significant. Introduces the CASP competition and how accuracy is measured. Looks at different approaches for solving the problem followed by a review of the current breakthroughs in the field introduced by AlphaFold 1 and AlphaFold 2.",
            "AlphaFold 2 illustrates the power of focusing the learning process by restricting the search space and embedding knowledge in the model. \u015e-BM wrote the manuscript with support from ST supervisor and MT co-supervisor. All authors contributed to the article and approved the submitted version. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",
            "AlphaFold2 prediction have been validated against the structure of ORF3a where the results have ended up being similar to structures later determined experimentally despite their challenging nature and having very few related sequences (Flower and Hurley, 2021).",
            "Initially used as components in a workflow, to predict 1D features such as backbone torsion angles or secondary structure (Kuhlman and Bradley, 2019), they have recently seen a boom in the field with end-to-end approaches (Surbhi et al., 2020). Works like End-to-End Differentiable Learning of Protein Structure by Mohammed AlQuraishi (AlQuraishi, 2019b) and later the AlphaFold architectures created by DeepMind (Senior et al., 2020) showing the true predicting power of machine learning."
          ],
          "title": "Frontiers | An Overview of Alphafold's Breakthrough",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://directorsblog.nih.gov/tag/alphafold/",
          "description": "These findings come from the lab ... of Technology (MIT), Cambridge, and his recently launched Antibiotics-AI Project. His audacious goal is to develop seven new classes of antibiotics to treat seven of the world\u2019s deadliest bacterial pathogens in just seven years. What makes this project so bold is that only two new classes of antibiotics have reached the market in the last 50 years! In the latest study, Collins and his team looked to an AI program called AlphaFold2 [3]. The name ...",
          "snippets": [
            "These findings come from the lab of James Collins, Massachusetts Institute of Technology (MIT), Cambridge, and his recently launched Antibiotics-AI Project. His audacious goal is to develop seven new classes of antibiotics to treat seven of the world\u2019s deadliest bacterial pathogens in just seven years. What makes this project so bold is that only two new classes of antibiotics have reached the market in the last 50 years! In the latest study, Collins and his team looked to an AI program called AlphaFold2 . The name might ring a bell.",
            "AlphaFold employs a deep learning approach that can predict most protein structures from their amino acid sequences about as well as more costly and time-consuming protein-mapping techniques. In the deep learning models used to predict protein structure, computers are \u201ctrained\u201d on existing data.",
            "Collins and his team hoped to combine AlphaFold with computer simulations commonly used in drug discovery as a way to predict interactions between essential bacterial proteins and antibacterial compounds. If it worked, researchers could then conduct virtual rapid screens of millions of new synthetic drug compounds targeting key bacterial proteins that existing antibiotics don\u2019t.",
            "Tags: AI, AlphaFold, antibiotic resistance, antibiotics, Antibiotics-AI Project, artificial intelligence, bacteria, bacterial infections, Breakthrough of the Year, computer simulation, deep learning, drug discovery, E."
          ],
          "title": "AlphaFold \u2013 NIH Director's Blog",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://singularityhub.com/2020/12/15/deepminds-alphafold-is-close-to-solving-one-of-biologys-greatest-challenges/",
          "description": "If we know a protein\u2019s structure, we can make educated guesses about its function. And by mapping thousands of protein structures, we can begin to decipher the biology of life.",
          "snippets": [
            "DeepMind isn\u2019t a newcomer to the challenge; back in 2018, its performance shocked many academic scientists who had long worked in the field. Sign up to receive top stories about groundbreaking technologies and visionary thinkers from SingularityHub. ... AlphaFold\u2019s strategy is similar to most entries in CASP this year, in that it relies on deep learning.",
            "DeepMind may just have cracked one of the grandest challenges in biology. One that rivals the discovery of DNA\u2019s double helix. It could change biomedicine, drug discovery, and vaccine development forever. The actual achievement sounds far less sexy at first glance. One of DeepMind\u2019s powerful AI algorithms, called AlphaFold, used its deep learning prowess to predict a protein\u2019s three-dimensional (3D) shape, down to the width of an atom.",
            "It\u2019s a challenge that\u2019s mystified biologists for 50 years and counting\u2014so much so that computer-based protein structure prediction has been made into crowd-sourcing games, global competitions, and a Nobel Prize in search of a breakthrough. We\u2019re at that inflection point. AlphaFold triumphed over roughly 100 other teams in a long-running challenge called Critical Assessment of Structure Prediction, or CASP, with a knockout, jaw-dropping performance.",
            "Having an AI-based method to decode protein structure could rapidly screen for tens of thousands of new drug targets. \u201cAlphaFold will open up a new area of research,\u201d said Dame Janet Thornton at the European Bioinformatics Institute in the UK to MIT Technology Review."
          ],
          "title": "DeepMind's AlphaFold Is Close to Solving One of Biology\u2019s Greatest ...",
          "meta": {
            "query": "commercialization challenges of AlphaFold technology",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations.",
          "snippets": [
            "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
            "While AlphaFold 3 offers immense benefits, its power requires careful consideration of some ethical issues:",
            "AlphaFold 3 is a giant leap forward in understanding the building blocks of life. Developed by DeepMind (a subsidiary of Alphabet), it\u2019s an AI model that can predict the 3D structures of various molecules, not just proteins, like its predecessor, AlphaFold 2.",
            "Deep Learning (The Secret Weapon): Deep learning is a special type of AI technique that allows AlphaFold 3 to learn independently. Think of it like giving the student tons of practice problems to solve. By analyzing vast amounts of data on known protein structures, AlphaFold 3 can identify hidden rules and relationships."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.scientificamerican.com/article/one-of-the-biggest-problems-in-biology-has-finally-been-solved/",
          "description": "If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. Scientific American spoke with Hassabis about developing AlphaFold, some of its most exciting potential applications and the ethical ...",
          "snippets": [
            "If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. Scientific American spoke with Hassabis about developing AlphaFold, some of its most exciting potential applications and the ethical considerations of highly sophisticated AI.",
            "Google DeepMind CEO Demis Hassabis explains how its AlphaFold AI program predicted the 3-D structure of every known protein",
            "AlphaFold, obviously, is huge in the scientific community. But with language and image AIs, it\u2019s starting to break through into the mainstream. Everyone, of course, knows about language and can appreciate images\u2014you don\u2019t have to have any scientific expertise. But I think we should always be thinking about the ethical issues, and that\u2019s one reason we haven\u2019t released our language-based AI yet.",
            "But last year an artificial-intelligence program called AlphaFold, developed by the Alphabet-owned company DeepMind, predicted the 3-D structures of almost every known protein\u2014about 200 million in all."
          ],
          "title": "One of the Biggest Problems in Biology Has Finally Been Solved ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
          "snippets": [
            "Nature\u2019s editor-in-chief, Magdalena Skipper, PhD stated that when making a decision on data and code availability, the journal reflects on several factors including \u201cthe potential implications for biosecurity and the ethical challenges this presents.\u201d In such cases, the journal works with authors to provide alternatives that will support reproducibility, such as pseudocode. However, John Jumper, PhD, one of the senior authors of the AlphaFold 3 article and lead author on AlphaFold 2, reportedly told the press that DeepMind and Isomorphic Labs had consulted more than 50 experts in biosecurity, bioethics, and AI safety and concluded that AlphaFold 3\u2019s marginal biosecurity risks were far outweighed by the system\u2019s potential benefits to science.",
            "Google DeepMind\u2019s renowned protein structure prediction algorithm, AlphaFold, which made a grand leap in solving one of biology\u2019s biggest problems, determining a protein\u2019s 3D structure from its sequence, has received a major update.",
            "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more.",
            "The publication, which is a collaboration between DeepMind and Isomorphic Labs, a London-based company launched in 2021 to build upon DeepMind\u2019s AI research to tackle biological problems, emphasizes AlphaFold 3\u2019s potential to advance therapeutic applications, including drug discovery."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@karena.law/alphafold-3-transforming-the-biological-world-and-drug-discovery-0ef7f4e5643d",
          "description": "Ethical Considerations While the benefits of AlphaFold 3 are undeniable, it is important to address the ethical considerations associated with its use. Bias in AI models can result from biased data sets, leading to skewed predictions. Ensuring fairness and inclusivity in the data used to train ...",
          "snippets": [
            "Ethical Considerations While the benefits of AlphaFold 3 are undeniable, it is important to address the ethical considerations associated with its use. Bias in AI models can result from biased data sets, leading to skewed predictions. Ensuring fairness and inclusivity in the data used to train AlphaFold 3 is paramount.",
            "Key Takeaway AlphaFold 3, the AI model developed by DeepMind, represents a monumental milestone in our quest to understand the building blocks of life. Its ability to predict the 3D structures of molecules, coupled with its potential to fast-track drug discovery and revolutionize various fields, holds immense promise. However, responsible use, ethical considerations, and equitable access are essential to ensure that the transformative power of AlphaFold 3 benefits humanity as a whole.",
            "In a groundbreaking development that has sent shockwaves through the scientific community, AlphaFold 3, the latest AI model developed by DeepMind, has emerged as a game-changer in our understanding\u2026",
            "In a groundbreaking development that has sent shockwaves through the scientific community, AlphaFold 3, the latest AI model developed by\u2026"
          ],
          "title": "AlphaFold 3: Transforming the Biological World and Drug Discovery ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.unite.ai/what-is-alphafold-3-the-ai-model-poised-to-transform-biology/",
          "description": "AlphaFold 3 is an AI model developed through a collaboration between Google DeepMind and Isomorphic Labs. This groundbreaking technology, which has garnered a lot of attention over the past couple of days as deserved, has achieved an unprecedented capability \u2013 accurately predicting the structure ...",
          "snippets": [
            "AlphaFold 3 is an AI model developed through a collaboration between Google DeepMind and Isomorphic Labs. This groundbreaking technology, which has garnered a lot of attention over the past couple of days as deserved, has achieved an unprecedented capability \u2013 accurately predicting the structure and interactions of all life's molecules.",
            "At its core, AlphaFold 3 possesses the remarkable ability to model the complex structures of large biomolecules that form the fundamental building blocks of life. With unparalleled precision, it can map the three-dimensional structures of proteins, DNA, RNA, and small molecules known as ligands.",
            "Furthermore, AlphaFold 3 demonstrates a unique capability to predict chemical modifications that play a critical role in regulating cellular functions. These modifications, which can have significant implications for health and disease when disrupted, can now be studied with remarkable accuracy.",
            "One of the most significant achievements of AlphaFold 3 lies in its unparalleled accuracy in predicting molecular interactions. This model surpasses the capabilities of existing systems, demonstrating at least a 50% improvement in predicting the interactions of proteins with other molecule types."
          ],
          "title": "What is AlphaFold 3? The AI Model Poised to Transform Biology - ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
          "snippets": [
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "Toxicity and Side Effects: Predicting adverse reactions and interactions with other drugs involves different types of models and experimental validations that consider the drug\u2019s behavior in complex biological systems. While AlphaFold 3 (AF3) brings unprecedented precision to protein structure prediction, its utility in drug discovery is largely confined to the post-translational landscape.",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far surpass its predecessor, AlphaFold 2 (AF2).",
            "I also talk about the significant limitations of AlphaFold 3 and how companies such as Cognit.AI which is working on simulation of gene regulatory network in a human cell, in-silico can complement in application areas like drug discovery for complex diseases."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool.",
            "To build on AlphaFold 3\u2019s potential for drug design, we at Isomorphic Labs are already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients.",
            "Our new model builds on the foundations of AlphaFold 2, which in 2020 made a fundamental breakthrough in protein structure prediction. So far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
            "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/discover/blog/how-our-principles-helped-define-alphafolds-release/",
          "description": "Our Operating Principles have come to define both our commitment to prioritising widespread benefit, as well as the areas of research and applications we refuse to pursue. These principles have...",
          "snippets": [
            "Building 3D visualisations into the database, with prominent labelling for high-confidence and low-confidence areas of the prediction, and, in general, aiming to be as clear as possible about AlphaFold\u2019s strengths and limitations in our documentation. We also designed the database to be as accessible as possible, for example, considering the needs of people with colour vision deficiency.",
            "While AlphaFold was more complex than most DeepMind research projects, we\u2019re using elements of what we\u2019ve learned and incorporating this into other releases. ... Increasing the range of input from external experts at every stage of the process, and exploring mechanisms for participatory ethics at greater scale.",
            "As we prepared for the CASP assessment in 2020, we realised that AlphaFold showed great potential for solving the challenge at hand. We spent considerable time and effort analysing the practical implications, questioning: How could AlphaFold accelerate biological research and applications?",
            "By signalling which of AlphaFold\u2019s predictions are likely to be accurate, users can estimate when they can trust a prediction and use it in their work \u2013 and when they should use alternative approaches in their research. We had initially considered omitting predictions for which AlphaFold had low confidence or high predictive uncertainty, but the external experts we consulted proved why this was especially important to retain these predictions in our release, and advised us on the most useful and transparent ways to present this information."
          ],
          "title": "How our principles helped define AlphaFold\u2019s release - Google ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "\u201cYou might be running through 100,000 possible variants of a solution. And that means you have to generate those 100,000 variants in the first place,\u201d he added. \u201cYou have to store them, run each one through AlphaFold, get a result, store the result.\u201d \u00b7 Another consideration for successful AI projects is talent.",
            "Last week, Google DeepMind launched AlphaFold 3, a significant update to its predecessor, AlphaFold 2. The latter has profoundly influenced structural biology and biomedicine in recent years while also attracting some skepticism. While AlphaFold 2 could accurately predict the structures of vast swathes of proteins, AlphaFold 3 ups the ante.",
            "A Nature paper, published early as it undergoes further editing, explains that AlphaFold 3 boasts a 58% success rate on ligand binding prediction, compared to 24% for AutoDock Vina, an open-source molecular docking program. AlphaFold also outperformed RoseTTAFold2NA, a machine learning-based tool for predicting 3D structures of protein-RNA and protein-DNA complexes.",
            "AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods. \u201cPrior to AlphaFold, what you had to do to try out a new drug is you came up with an idea yourself as a human being,\u201d Bangert said."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://libraetd.lib.virginia.edu/public_view/d791sh20h",
          "description": "The literature review serves as ... for 3D visualization of CPIs based on the successes of Alpha Fold. One source of information for genetic databases handled in pharmaceutical research and development lends itself to the sale of data by direct-to-consumer genetic testing companies to pharmaceutical companies. Three major ethical concerns arise ...",
          "snippets": [
            "The literature review serves as a starting point towards the end of creating an effective predictive model for 3D visualization of CPIs based on the successes of Alpha Fold. One source of information for genetic databases handled in pharmaceutical research and development lends itself to the sale of data by direct-to-consumer genetic testing companies to pharmaceutical companies. Three major ethical concerns arise from these alliances: (1) whether informed consent for research conducted on DNA is obtained by agreements signed in the initial collection of data, (2) whether consumers have sufficient knowledge of the implications of the storage and sale of their DNA, and (3) whether therapies derived from the DNA of an individual are eligible for patenting."
          ],
          "title": "Understanding AlphaFold and Its Implications for a Deep Learning ...",
          "meta": {
            "query": "AlphaFold 3 ethical considerations",
            "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The introduction of AlphaFold 3 has significantly accelerated the speed and efficiency of drug discovery in the pharmaceutical industry, marking a transformative shift in how researchers approach this complex and time-intensive process. Traditional drug development often involves years of trial and error in laboratories, with high costs and low probabilities of success. AlphaFold 3, however, offers a computational approach that has proven to be not only faster but also more cost-effective than traditional medicinal chemistry methods[32][42].\n\nOne of AlphaFold 3\u2019s most notable contributions is its ability to predict how proteins interact with other molecules, including DNA, RNA, and small molecule ligands. This capability goes beyond simply modeling protein structures, providing insights into the molecular interactions that are foundational to drug design[38][40]. These predictions also extend to understanding chemical modifications and post-translational changes, which play critical roles in cellular functions and disease mechanisms[38][40]. Such an advanced level of structural and functional modeling helps scientists tackle targets that were previously considered difficult or even intractable[38].\n\nThe collaborative efforts between Isomorphic Labs and pharmaceutical companies are a testament to AlphaFold 3\u2019s practical impact. By working on real-world drug design challenges, the tool is being used to identify novel therapeutic approaches and develop treatments for complex diseases. This collaboration demonstrates how AlphaFold 3 is bridging the gap between academic research and industrial application, ultimately benefiting patients by accelerating the development of life-changing treatments[31][35][36].\n\nAdditionally, the AlphaFold Server, which provides free access to most of the tool's capabilities, empowers researchers worldwide to address a wide range of biological questions, further boosting the pace of scientific discovery. For example, AlphaFold 2, its predecessor, had already been used to make breakthroughs in areas like malaria vaccine development, cancer treatment design, and enzyme engineering. AlphaFold 3 builds on this legacy with broader and more accurate capabilities, significantly expanding its utility in drug discovery[33][39].\n\nMoreover, AlphaFold 3\u2019s ability to provide confidence scores for its predictions ensures that researchers can make informed decisions about the reliability of the generated models. This added layer of precision reduces the risks associated with traditional experimental approaches, allowing scientists to focus their efforts more strategically[37].\n\nPerhaps most importantly, the cost-effectiveness of AlphaFold 3 is a game-changer for the industry. Drug development is often described as a high-stakes gamble, requiring significant financial investment with no guarantee of success. AlphaFold 3 offers a way to dramatically reduce these costs while increasing the likelihood of identifying viable drug candidates. This shift has been described as \"game-changing\" and could fundamentally reshape the economics of pharmaceutical research and development[32][42].\n\nIn summary, AlphaFold 3 has transformed the speed and efficiency of drug discovery by providing unprecedented insights into protein interactions, enabling collaborations between academia and industry, and drastically reducing costs. While access to its full capabilities is somewhat restricted for commercial use, its overall impact on the field has been profound, offering hope for faster and more effective therapeutic development[34][36][41].",
      "raw_utterance": "The introduction of AlphaFold 3 has significantly accelerated the speed and efficiency of drug discovery in the pharmaceutical industry, marking a transformative shift in how researchers approach this complex and time-intensive process. Traditional drug development often involves years of trial and error in laboratories, with high costs and low probabilities of success. AlphaFold 3, however, offers a computational approach that has proven to be not only faster but also more cost-effective than traditional medicinal chemistry methods[32][42].\n\nOne of AlphaFold 3\u2019s most notable contributions is its ability to predict how proteins interact with other molecules, including DNA, RNA, and small molecule ligands. This capability goes beyond simply modeling protein structures, providing insights into the molecular interactions that are foundational to drug design[38][40]. These predictions also extend to understanding chemical modifications and post-translational changes, which play critical roles in cellular functions and disease mechanisms[38][40]. Such an advanced level of structural and functional modeling helps scientists tackle targets that were previously considered difficult or even intractable[38].\n\nThe collaborative efforts between Isomorphic Labs and pharmaceutical companies are a testament to AlphaFold 3\u2019s practical impact. By working on real-world drug design challenges, the tool is being used to identify novel therapeutic approaches and develop treatments for complex diseases. This collaboration demonstrates how AlphaFold 3 is bridging the gap between academic research and industrial application, ultimately benefiting patients by accelerating the development of life-changing treatments[31][35][36].\n\nAdditionally, the AlphaFold Server, which provides free access to most of the tool's capabilities, empowers researchers worldwide to address a wide range of biological questions, further boosting the pace of scientific discovery. For example, AlphaFold 2, its predecessor, had already been used to make breakthroughs in areas like malaria vaccine development, cancer treatment design, and enzyme engineering. AlphaFold 3 builds on this legacy with broader and more accurate capabilities, significantly expanding its utility in drug discovery[33][39].\n\nMoreover, AlphaFold 3\u2019s ability to provide confidence scores for its predictions ensures that researchers can make informed decisions about the reliability of the generated models. This added layer of precision reduces the risks associated with traditional experimental approaches, allowing scientists to focus their efforts more strategically[37].\n\nPerhaps most importantly, the cost-effectiveness of AlphaFold 3 is a game-changer for the industry. Drug development is often described as a high-stakes gamble, requiring significant financial investment with no guarantee of success. AlphaFold 3 offers a way to dramatically reduce these costs while increasing the likelihood of identifying viable drug candidates. This shift has been described as \"game-changing\" and could fundamentally reshape the economics of pharmaceutical research and development[32][42].\n\nIn summary, AlphaFold 3 has transformed the speed and efficiency of drug discovery by providing unprecedented insights into protein interactions, enabling collaborations between academia and industry, and drastically reducing costs. While access to its full capabilities is somewhat restricted for commercial use, its overall impact on the field has been profound, offering hope for faster and more effective therapeutic development[34][36][41].",
      "role": "Pharmaceutical Researcher",
      "role_description": " With a background in drug discovery and development, this expert will provide insights into how AlphaFold 3 can accelerate the process of identifying potential drug targets and designing new therapeutics. They will discuss the impact of AlphaFold 3 on pharmaceutical research and its potential for drug discovery.",
      "queries": [
        "AlphaFold 3 impact on drug discovery",
        "How AlphaFold 3 accelerates pharmaceutical research"
      ],
      "utterance_type": "Support",
      "claim_to_make": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives. This collaborative approach underscores the commitment to harnessing the potential of AlphaFold 3 for advancing medical science and research. In summary, AlphaFold 3's introduction marks a pivotal moment in the understanding of biomolecular interactions and the acceleration ...",
          "snippets": [
            "Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives. This collaborative approach underscores the commitment to harnessing the potential of AlphaFold 3 for advancing medical science and research. In summary, AlphaFold 3's introduction marks a pivotal moment in the understanding of biomolecular interactions and the acceleration of drug discovery processes.",
            "Isomorphic Labs leverages AlphaFold 3 in collaboration with pharmaceutical partners to enhance drug design processes . This partnership approach not only accelerates drug development cycles but also ensures that new treatments are both innovative and effective, addressing previously intractable disease targets.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "By modeling proteins, ligands, and antibodies with unprecedented precision, this AI-driven tool allows for the rapid design of drugs targeting specific molecules, which is especially vital in cancer research . The ability to design molecules that can specifically bind to target proteins may lead to more effective treatments with fewer side effects, revolutionizing therapeutic approaches [20-24]. Accelerating Discovery and Reducing Development Costs \u00b7 The predictive power of AlphaFold 3 extends beyond traditional methods like X-ray crystallography or cryo-electron microscopy, which are both time-consuming and costly."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.researchgate.net/publication/381949797_Review_of_AlphaFold_3_Transformative_Advances_in_Drug_Design_and_Therapeutics",
          "description": "PDF | Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial... | Find, read and cite all the research you need on ResearchGate",
          "snippets": [
            "with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to \u00b7 develop new treatments that could change patients' lives. This collaborative approach underscores the \u00b7 commitment to harnessing the potential of AlphaFold 3 for advancing medical science and research. In summary, AlphaFold 3's introduction marks a pivotal moment in the understanding of biomolecular \u00b7 interactions and the acceleration of drug discovery processes.",
            "With its comprehensive approach to modeling life\u2019s molecules, AlphaFold 3 broadens the scope of scientific \u00b7 inquiry, enabling researchers to explore a wider range of biological molecules and their interactions . This expansion of capabilities accelerates the discovery process and opens new avenues for research that",
            "AlphaFold 3 stands at the forefront of a scientific revolution, with its impact extending beyond immediate \u00b7 applications in drug discovery and genomics to potentially reshape our approach to biological research and \u00b7 material science. As this technology evolves, its integration into various scientific domains is likely to \u00b7 accelerate discoveries and innovations, marking a new era in the intersection of AI and biology .",
            "Fandino R: The role of AI in drug discovery: challenges, opportunities, and strategies . Pharmaceuticals ... 8. Revolutionizing medicine with alphafold 3: the new frontier in biomedical research ."
          ],
          "title": "(PDF) Review of AlphaFold 3: Transformative Advances in Drug Design ...",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods.",
            "Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed.",
            "Thanks to AlphaFold, startups with roughly $5\u201310 million in VC funding have \u201ca realistic chance at developing a new drug,\u201d which can be sufficient to cover the costs of infrastructure, talent acquisition and initial research.",
            "This is especially true for organizations deploying AlphaFold at scale. \u201cNow, you don\u2019t need a lot of staff,\u201d Bangert said. \u201cWe\u2019re not talking about dozens of people. We\u2019re more like talking about maybe five people-ish, plus or minus,\u201d Bangert said. But those five people need to be \u201cabsolutely stellar researchers.\u201d And it would be ideal of about half of the team were biochemical experts while the other were highly-trained AI specialists who \u201cgot along well and spoke each other\u2019s language,\u201d Bangert said."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
          "snippets": [
            "Earlier versions of AlphaFold, available through open-source code, were limited primarily by an inability to predict how proteins would interact with other molecules throughout the cell. Even so, they spurred significant progress. \u201cSo far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design,\u201d according to the Google AlphaFold 3 announcement.",
            "Given its potential in life science research, DeepMind and Isomorphic\u2019s CEO said this month the platform could eventually be a \u201cmulti-hundred billion\u201d dollar business. And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain.",
            "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "AlphaFold 3\u2019s capabilities, outlined in the journal Nature, build on two of its earlier AI models, enabling drug developers to quickly identify promising targets, potentially slashing the time to market by years."
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "Scientists can access most of its ... research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients. AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, ...",
          "snippets": [
            "Scientists can access most of its capabilities for free through the newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients. AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations.",
            "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
            "Traditionally, this process can be slow and expensive. AlphaFold 3 can significantly accelerate it by: Predicting drug interactions with disease-causing proteins: This allows researchers to prioritize promising drug candidates and eliminate those unlikely to be effective.",
            "Drug Design for Rare Diseases: AlphaFold could accelerate the development of drugs for rare diseases, while traditional methods are slow and expensive. Biomimicry in Engineering: By understanding how nature builds complex structures, engineers could use AlphaFold to design new biomimetic materials and technologies. No, AlphaFold 3 is not currently fully open source. There has been debate about this, with some researchers calling for the code to be released for wider access and scrutiny."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.researchgate.net/publication/358148838_AlphaFold_Accelerates_Artificial_Intelligence_Powered_Drug_Discovery_Efficient_Discovery_of_a_Novel_Cyclin-dependent_Kinase_20_CDK20_Small_Molecule_Inhibitor",
          "description": "PDF | The AlphaFold computer program predicted protein structures for the whole human genome, which has been considered as a remarkable breakthrough... | Find, read and cite all the research you need on ResearchGate",
          "snippets": [
            "Nucleic acids research ... Baek, M. et al. Accurate prediction of protein structures and interactions using a 3-track network. bioRxiv \u00b7 preprint bioRxiv:2021.06.14.448402 DOI: 10.1101/2021.06.14.448402 (2021). ... Jendrusch, M., Korbel, J. O. & Sadiq, S. K. AlphaDesign: A de novo protein design framework based on \u00b7 AlphaFold.",
            "3Department of Chemistry, Department of Computer Science, University of Toronto, Toronto, Ontario, Canada; Vector Institute for Arti\ufb01cial Intelligence, Toronto, Ontario, Canada; Canadian Institute for Advanced Research, ... *Corresponding authors: Alex Zhavoronkov, email: alex@insilico.com; Feng Ren, email: feng.ren@insilico.ai ... The AlphaFold computer program predicted protein structures for the whole human genome, which has been",
            "Preprints and early-stage research may not have been peer reviewed yet. ... The AlphaFold computer program predicted protein structures for the whole human genome, which has been considered as a remarkable breakthrough both in artificial intelligence (AI) application and structural biology.",
            "Keywords: AlphaFold, CDK20, Chemistry42, Hepatocellular carcinoma (HCC), PandaOmics ... The 3D structures of proteins are highly correlated with how they function in a cell and the impacts amino acid"
          ],
          "title": "(PDF) AlphaFold Accelerates Artificial Intelligence Powered Drug ...",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.technologyreview.com/2024/05/08/1092183/google-deepminds-new-alphafold-can-model-a-much-larger-slice-of-biological-life/",
          "description": "AlphaFold 3 can predict how DNA, RNA, and other molecules interact, further cementing its leading role in drug discovery and research. Who will benefit? ... Google DeepMind has released an improved version of its biology prediction tool, AlphaFold, that can predict the structures not only of proteins but of nearly all the elements of biological life. It\u2019s a development that could help accelerate ...",
          "snippets": [
            "AlphaFold 3 can predict how DNA, RNA, and other molecules interact, further cementing its leading role in drug discovery and research. Who will benefit? ... Google DeepMind has released an improved version of its biology prediction tool, AlphaFold, that can predict the structures not only of proteins but of nearly all the elements of biological life. It\u2019s a development that could help accelerate drug discovery and other scientific research.",
            "AlphaFold 3 can predict how DNA, RNA and other molecules interact, further cementing its leading role in drug discovery and research. Who will benefit?",
            "Isomorphic Labs, a drug discovery spinoff of DeepMind, is already using the model for exactly that purpose, collaborating with pharmaceutical companies to try to develop new treatments for diseases, according to DeepMind. AlQuraishi says the release marks a big leap forward. But there are caveats. \u201cIt makes the system much more general, and in particular for drug discovery purposes (in early-stage research), it\u2019s far more useful now than AlphaFold 2,\u201d he says.",
            "For some uses, AlphaFold 3 has double the success rate of similar leading models like RoseTTAFold. But for others, like protein-RNA interactions, AlQuraishi says it\u2019s still very inaccurate. DeepMind says that depending on the interaction being modeled, accuracy can range from 40% to over 80%, and the model will let researchers know how confident it is in its prediction."
          ],
          "title": "Google DeepMind\u2019s new AlphaFold can model a much larger slice ...",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping ...",
          "snippets": [
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "AlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences. AlphaFold 3 takes us beyond proteins to a broad spectrum of biomolecules. This leap could unlock more transformative science, from developing biorenewable materials and more resilient crops, to accelerating drug design and genomics research.",
            "We\u2019ll also be expanding our free AlphaFold education online course with EMBL-EBI and partnerships with organizations in the Global South to equip scientists with the tools they need to accelerate adoption and research, including on underfunded areas such as neglected diseases and food security."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.theatlantic.com/sponsored/google/ai-powered-future-drug-discovery/3962/",
          "description": "To ground predictions, AlphaFold ... giving researchers an estimate of the model\u2019s accuracy. Science is an iterative enterprise. Trial and error in the laboratory is how progress has traditionally been made. But now, AI systems are poised to dramatically accelerate this painstaking process. One area in which AlphaFold 3 shows particular ...",
          "snippets": [
            "To ground predictions, AlphaFold provides a confidence score, giving researchers an estimate of the model\u2019s accuracy. Science is an iterative enterprise. Trial and error in the laboratory is how progress has traditionally been made. But now, AI systems are poised to dramatically accelerate this painstaking process. One area in which AlphaFold 3 shows particular promise is the rational design of drugs.",
            "The pioneering AI model AlphaFold can predict the structure and interactions of molecules with unprecedented accuracy.",
            "\u201cFinding new therapeutic antibodies is really sort of like panning for gold,\u201d explains Derek Lowe, a veteran pharmaceutical researcher. \u201cYou have to check against incredible numbers of possibilities to find things that bind, and then you try to make them better and better.\u201d \u00b7 Taking advantage of AlphaFold 3\u2019s ability to accurately model protein interactions, scientists can computationally screen vast numbers of potential candidates and identify the most promising ones for experimental validation.",
            "AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but also has the potential to ultimately impact the overall cost of development. \u201cAlphaFold was a watershed moment for AI in biology."
          ],
          "title": "The AI-Powered Future of Drug Discovery - Sponsor Content - Google",
          "meta": {
            "query": "How AlphaFold 3 accelerates pharmaceutical research",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
          "snippets": [
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "This new window on the molecules ... actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open ...",
          "snippets": [
            "This new window on the molecules of life reveals how they\u2019re all connected and helps understand how those connections affect biological functions \u2014 such as the actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open questions in biology and new lines of research.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "Introducing AlphaFold 3, a new AI model developed by Google DeepMind and Isomorphic Labs. By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery.",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact ...",
          "snippets": [
            "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding",
            "Researchers are excited about the prospect of speedier drug discovery, facilitated by the greater range of predictive abilities offered by AlphaFold 3 . ... To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server.",
            "This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context. This capability is crucial for drug discovery, as many drugs fall under the ligand category.",
            "By integrating these advanced predictive tools, AlphaFold 3 not only streamlines the drug discovery process but also opens up new possibilities for innovative therapeutic approaches, ultimately aiming to improve patient outcomes and advance the field of medical science. ... AlphaFold's capabilities extend into the realm of viral research, significantly impacting the development of therapies."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d ... a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery...",
          "snippets": [
            "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said. \u201cThis is prior to doing any chemical experimentation, certainly prior to any kind of clinical trials, that even if you did make a mistake, it wouldn't matter because you wouldn't be impacting anything.",
            "\u201cSo far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design,\u201d according to the Google AlphaFold 3 announcement. \u201cAlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences.\u201d"
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://time.com/6975934/google-deepmind-alphafold-3-ai/",
          "description": "The innovative AI model, announced on May 8, is likely to dramatically accelerate biological research.",
          "snippets": [
            "In 2021, Google parent company Alphabet announced the creation of Isomorphic Labs, which aims to take an AI-first approach to drug discovery. Researchers from Isomorphic Labs contributed to the development of AlphaFold 3 and, while AlphaFold Server can be used by anyone from non-commercial research, researchers at Isomorphic Labs will have exclusive access to AlphaFold 3 for commercial use.",
            "\u201cWe've been using AlphaFold 3\u2019s capabilities day-to-day in our drug design programmes,\u201d said Max Jaderberg, chief AI officer at Isomorphic labs, at the announcement briefing. \u201cWe're already seeing that potential to accelerate, improve, and ultimately transform the way that we do drug discovery, and it's really because of the new level of accuracy of this model, and the increased breadth of biomolecules that this model is able to predict, that really enables that for us.\u201d",
            "In addition to the AlphaFold family of AI systems, Google DeepMind has made several breakthroughs that use AI to further science and technology. In 2022 the company released an AI system that can discover novel algorithms, and in 2023 it released an AI model that could forecast the weather with unprecedented accuracy.",
            "Researchers at Google DeepMind have developed AlphaFold 3, an AI model that can predict the structure of and interactions between biological molecules including proteins, DNA and RNA, and small molecules that could function as drugs. Google DeepMind will make the model available for non-commercial use through AlphaFold server."
          ],
          "title": "Google DeepMind\u2019s AlphaFold 3 Could Transform Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "All the users of AlphaFold don\u2019t really care about speed, performance, latency, or any of those usual IT topics,\u201d Bangert said. \u201cWhat they really care about is accuracy. And that\u2019s why this move beyond essentially just a language model into molecular dynamics is really a good one.\u201d \u00b7 While R&D productivity rates in biopharma have declined in recent decades, blockbuster drugs still deliver substantial returns."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
            "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pubs.rsc.org/en/content/articlelanding/2023/sc/d2sc05709c",
          "description": "The application of artificial intelligence (AI) has been considered a revolutionary change in drug discovery and development. In 2020, the AlphaFold computer program predicted protein structures for the whole human genome, which has been considered a remarkable breakthrough in both AI applications ...",
          "snippets": [
            "The application of artificial intelligence (AI) has been considered a revolutionary change in drug discovery and development. In 2020, the AlphaFold computer program predicted protein structures for the whole human genome, which has been considered a remarkable breakthrough in both AI applications and struct Computational protein design and structure prediction: Celebrating the 2024 Nobel Prize in Chemistry Most popular 2023 physical and theoretical chemistry articles",
            "Based on the available data, a second round of AI-powered compound generation was conducted and through this, a more potent hit molecule, ISM042-2-048, was discovered with an average Kd value of 566.7 \u00b1 256.2 nM (n = 3). Compound ISM042-2-048 also showed good CDK20 inhibitory activity with an IC50 value of 33.4 \u00b1 22.6 nM (n = 3). In addition, ISM042-2-048 demonstrated selective anti-proliferation activity in an HCC cell line with CDK20 overexpression, Huh7, with an IC50 of 208.7 \u00b1 3.3 nM, compared to a counter screen cell line HEK293 (IC50 = 1706.7 \u00b1 670.0 nM). This work is the first demonstration of applying AlphaFold to the hit identification process in drug discovery.",
            "This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.",
            "b Insilico Medicine Kong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong, China"
          ],
          "title": "AlphaFold accelerates artificial intelligence powered drug discovery: ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "The new study is part of an effort recently launched by Collins\u2019 lab called the Antibiotics-AI Project, which has the goal of using artificial intelligence to discover and design new antibiotics. AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "\u201cBreakthroughs such as AlphaFold are expanding the possibilities for in silico drug discovery efforts, but these developments need to be coupled with additional advances in other aspects of modeling that are part of drug discovery efforts,\u201d Collins says.",
            "\u201cOur study speaks to both the current abilities and the current limitations of computational platforms for drug discovery.\u201d \u00b7 In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sify.com/ai-analytics/alphafold-3-by-deepmind-the-future-of-protein-folding-and-drug-discovery/",
          "description": "Tiny Tech, Big Impact: Edge AI and TinyML are revolutionising data processing \u00b7 Tech in the Shadows: The Rise of Ambient Computing and Seamless Integration \u00b7 GPT-2 Chatbot Mystery: Outperforming GPT-4 or Next-Gen AI? ... AI AlphaFold 3 Artificial Intelligence DeepMind DNA drug discovery Gautham ...",
          "snippets": [
            "Tiny Tech, Big Impact: Edge AI and TinyML are revolutionising data processing \u00b7 Tech in the Shadows: The Rise of Ambient Computing and Seamless Integration \u00b7 GPT-2 Chatbot Mystery: Outperforming GPT-4 or Next-Gen AI? ... AI AlphaFold 3 Artificial Intelligence DeepMind DNA drug discovery Gautham T medicine protein folding RNA",
            "A super artificial intelligence that is as smart as an architect and may predict the molecular configuration of proteins to a great extent.",
            "Medicine: AlphaFold 3 facilitates faster drug discovery since it effectively captures protein folds. It recently supported a study of a protein that is important for a malaria vaccine. In the past, the images were not clear enough and thus it was challenging to identify the most effective target.",
            "But how do these single but indisputably essential proteins design their unique form as if they are made by special origami skills? This over time has become a \u2018science fiction conjecture\u2019 that has immensely hit the area of disease diagnosis and drug development. Now, there\u2019s a game-changer: AlphaFold 3."
          ],
          "title": "AlphaFold 3 by DeepMind: The Future of Protein Folding and Drug ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "The integration of AlphaFold 3 into drug discovery workflows has significantly improved the identification of novel drug targets and the design of new therapeutics when compared to traditional methods. This is largely due to AlphaFold 3's ability to predict protein structures with unprecedented accuracy and efficiency. Traditional methods for determining protein structures, such as X-ray crystallography and nuclear magnetic resonance, are time-consuming and costly. In contrast, AlphaFold 3 can model protein structures without requiring extensive experimental data, thereby reducing the time and financial resources needed for drug development [47][49].\n\nOne of the key advantages of AlphaFold 3 is its ability to predict how drugs interact with proteins. This capability is crucial for the design of targeted therapies, allowing scientists to understand how potential drugs bind to specific protein targets. As a result, AlphaFold 3 can facilitate the creation of more effective and precise therapeutics, which is a game-changer in the field of drug discovery [46][48].\n\nFurthermore, AlphaFold 3's predictive prowess is reported to be 50% more accurate than traditional methods, such as those evaluated in the PoseBusters benchmark, without needing prior structural information [43][48][49]. This enhanced accuracy translates into better identification of drug-target interactions and the ability to explore new therapeutic applications for existing drugs, a process known as drug repurposing. This approach not only speeds up the discovery process but also opens up possibilities for addressing diseases that were previously challenging to target [43][50].\n\nAlphaFold 3 also enables scientists to delve deeper into the context of drug targets, understanding the broader biological systems in which they operate. This understanding can lead to the development of drugs that are not only effective but also have fewer side effects, ultimately translating into more successful outcomes in clinical settings [44][45].\n\nDespite these advancements, there are limitations and challenges. For instance, while AlphaFold 3 models how proteins interact with other molecules, access to the tool is currently restricted, which might limit its broader application in the industry [51]. Nevertheless, the impact of AlphaFold 3 on drug discovery is profound, offering a more rational and streamlined approach to developing therapeutics against previously intractable targets [50][52].\n\nIn summary, AlphaFold 3 represents a significant leap forward in drug discovery, offering unprecedented accuracy and efficiency in identifying novel drug targets and designing new therapeutics compared to traditional methods. Its integration into drug discovery workflows holds the potential to revolutionize the field, making the process faster, more cost-effective, and ultimately more successful in bringing new treatments to patients [45][46][48][52].",
      "raw_utterance": "The integration of AlphaFold 3 into drug discovery workflows has significantly improved the identification of novel drug targets and the design of new therapeutics when compared to traditional methods. This is largely due to AlphaFold 3's ability to predict protein structures with unprecedented accuracy and efficiency. Traditional methods for determining protein structures, such as X-ray crystallography and nuclear magnetic resonance, are time-consuming and costly. In contrast, AlphaFold 3 can model protein structures without requiring extensive experimental data, thereby reducing the time and financial resources needed for drug development [47][49].\n\nOne of the key advantages of AlphaFold 3 is its ability to predict how drugs interact with proteins. This capability is crucial for the design of targeted therapies, allowing scientists to understand how potential drugs bind to specific protein targets. As a result, AlphaFold 3 can facilitate the creation of more effective and precise therapeutics, which is a game-changer in the field of drug discovery [46][48].\n\nFurthermore, AlphaFold 3's predictive prowess is reported to be 50% more accurate than traditional methods, such as those evaluated in the PoseBusters benchmark, without needing prior structural information [43][48][49]. This enhanced accuracy translates into better identification of drug-target interactions and the ability to explore new therapeutic applications for existing drugs, a process known as drug repurposing. This approach not only speeds up the discovery process but also opens up possibilities for addressing diseases that were previously challenging to target [43][50].\n\nAlphaFold 3 also enables scientists to delve deeper into the context of drug targets, understanding the broader biological systems in which they operate. This understanding can lead to the development of drugs that are not only effective but also have fewer side effects, ultimately translating into more successful outcomes in clinical settings [44][45].\n\nDespite these advancements, there are limitations and challenges. For instance, while AlphaFold 3 models how proteins interact with other molecules, access to the tool is currently restricted, which might limit its broader application in the industry [51]. Nevertheless, the impact of AlphaFold 3 on drug discovery is profound, offering a more rational and streamlined approach to developing therapeutics against previously intractable targets [50][52].\n\nIn summary, AlphaFold 3 represents a significant leap forward in drug discovery, offering unprecedented accuracy and efficiency in identifying novel drug targets and designing new therapeutics compared to traditional methods. Its integration into drug discovery workflows holds the potential to revolutionize the field, making the process faster, more cost-effective, and ultimately more successful in bringing new treatments to patients [45][46][48][52].",
      "role": "Pharmaceutical Researcher",
      "role_description": " With a background in drug discovery and development, this expert will provide insights into how AlphaFold 3 can accelerate the process of identifying potential drug targets and designing new therapeutics. They will discuss the impact of AlphaFold 3 on pharmaceutical research and its potential for drug discovery.",
      "queries": [
        "AlphaFold 3 impact on drug discovery",
        "AlphaFold 3 vs traditional methods in drug target identification"
      ],
      "utterance_type": "Support",
      "claim_to_make": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Its predictive prowess is 50% more accurate than traditional methods, making it a valuable tool for developing new therapeutics [6,20]. ... The use of machine learning in drug repurposing has become increasingly important. AlphaFold 3 analyzes data on drug-target interactions and side effects to identify ...",
          "snippets": [
            "Its predictive prowess is 50% more accurate than traditional methods, making it a valuable tool for developing new therapeutics . ... The use of machine learning in drug repurposing has become increasingly important. AlphaFold 3 analyzes data on drug-target interactions and side effects to identify new therapeutic applications for existing drugs.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "The model's predictive accuracy in modeling molecular interactions, including the binding of proteins with ligands and antibodies with their target proteins, sets a new standard. AlphaFold 3 is reported to be 50% more accurate than the best traditional methods on the PoseBusters benchmark, marking it as the first AI system to outperform physics-based tools in biomolecular structure prediction . This leap in predictive accuracy offers a new lens through which to view the molecular underpinnings of life, from drug interactions to the human immune response.",
            "By modeling proteins, ligands, and antibodies with unprecedented precision, this AI-driven tool allows for the rapid design of drugs targeting specific molecules, which is especially vital in cancer research . The ability to design molecules that can specifically bind to target proteins may lead to more effective treatments with fewer side effects, revolutionizing therapeutic approaches [20-24]. Accelerating Discovery and Reducing Development Costs \u00b7 The predictive power of AlphaFold 3 extends beyond traditional methods like X-ray crystallography or cryo-electron microscopy, which are both time-consuming and costly."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods.",
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAnd you tried that out in the lab physically and you had to go through a few thousand physical tests with each new attempt.\u201d Drug developers can now conduct these experiments computationally at a fraction of the cost using AlphaFold, compared to the time-consuming and resource-intensive process of traditional methods.",
            "All the users of AlphaFold don\u2019t really care about speed, performance, latency, or any of those usual IT topics,\u201d Bangert said. \u201cWhat they really care about is accuracy. And that\u2019s why this move beyond essentially just a language model into molecular dynamics is really a good one.\u201d \u00b7 While R&D productivity rates in biopharma have declined in recent decades, blockbuster drugs still deliver substantial returns."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "We believe that this broader understanding of the context within which drug targets operate will translate into more effective drugs in the clinic. ... To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems. And as we learn more about the molecular machines within us, with more structural and biological context, we can use this understanding to identify novel targets for drug design, as well as to approach existing targets with novel therapeutic mechanisms.",
            "This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate. ... AlphaFold 3 is an AI model that allows a scientist to input a description of a biomolecular complex that they are interested in, and predicts the 3D structure of that biomolecular complex.",
            "Understanding the biomolecular world within us, and how complex networks of molecules interact within our cells, is a crucial starting point for understanding and treating disease with rational drug design. ... To move this understanding forwards, together with Google DeepMind we have developed AlphaFold 3, our breakthrough artificial intelligence (AI) model that provides an accurate atomic-level view of the structure of biomolecular systems."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
          "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
          "snippets": [
            "This makes AlphaFold3 the perfect tool for drug discovery, ultimately enabling scientists to simulate vital molecular interactions with unprecedented speed and precision, and offering a faster, more cost-effective alternative to traditional lab methods. As scientists use AlphaFold3 to better understand protein structures and interactions, they can also create better targets for medications, better understand side effects, and delve into new areas of protein-drug interactions that may not have previously been fathomable.",
            "AlphaFold3 is also particularly accurate at predicting interactions between proteins and small molecules. \u201cBy analyzing protein surface charges and predicting druggable pockets, AF3 delivers deep insights into the druggability of potential targets,\u201d explained Tan. \u201cThis capability is instrumental in identifying and optimizing therapeutic candidates, significantly accelerating the discovery and development of next-generation treatments.\u201d",
            "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs.",
            "\u201cThe drug discovery industry is constantly evolving to explore innovative approaches that go beyond the traditional \u2018one drug per target\u2019 model,\u201d said Tan. \u201cStrategies such as disrupting preformed protein complexes or promoting protein-protein interactions are gaining traction. A critical first step in this process is the ability to produce target proteins, often in pre-formed complexes, to study such interactions effectively.\u201d \u00b7 As an example, Tan said that cell and gene therapy is an area where AlphaFold3 could make a key difference."
          ],
          "title": "Can AlphaFold3's open-source platform revolutionize the way we ...",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
          "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
          "snippets": [
            "Predict how drugs interact with proteins: This is a game-changer in drug discovery. Scientists can design more effective and targeted therapies by understanding how a potential drug binds to a specific protein. One of the most exciting applications of AlphaFold 3 lies in drug discovery. Traditionally, this process can be slow and expensive.",
            "Imagine a scenario where researchers can quickly identify potential drugs that perfectly fit the target protein, like a key fitting a lock. This paves the way for faster development of life-saving medications and personalized treatments. Scientists can access most of its capabilities for free through the newly launched AlphaFold Server, an easy-to-use research tool.",
            "Drug Design for Rare Diseases: AlphaFold could accelerate the development of drugs for rare diseases, while traditional methods are slow and expensive.",
            "Deep Learning (The Secret Weapon): Deep learning is a special type of AI technique that allows AlphaFold 3 to learn independently. Think of it like giving the student tons of practice problems to solve. By analyzing vast amounts of data on known protein structures, AlphaFold 3 can identify hidden rules and relationships."
          ],
          "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.prescouter.com/2024/05/google-deepmind-alphafold-3/",
          "description": "Google DeepMind's AlphaFold 3 improves drug discovery by predicting complex protein interactions and structures with high accuracy.",
          "snippets": [
            "AlphaFold 3 can identify protein\u2019s 3D structures without the meticulous trial and error that entails years of painstaking labor and costly financial investment. AlphaFold 3\u2019s capability to predict protein-ligand interactions is essential for drug discovery. It enables precise modeling of how potential drug molecules bind to their target proteins.",
            "AlphaFold 3 uses precise protein structure predictions to expedite the identification of new drug targets and enhance the design of more effective therapeutics.",
            "As more data becomes available and AlphaFold AI models can gradually learn more, the continuous development of protein structures will pose opportunities and challenges for related industries and verticals. While AlphaFold presents immense potential for progress and innovation, it may also pose difficulties for traditional companies to respond as required.",
            "Combining the technology with AlphaFold predictive models, researchers at the University of Oxford were able to identify which was the critical malaria protein. They also identified key components for the vaccine."
          ],
          "title": "AlphaFold 3: Google DeepMind\u2019s latest AI tech in drug discovery",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins. AlphaFold 3 is 50% more accurate than the best traditional methods on the PoseBusters benchmark, without needing the input of any structural information, making AlphaFold 3 the first AI system to surpass physics-based tools for biomolecular structure prediction.",
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, we are working on drug design for internal projects as well as with pharmaceutical partners. We are using AlphaFold 3 to accelerate and improve the success of drug design - by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach.",
            "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. ... We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds. Credits: Image: MIT News, with images from iStockphoto ... Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.",
            "Using protein structures generated by an artificial intelligence program called AlphaFold, the researchers explored whether existing models could accurately predict the interactions between bacterial proteins and antibacterial compounds. If so, then researchers could begin to use this type of modeling to do large-scale screens for new compounds that target previously untargeted proteins.",
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "But in this case, where the researchers were trying to screen many compounds against many potential targets, the predictions turned out to be much less accurate. By comparing the predictions produced by the model with actual interactions for 12 essential proteins, obtained from lab experiments, the researchers found that the model had false positive rates similar to true positive rates. That suggests that the model was unable to consistently identify true interactions between existing drugs and their targets."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
          "snippets": [
            "AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins. AlphaFold 3 is 50% more accurate than the best traditional methods on the PoseBusters benchmark without needing the input of any structural information, making AlphaFold 3 the first AI system to surpass physics-based tools for biomolecular structure prediction.",
            "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach.",
            "For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy. We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery.",
            "Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/abs/pii/S0959440X22002056",
          "description": "The drug discovery process involves designing compounds to selectively interact with their targets. The majority of therapeutic targets for low molecu\u2026",
          "snippets": [
            "In this review, we describe how such advances in protein structure prediction, e.g., AlphaFold2  and RoseTTA , are likely to impact research approaches in the various stages of the drug discovery process (See Graphical Abstract). The first step of the drug discovery process is to identify a target and validate that it has an impact on the disease under study. The selection of targets for therapeutic intervention (protein, DNA, and RNA) has traditionally been based on data from the scientific literature for insights into molecular pathways and biology of disease.",
            "Given the accuracy of protein structure prediction by AlphaFold2 , all protein targets identified on the basis of biology are now effectively complemented by three-dimensional data for the assessment of target tractability. We should note that almost all targets for approved drugs to date (especially in humans) have an experimental structure (either in native or in complex form) or a good model built by standard homology modeling methods.",
            "To illustrate an application, the use of AlphaFold2 (AF2) to model the replicase encoded by the 1708 amino acid polyprotein of the human-infecting hepatitis E virus (HEV-3) has predicted five non-structural proteins . The models have different levels of confidence/accuracy, provided by AF2, and this is critical to consider when using for SBDD (See Figure 2). These models provide a basis for assessing the suitability of the individual proteins as potential drug targets by ranking them according to.",
            "The confidence level (predicted local distance difference test or pLDDT score) of the structure predicted by AlphaFold2 . ... Details of the size and accessibility of binding pockets . ... Access, through public  or private databases, to experimentally observed data on substrate- or ligand-binding sites on proteins with structures similar to that of the predicted target (Figure 2) or"
          ],
          "title": "AlphaFold2 protein structure prediction: Implications for drug ...",
          "meta": {
            "query": "AlphaFold 3 vs traditional methods in drug target identification",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
          "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
          "snippets": [
            "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate.",
            "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
            "To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication. ... The study focused on the discovery and design of small molecules capable of binding TIM-3 with high affinity.",
            "But AlphaFold 3 is one of the many AI-powered breakthroughs we\u2019re working on which are needed to transform drug discovery - structural understanding is just a part of the picture. We\u2019re combining AlphaFold 3 with our other proprietary AI models in our platform that help us understand more about the properties, function, and dynamics of molecular systems."
          ],
          "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Improved Drug Target Identification"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "This new window on the molecules ... actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open ...",
          "snippets": [
            "This new window on the molecules of life reveals how they\u2019re all connected and helps understand how those connections affect biological functions \u2014 such as the actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open questions in biology and new lines of research.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "Introducing AlphaFold 3, a new AI model developed by Google DeepMind and Isomorphic Labs. By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery.",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/d41586-024-01383-z",
          "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
          "snippets": [
            "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Nature - Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
            "Since the powerhouse artificial intelligence (AI) tool AlphaFold2 was released in 2021, scientists have used the protein-structure-prediction model to map one of our cells\u2019 biggest machines, discover drugs and chart the universe of every known protein."
          ],
          "title": "Major AlphaFold upgrade offers boost for drug discovery",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Improved Drug Target Identification"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact ...",
          "snippets": [
            "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding",
            "Researchers are excited about the prospect of speedier drug discovery, facilitated by the greater range of predictive abilities offered by AlphaFold 3 . ... To maximize the impact of AlphaFold 3 on scientific research and drug discovery, its capabilities are made accessible to scientists through the AlphaFold Server.",
            "This section delves into the core of AlphaFold 3's capabilities, shedding light on its profound impact on our understanding of biomolecular interactions . ... AlphaFold 3's methodology allows for the generation of joint 3D structures of molecules, facilitating a comprehensive view of how various biomolecules, including proteins, DNA, RNA, and ligands, interact within a cellular context. This capability is crucial for drug discovery, as many drugs fall under the ligand category.",
            "By integrating these advanced predictive tools, AlphaFold 3 not only streamlines the drug discovery process but also opens up new possibilities for innovative therapeutic approaches, ultimately aiming to improve patient outcomes and advance the field of medical science. ... AlphaFold's capabilities extend into the realm of viral research, significantly impacting the development of therapies."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
          "description": "The \u201cNobel Prize-worthy invention\u201d ... a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery...",
          "snippets": [
            "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery.",
            "And while AlphaFold 3 could identify promising compounds faster, the usual hurdles to market will remain. \u201cThis isn't necessarily a Holy Grail to instantly make the drug development process more successful,\u201d Bangert said. \u201cYou're still going to have the traditional challenges, but this is a piece of that puzzle that's fitting better now.\u201d \u00b7 AI has secured a footing in drug discovery.",
            "It\u2019s hard to find the downside of AlphaFold 3, Bangert said. \u201cThis is actually one of those rare examples where I genuinely can't think of a drawback, mainly because this protein folding problem is so early in the process of drug development,\u201d he said. \u201cThis is prior to doing any chemical experimentation, certainly prior to any kind of clinical trials, that even if you did make a mistake, it wouldn't matter because you wouldn't be impacting anything.",
            "\u201cSo far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design,\u201d according to the Google AlphaFold 3 announcement. \u201cAlphaFold has been cited more than 20,000 times and its scientific impact recognized through many prizes, most recently the Breakthrough Prize in Life Sciences.\u201d"
          ],
          "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
            "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Improved Drug Target Identification"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://time.com/6975934/google-deepmind-alphafold-3-ai/",
          "description": "The innovative AI model, announced on May 8, is likely to dramatically accelerate biological research.",
          "snippets": [
            "In 2021, Google parent company Alphabet announced the creation of Isomorphic Labs, which aims to take an AI-first approach to drug discovery. Researchers from Isomorphic Labs contributed to the development of AlphaFold 3 and, while AlphaFold Server can be used by anyone from non-commercial research, researchers at Isomorphic Labs will have exclusive access to AlphaFold 3 for commercial use.",
            "\u201cWe've been using AlphaFold 3\u2019s capabilities day-to-day in our drug design programmes,\u201d said Max Jaderberg, chief AI officer at Isomorphic labs, at the announcement briefing. \u201cWe're already seeing that potential to accelerate, improve, and ultimately transform the way that we do drug discovery, and it's really because of the new level of accuracy of this model, and the increased breadth of biomolecules that this model is able to predict, that really enables that for us.\u201d",
            "In addition to the AlphaFold family of AI systems, Google DeepMind has made several breakthroughs that use AI to further science and technology. In 2022 the company released an AI system that can discover novel algorithms, and in 2023 it released an AI model that could forecast the weather with unprecedented accuracy.",
            "Researchers at Google DeepMind have developed AlphaFold 3, an AI model that can predict the structure of and interactions between biological molecules including proteins, DNA and RNA, and small molecules that could function as drugs. Google DeepMind will make the model available for non-commercial use through AlphaFold server."
          ],
          "title": "Google DeepMind\u2019s AlphaFold 3 Could Transform Drug Discovery",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said.",
            "\u201cAlphaFold itself is like the heart but you need the lungs and the liver and the kidneys and blood vessels and all that as well,\u201d Bangert said. Deploying AlphaFold 3 at a production scale to accelerate drug discovery involves assembling an ecosystem of IT infrastructure, data pipelines and domain expertise.",
            "Filed Under: Data science, Drug Discovery, machine learning and AI Tagged With: AI in Pharma, AI tools, AlphaFold 3, biopharma innovation, drug discovery, pharmaceutical R&D, protein structure prediction",
            "All the users of AlphaFold don\u2019t really care about speed, performance, latency, or any of those usual IT topics,\u201d Bangert said. \u201cWhat they really care about is accuracy. And that\u2019s why this move beyond essentially just a language model into molecular dynamics is really a good one.\u201d \u00b7 While R&D productivity rates in biopharma have declined in recent decades, blockbuster drugs still deliver substantial returns."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pubs.rsc.org/en/content/articlelanding/2023/sc/d2sc05709c",
          "description": "The application of artificial intelligence (AI) has been considered a revolutionary change in drug discovery and development. In 2020, the AlphaFold computer program predicted protein structures for the whole human genome, which has been considered a remarkable breakthrough in both AI applications ...",
          "snippets": [
            "The application of artificial intelligence (AI) has been considered a revolutionary change in drug discovery and development. In 2020, the AlphaFold computer program predicted protein structures for the whole human genome, which has been considered a remarkable breakthrough in both AI applications and struct Computational protein design and structure prediction: Celebrating the 2024 Nobel Prize in Chemistry Most popular 2023 physical and theoretical chemistry articles",
            "Based on the available data, a second round of AI-powered compound generation was conducted and through this, a more potent hit molecule, ISM042-2-048, was discovered with an average Kd value of 566.7 \u00b1 256.2 nM (n = 3). Compound ISM042-2-048 also showed good CDK20 inhibitory activity with an IC50 value of 33.4 \u00b1 22.6 nM (n = 3). In addition, ISM042-2-048 demonstrated selective anti-proliferation activity in an HCC cell line with CDK20 overexpression, Huh7, with an IC50 of 208.7 \u00b1 3.3 nM, compared to a counter screen cell line HEK293 (IC50 = 1706.7 \u00b1 670.0 nM). This work is the first demonstration of applying AlphaFold to the hit identification process in drug discovery.",
            "This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.",
            "b Insilico Medicine Kong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong, China"
          ],
          "title": "AlphaFold accelerates artificial intelligence powered drug discovery: ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://news.mit.edu/2022/alphafold-potential-protein-drug-0906",
          "description": "Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
          "snippets": [
            "Study finds computer models that predict molecular interactions need improvement before they can help identify drug mechanisms of action. ... Caption: Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.",
            "The new study is part of an effort recently launched by Collins\u2019 lab called the Antibiotics-AI Project, which has the goal of using artificial intelligence to discover and design new antibiotics. AlphaFold, an AI software developed by DeepMind and Google, has accurately predicted protein structures from their amino acid sequences. This technology has generated excitement among researchers looking for new antibiotics, who hope that they could use the AlphaFold structures to find drugs that bind to specific bacterial proteins.",
            "\u201cBreakthroughs such as AlphaFold are expanding the possibilities for in silico drug discovery efforts, but these developments need to be coupled with additional advances in other aspects of modeling that are part of drug discovery efforts,\u201d Collins says.",
            "\u201cOur study speaks to both the current abilities and the current limitations of computational platforms for drug discovery.\u201d \u00b7 In their new study, the researchers were able to improve the performance of these types of models, known as molecular docking simulations, by applying machine-learning techniques to refine the results. However, more improvement will be necessary to fully take advantage of the protein structures provided by AlphaFold, the researchers say."
          ],
          "title": "Analyzing the potential of AlphaFold in drug discovery | MIT News ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sify.com/ai-analytics/alphafold-3-by-deepmind-the-future-of-protein-folding-and-drug-discovery/",
          "description": "Tiny Tech, Big Impact: Edge AI and TinyML are revolutionising data processing \u00b7 Tech in the Shadows: The Rise of Ambient Computing and Seamless Integration \u00b7 GPT-2 Chatbot Mystery: Outperforming GPT-4 or Next-Gen AI? ... AI AlphaFold 3 Artificial Intelligence DeepMind DNA drug discovery Gautham ...",
          "snippets": [
            "Tiny Tech, Big Impact: Edge AI and TinyML are revolutionising data processing \u00b7 Tech in the Shadows: The Rise of Ambient Computing and Seamless Integration \u00b7 GPT-2 Chatbot Mystery: Outperforming GPT-4 or Next-Gen AI? ... AI AlphaFold 3 Artificial Intelligence DeepMind DNA drug discovery Gautham T medicine protein folding RNA",
            "A super artificial intelligence that is as smart as an architect and may predict the molecular configuration of proteins to a great extent.",
            "Medicine: AlphaFold 3 facilitates faster drug discovery since it effectively captures protein folds. It recently supported a study of a protein that is important for a malaria vaccine. In the past, the images were not clear enough and thus it was challenging to identify the most effective target.",
            "But how do these single but indisputably essential proteins design their unique form as if they are made by special origami skills? This over time has become a \u2018science fiction conjecture\u2019 that has immensely hit the area of disease diagnosis and drug development. Now, there\u2019s a game-changer: AlphaFold 3."
          ],
          "title": "AlphaFold 3 by DeepMind: The Future of Protein Folding and Drug ...",
          "meta": {
            "query": "AlphaFold 3 impact on drug discovery",
            "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "AlphaFold 3, the latest iteration of Google DeepMind's protein folding AI, has introduced several notable advancements that have significantly enhanced its accuracy and speed in predicting protein structures compared to its predecessor, AlphaFold 2. One of the most remarkable improvements is its ability to predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. This new capability has resulted in a minimum 50% improvement in accuracy for predicting protein interactions with other molecules [55]. \n\nAlphaFold 3 also benefits from a substantially updated diffusion-based architecture that enables it to predict joint structures of more complex biomolecular assemblies, including proteins, nucleic acids, small molecules, ions, and modified residues [59]. These architectural enhancements are supported by changes in hardware and memory-optimized geometrical attention building blocks, leading to higher inference throughput and better scaling of the model [56]. This, in turn, translates to increased prediction speed and capability, making it superior to non-AlphaFold docking methods like Vina, DiffDock, and TankBind [56].\n\nMoreover, AlphaFold 3's training dataset has been expanded to include protein-nucleic acid complexes and the presence of post-translational modifications and cofactors, thereby broadening the range of applications and further enhancing prediction accuracy [56]. The advanced deep learning methodologies employed by AlphaFold 3 have been instrumental in these improvements, as they offer a more nuanced understanding of biomolecular interactions [58].\n\nThese advancements underscore AlphaFold 3's contribution to the rapidly evolving field of protein structure prediction, facilitating not only enhanced scientific discovery but also practical applications in drug discovery and design [57]. Overall, AlphaFold 3 marks another significant leap forward in the ability to accurately predict protein structures, reinforcing the revolutionary potential of AI in biological sciences [53][54].",
      "raw_utterance": "AlphaFold 3, the latest iteration of Google DeepMind's protein folding AI, has introduced several notable advancements that have significantly enhanced its accuracy and speed in predicting protein structures compared to its predecessor, AlphaFold 2. One of the most remarkable improvements is its ability to predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. This new capability has resulted in a minimum 50% improvement in accuracy for predicting protein interactions with other molecules [55]. \n\nAlphaFold 3 also benefits from a substantially updated diffusion-based architecture that enables it to predict joint structures of more complex biomolecular assemblies, including proteins, nucleic acids, small molecules, ions, and modified residues [59]. These architectural enhancements are supported by changes in hardware and memory-optimized geometrical attention building blocks, leading to higher inference throughput and better scaling of the model [56]. This, in turn, translates to increased prediction speed and capability, making it superior to non-AlphaFold docking methods like Vina, DiffDock, and TankBind [56].\n\nMoreover, AlphaFold 3's training dataset has been expanded to include protein-nucleic acid complexes and the presence of post-translational modifications and cofactors, thereby broadening the range of applications and further enhancing prediction accuracy [56]. The advanced deep learning methodologies employed by AlphaFold 3 have been instrumental in these improvements, as they offer a more nuanced understanding of biomolecular interactions [58].\n\nThese advancements underscore AlphaFold 3's contribution to the rapidly evolving field of protein structure prediction, facilitating not only enhanced scientific discovery but also practical applications in drug discovery and design [57]. Overall, AlphaFold 3 marks another significant leap forward in the ability to accurately predict protein structures, reinforcing the revolutionary potential of AI in biological sciences [53][54].",
      "role": "Computational Biologist",
      "role_description": " This expert specializes in using computational methods to analyze biological data, including protein structures. They will focus on the technical aspects of AlphaFold 3, discussing how the AI model works and its implications for protein structure prediction.",
      "queries": [
        "AlphaFold 3 advancements in protein structure prediction",
        "What\u2019s new in AlphaFold 3 compared to AlphaFold 2"
      ],
      "utterance_type": "Support",
      "claim_to_make": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
      "raw_retrieved_info": [
        {
          "url": "https://www.linkedin.com/pulse/hype-around-alphafold-3-results-vs-limitations-andrii-buvailo-ph-d--jqewc",
          "description": "",
          "snippets": [],
          "title": "Hype Around AlphaFold 3: Results vs Limitations",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
          "description": "In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again. In this news highlight, we explore the new tech, compare it to its predecessor and take a ...",
          "snippets": [
            "In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again. In this news highlight, we explore the new tech, compare it to its predecessor and take a look to the future.",
            "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
            "AlphaFold 2 utilised a deep learning architecture called Evoformer. This model has been instrumental in advancing research into protein structures and folding mechanisms, leading to breakthroughs in subsequent areas such as drug discovery and vaccine development. The model uses a multiple sequence alignment, which compares sequences found throughout living organisms, and a pair representation based on proteins that may have a similar structure.",
            "In addition, after processing inputs, AlphaFold 3 uses a \u2018diffusion network\u2019, described by DeepMind as being similar to the tools used in AI image generation. These improvements to the model have led the company to claim that AlphaFold 3 has the highest accuracy yet. Perhaps the most exciting comparison that can be drawn between AlphaFold 2 and 3 is the latter\u2019s ability to make predictions not just about protein structure, but about interactions between proteins and biological molecules such as DNA, RNA and ligands \u2013 an acknowledgment that no molecules operate on their own."
          ],
          "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@falk_hoffmann/alphafold3-and-its-improvements-in-comparison-to-alphafold2-96815ffbb044",
          "description": "Predicting protein structures is one of the most important challenges in biochemistry. Highly accurate protein structures are essential for drug discovery purposes. Here, you can find more about the\u2026",
          "snippets": [
            "Are you curious about what this text holds for you?",
            "The number of good predictions, measured by a pocket RMSD of less than 2\u00c5 on high-quality experimental datasets, varies between 40% for RNA-modified residues and nearly 80% for bonded ligands. The limited number of examples in the datasets generates a relatively high statistical error on those values. AlphaFold3 also improves the prediction of protein-protein complexes, with a significant improvement in antibody-protein interfaces compared to AlphaFold-Multimer v2.3.",
            "Algorithm of relative position encoding extracted from the Supporting Information of the AlphaFold3 paper. Steps 1, 2 and 3 identify token pairs i and j from the same chain, with the same residue index and even with the same entity, respectively.",
            "Google\u2019s DeepMind introduced AlphaFold in the 13th CASP competition, which was held in 2018. AlphaFold uses a neural network approach that directly predicts the 3D coordinates of all non-hydrogen atoms for a given protein using the protein sequence and sequence homology."
          ],
          "title": "AlphaFold3 and its improvements in comparison to AlphaFold2 | by ...",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed.",
            "In the rapidly evolving landscape of life sciences, the intersection of artificial intelligence (AI) and biology has heralded a new era of discovery and innovation. At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines .",
            "AlphaFold 3's contributions to our understanding of biomolecular interactions offer a new window into the molecular dynamics that drive life's processes. By providing detailed insights into how molecules interact and influence biological functions, it paves the way for groundbreaking advancements in medical science and research . ... AlphaFold 3 represents a significant evolution from its predecessor, AlphaFold 2, primarily through its advanced architectural framework . The core of this new model, the Evoformer module, has been significantly enhanced to improve performance across a broader spectrum of biomolecules, extending beyond proteins to include DNA, RNA, and ligands . This architectural refinement has enabled AlphaFold 3 to achieve unprecedented accuracy in predicting drug-like interactions, setting a new benchmark in the field .",
            "These predictions facilitate the discovery of enzymes originating from bacteriophages that can degrade bacterial pathogens' cell walls, offering new avenues in antibacterial treatment strategies . ... In the fight against viruses like SARS-CoV-2, AlphaFold has been instrumental."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new ...",
          "snippets": [
            "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
            "In November 2020, DeepMind's new version, AlphaFold 2, won CASP14. Overall, AlphaFold 2 made the best prediction for 88 out of the 97 targets. On the competition's preferred global distance test (GDT) measure of accuracy, the program achieved a median score of 92.4 (out of 100), meaning that more than half of its predictions were scored at better than 92.4% for having their atoms in more-or-less the right place, a level of accuracy reported to be comparable to experimental techniques like X-ray crystallography.",
            "AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
            "Measured by the root-mean-square deviation (RMS-D) of the placement of the alpha-carbon atoms of the protein backbone chain, which tends to be dominated by the performance of the worst-fitted outliers, 88% of AlphaFold 2's predictions had an RMS deviation of less than 4 \u00c5 for the set of overlapped C-alpha atoms. 76% of predictions achieved better than 3 \u00c5, and 46% had a C-alpha atom RMS accuracy better than 2 \u00c5, with a median RMS deviation in its predictions of 2.1 \u00c5 for a set of overlapped CA atoms."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10011655/",
          "description": "Three-dimensional protein structure is directly correlated with its function and its determination is critical to understanding biological processes and addressing human health and life science problems in general. Although new protein structures ...",
          "snippets": [
            "In 2018, DeepMind, a startup of Google, presented a new software that best performed in the 13th edition of CASP, named AlphaFold. In this competition, AlphaFold achieved the best position in the FM (best-of-five), reaching a summed z-score of 52.8 versus 36.6 from the second place and, combining FM and FM/TBM categories, achieved 68.3 z-score versus 48.2 (Senior et al., 2019).",
            "As the comparison made in this work was not fair, since EMBER2 predicts 2D structures and AlphaFold, 3D structures, the authors developed a new approach that uses EMBER2 model, but now applied in three-dimensional structure prediction, named EMBER3D (Weissenow et al., 2022b).",
            "Whereas AlphaFold2 do not perform efficiently in the study of the impact of single amino acids variants into protein structure, Weissenow et al. (2022b) demonstrated that the differences in predicted distances maps generated by EMBER3D correlated well with native and mutant 3D structures from deep mutational scanning, having a better result than ESMfold.",
            "(2022a), that uses embeddings to predict inter-residue distance (2D structure) introducing attention heads derived from a pre-trained protein language model instead of MSA. Using EMBER2 in trRosetta to predict 3D structures is less accurate than AlphaFold2 in predicting a native structure and presents an inferior TM score (0.5 versus 0.79 in ColabFold) (Yang et al., 2020)."
          ],
          "title": "Before and after AlphaFold2: An overview of protein structure ...",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/@falk_hoffmann/promising-alternatives-to-alphafold-3-how-they-work-and-when-to-use-them-ccbcde490b14",
          "description": "Changes include hardware and ... also the comparison to AF3) and better scaling of the model. Based on the reported values in the press release on the PostBusters dataset, it reaches a success rate, measured as correctly predicted protein structure with an RMSD of less than 2 A, of 54.9% and 76.8% if pocket residues are not specified or are specified, respectively. This beats all non-AlphaFold docking methods like Vina, DiffDock and TankBind but is inferior to the new ...",
          "snippets": [
            "Changes include hardware and memory-optimized geometrical attention building blocks for higher inference throughput, an expansion of the training data to protein-nucleic acid complexes and the presence of post-translational modifications (PTM) and cofactors for more applications (see also the comparison to AF3) and better scaling of the model. Based on the reported values in the press release on the PostBusters dataset, it reaches a success rate, measured as correctly predicted protein structure with an RMSD of less than 2 A, of 54.9% and 76.8% if pocket residues are not specified or are specified, respectively. This beats all non-AlphaFold docking methods like Vina, DiffDock and TankBind but is inferior to the new AF3.",
            "As mentioned in my last text, AlphaFold 3 (AF3) sets the new standard for protein-ligand structure prediction. However, AlphaFold 3 has several limitations. Those include: Those limitations show a\u2026",
            "Are you curious about what this text holds for you?",
            "Second, if template structures should be used, they are generated with AlphaFold2 or \u2014 if available \u2014 extracted from alternative experimental structures and template features are computed from those structures (Lines 2\u20134)."
          ],
          "title": "Alternatives to AlphaFold 3\u2014 how they work and when to use them ...",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://hyperlab.hits.ai/en/blog/google-deepmind-alphafoldlatest",
          "description": "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule ...",
          "snippets": [
            "AlphaFold-latest, the next generation of AlphaFold, has the ability to predict the structure of almost all biomolecules along with proteins compared to previous models. The model can predict a variety of molecular combinations, including protein-nucleic acid complexes and protein-small molecule complexes, and shows higher prediction accuracy than traditional docking programs.",
            "AlphaFold has steadily evolved from Version 1 (2018), to Version 2 (2020), to AlphaFold-Multimer (2021), to the most recent Version 2.3 (2022), increasing its predictive protein size and accuracy.  \u00b7 On August 31, 2023, Google DeepMind shared news of the next generation of AlphaFold. Dubbed AlphaFold-latest, this model is setting off alarm bells for researchers in related fields, just as it did when AlphaFold's performance was first revealed. But what's different? When comparing Google DeepMind's AlphaFold-latest to the last publicly available model, AlphaFold 2.3, the biggest change is that it can now predict almost all biomolecular structures, including proteins, small molecules, DNA and RNA, ions, and modified amino acids.",
            "Complex protein structures, such as protein multimers and protein-antibody conjugates, have also been reported to show significant accuracy improvements over the previous AlphaFold 2.3. Comparison of structure prediction performance on 428 protein-small molecule complexes from the [PoseBusters benchmark]. Deep learning models including EquiBind, DeepDock, TankBind, Uni-Mol, DiffDock, etc.",
            "And AlphaFold-latest won't just impact small molecule targeting: as we've seen, AlphaFold-latest improves on AlphaFold 2.3 in terms of protein structure prediction, and will have a significant impact on problems where protein-protein interactions are important, such as antibody design."
          ],
          "title": "Google DeepMind AlphaFold-latest l What's different from previous ...",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://310.ai/blog/alphafold2-alphafold-multimer-alphafold3",
          "description": "AlphaFold3 extends its predecessors\u2019 capabilities by predicting structures not only for proteins but also for DNA, RNA, and their interactions. It marks a breakthrough in biomolecular modeling but still struggles with dynamic proteins and complex environments.",
          "snippets": [
            "To learn more about computer science/machine learning aspects of AlphaFold3, look at \u201cAlphaFold: Protein Structure Prediction\u201d or \u201cAlphaFold3 and its improvements in comparison to AlphaFold2\u201d. There, you can find out more about the technical aspects behind AlphaFold2 and AlphaFold3 models, with a specific focus on their architectures and the changes between the two versions. To learn the difference between AlphaFold2, AlphaFold3, and AlphaFold-Multimer, look at \u201cAlphaFold 3 vs AlphaFold 2/AlphaFold2-Multimer: A Summary\u201d. There, you can find a short summary of the main differences and similarities between these 3 models that covers the main computer science/machine learning aspects of the model.",
            "To get an overview of AlphaFold3, its advantages, and disadvantages in a concise form, look at \u201cAlphaFold 3: A Leap Forward in Biomolecular Structure Prediction \u2014 Opportunities and Limitations\u201d. To find out more about other tools available as open source that can be compared to AlphaFold3, look at \u201cAlternatives to AlphaFold 3\u2014 how they work and when to use them\u201d.",
            "One more interesting thing to mention about the new AlphaFold3 paper is there is no direct comparison to the previous models in terms of protein structure prediction accuracy. Where is the Global Distance Test (GDT) for AlphaFold3 on this barplot (replicated from \u201cDrug design for beginners\u201d)?",
            "Here we cover practical considerations for people with a biological background: strong and weak sides of all AlphaFold models, types of structures AlphaFold3 fails to predict, things to be cautious about, and why we still need experimental structures even with all AlphaFold models. Structure prediction is often used in the context of protein structure prediction in particular (even though you can also predict structure of RNA or DNA or small molecules). It\u2019s a computational method used to determine the 3D structure of a protein based on its amino acid sequence."
          ],
          "title": "AlphaFold2, AlphaFold-Multimer, AlphaFold3",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://cen.acs.org/analytical-chemistry/structural-biology/AlphaFold-3-offer-structure-prediction/102/i15",
          "description": "Tool can predict structures of proteins and nucleic acids bound to ions, ligands, and one another",
          "snippets": [
            "The new tool can predict the structures and interactions of an array of molecules, including nucleic acids, small-molecule ligands, and macromolecule modifications (Nature 2024, DOI: 10.1038/s41586-024-07487-w). \u201cEvery time I gave an AlphaFold 2 talk . . . people would always ask me, That\u2019s really good, but I have a DNA-binding protein.",
            "In response, Max Jaderberg, chief AI officer at Isomorphic Labs, and DeepMind vice president of research Pushmeet Kohli posted simultaneously to X that the companies planned to release the code within 6 months for academic use. While DeepMind has released the code for predecessor model AlphaFold 2, it has not released training data or procedures\u2014a critical part of a machine learning model.",
            "In mid-May, researchers led by Mohammed AlQuraishi at Columbia University published OpenFold, an open-source equivalent to AlphaFold 2 that includes that information (Nat. Methods 2024, DOI: 10.1038/s41592-024-02272-z).",
            "In principle, a laboratory at a company or university could train its own variant of OpenFold\u2014for example, using proprietary structure data\u2014and generate predictions that resemble what AlphaFold 2 might predict, without using Google\u2019s servers. A lab might also optimize the model to solve a different type of problem."
          ],
          "title": "AlphaFold 3 to offer structure prediction via web browser",
          "meta": {
            "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions ...",
          "snippets": [
            "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions of known protein sequences6,7. Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure.",
            "Nature - AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture.",
            "By developing an accurate protein structure prediction algorithm, coupled with existing large and well-curated structure and sequence databases assembled by the experimental community, we hope to accelerate the advancement of structural bioinformatics that can keep pace with the genomics revolution. We hope that AlphaFold\u2014and computational approaches that apply its techniques for other biophysical problems\u2014will become essential tools of modern biology.",
            "Underpinning the latest version of AlphaFold is a novel machine learning approach that incorporates physical and biological knowledge about protein structure, leveraging multi-sequence alignments, into the design of the deep learning algorithm. ... The development of computational methods to predict three-dimensional (3D) protein structures from the protein sequence has proceeded along two complementary paths that focus on either the physical interactions or the evolutionary history."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://bjbas.springeropen.com/articles/10.1186/s43088-024-00503-y",
          "description": "In conclusion, this AlphaFold framework has the ability to yield atomically-accurate structural predictions for a variety of biomolecular interactions, hence facilitating advancements in drug discovery. ... Recent advances in protein structure prediction have witnessed groundbreaking developments, largely propelled by the emergence of advanced machine learning techniques and substantial improvements in algorithmic approaches [1,2,3...",
          "snippets": [
            "In conclusion, this AlphaFold framework has the ability to yield atomically-accurate structural predictions for a variety of biomolecular interactions, hence facilitating advancements in drug discovery. ... Recent advances in protein structure prediction have witnessed groundbreaking developments, largely propelled by the emergence of advanced machine learning techniques and substantial improvements in algorithmic approaches . Key highlights in this dynamic field include the release of AlphaFold2 by DeepMind which marked a watershed moment in protein structure prediction . Leveraging",
            "Looking ahead, recent strides in protein structure prediction signal a transformative era poised to reshape the landscape of biomolecular research and therapeutic development. Fueled by advancements in machine learning techniques and algorithmic approaches, the field is witnessing unprecedented progress, propelled by seminal innovations such as DeepMind's AlphaFold2 .",
            "Breakthrough achievements in protein structure prediction have occurred recently, mostly due to the advent of sophisticated machine learning methods and significant advancements in algorithmic approaches. The most recent version of the AlphaFold model, known as \u201cAlphaFold-latest,\u201d which expands the functionalities of the groundbreaking AlphaFold2, is the subject of this article.",
            "This addresses a longstanding challenge in the field, making structural predictions applicable to a more extensive range of biological entities . Language model has become a household phrase. Yet, what many may not realize is the profound impact language models have had within the realm of protein research . Among these advancements stand the illustrious AlphaFold2, renowned for its uncanny ability to accurately predict protein structures solely from amino acid sequences, employing an attention-based transformer architecture . This transformative architecture, pioneered by Google in 2017, marked a paradigm shift in natural language processing, enabling machines to understand and process language with unprecedented nuance and context."
          ],
          "title": "AlphaFold-latest: revolutionizing protein structure prediction ...",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2023.1120370/full",
          "description": "The development of a new vaccine ... the prediction of the mutations and its potential effects in spike protein domain allowed the generation of an immunogen, highlights the window of opportunity that AlphaFold2 offers in the structure-guided vaccine design (Higgins, 2021). The recent advances in protein ...",
          "snippets": [
            "The development of a new vaccine strategy used against COVID-19 by Pfizer, Moderna and Johnson & Johnson, in which the prediction of the mutations and its potential effects in spike protein domain allowed the generation of an immunogen, highlights the window of opportunity that AlphaFold2 offers in the structure-guided vaccine design (Higgins, 2021). The recent advances in protein structure prediction have contributed to improve protein folding issues.",
            "FIGURE 1. Timeline with main events and programs/webserver in the protein structure prediction. Colored boxes indicate the method or important event in the field. In 2018, DeepMind, a startup of Google, presented a new software that best performed in the 13th edition of CASP, named AlphaFold. In this competition, AlphaFold achieved the best position in the FM (best-of-five), reaching a summed z-score of 52.8 versus 36.6 from the second place and, combining FM and FM/TBM categories, achieved 68.3 z-score versus 48.2 (Senior et al., 2019).",
            "As the comparison made in this work was not fair, since EMBER2 predicts 2D structures and AlphaFold, 3D structures, the authors developed a new approach that uses EMBER2 model, but now applied in three-dimensional structure prediction, named EMBER3D (Weissenow et al., 2022b). Again, Ember3D did not outperform AlphaFold, but is much faster than it and ESMFold. Whereas AlphaFold2 do not perform efficiently in the study of the impact of single amino acids variants into protein structure, Weissenow et al.",
            "For this, ESM Metagenomic Atlas is an important 3D protein structures resource to be deeply investigated by the scientific community (Lin et al., 2022). Finally, the efforts to better predict how mutations affect protein structure using these new approaches are essential to gain insights in human genetic disease and further improve disease management and prediction. Today, these methods do not outperform AlphaFold2, but with the improvement of deep language models and the enrichment of these models with biological information through multi-task learning, they promise to revolutionize the protein structural biology."
          ],
          "title": "Frontiers | Before and after AlphaFold2: An overview of protein ...",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "On May 8, 2024, an article was ... accurate structure prediction of biomolecular interactions [1]. In the rapidly evolving landscape of life sciences, the intersection of artificial intelligence (AI) and biology has heralded a new era of discovery and innovation. At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning ...",
          "snippets": [
            "On May 8, 2024, an article was published by Josh Abramson regarding the successful use of AlphaFold 3 (Google DeepMind Technologies Limited, London, United Kingdom) in the accurate structure prediction of biomolecular interactions . In the rapidly evolving landscape of life sciences, the intersection of artificial intelligence (AI) and biology has heralded a new era of discovery and innovation. At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning methodologies, AlphaFold 3 has achie",
            "This review, by exploring advancements in machine learning and deep learning technologies such as the the innovative use of AI by Bileschi and Colwell  to harness molecular structure predictions and the Gemini model (Google DeepMind Technologies Limited) , will attempt to reveal how AlphaFold 3 sets new benchmarks in the accurate modeling of protein structures and their complexes with ligands.",
            "The structure module has also been redesigned to include an explicit 3D structure for each residue, rapidly developing and refining a highly accurate protein structure . ... One of the most notable advancements in AlphaFold 3 is its expanded predictive abilities.",
            "Advancements in Genomics and Personalized Medicine \u00b7 The detailed structural insights provided by AlphaFold 3 into DNA and RNA open new avenues in genomics, significantly impacting personalized medicine. By understanding how genetic variations affect protein functions, tailored therapeutic strategies can be developed for individuals based on their unique genetic profiles . ... AlphaFold 3's capability to predict the structure of small molecules paves the way for creating novel biomaterials."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-024-07487-w",
          "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
          "snippets": [
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "Nature - AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and...",
            "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2,3,4,5,6. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues.",
            "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biologica"
          ],
          "title": "Accurate structure prediction of biomolecular interactions with ...",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
            "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://alphafold.ebi.ac.uk/",
          "description": "AlphaFold Protein Structure Database",
          "snippets": [],
          "title": "AlphaFold Protein Structure Database",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/meet-alphafold-3-which-can-accurately-model-more-than-99-of-molecular-types-in-the-protein-data-bank/",
          "description": "DeepMind had already freely published ... million proteins known to science made using earlier versions of AlphaFold. By fostering collaboration and knowledge sharing, DeepMind\u2019s open science approach has the potential to accelerate scientific discoveries and pharmaceutical development worldwide. This initiative ensures that the groundbreaking predictions of AlphaFold 3 are not limited to a select few but rather contribute to the collective advancement of scientific ...",
          "snippets": [
            "DeepMind had already freely published the predicted structures of more than 200 million proteins known to science made using earlier versions of AlphaFold. By fostering collaboration and knowledge sharing, DeepMind\u2019s open science approach has the potential to accelerate scientific discoveries and pharmaceutical development worldwide. This initiative ensures that the groundbreaking predictions of AlphaFold 3 are not limited to a select few but rather contribute to the collective advancement of scientific progress.",
            "AlphaFold 3 by DeepMind accurately predicts protein structures and interactions, transforming drug discovery and structural biology.",
            "In a press briefing, Demis Hassabis, CEO of DeepMind Technologies, explained the evolution of AlphaFold over the years and the significance of AlphaFold 3: \u201cWith AlphaFold 2, the big milestone moment in structural biology was in essence you can think of it as our solution to the static picture of proteins, going from predicting the amino acid sequence to the 3D structure of the protein,\u201d he said.",
            "Alongside this debut, Google DeepMind is launching the AlphaFold Server, a user-friendly tool that allows non-commercial researchers to harness the capabilities of AlphaFold 3. With just a few clicks, biologists can generate large and complex protein structures that have previously been challenging to predict quickly and accurately."
          ],
          "title": "AlphaFold 3 offers even more accurate protein structure prediction",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
          "description": "By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery. ... Update November 11, 2024: As of November 2024, we have released AlphaFold 3 model code and weights for academic use to help advance ...",
          "snippets": [
            "By accurately predicting the structure of proteins, DNA, RNA, ligands and more, and how they interact, we hope it will transform our understanding of the biological world and drug discovery. ... Update November 11, 2024: As of November 2024, we have released AlphaFold 3 model code and weights for academic use to help advance research.",
            "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
            "7PNM - Spike protein of a common cold virus (Coronavirus OC43): AlphaFold 3\u2019s structural prediction for a spike protein (blue) of a cold virus as it interacts with antibodies (turquoise) and simple sugars (yellow), accurately matches the true structure (gray). The animation shows the protein interacting with an antibody, then a sugar. Advancing our knowledge of such immune-system processes helps better understand coronaviruses, including COVID-19, raising possibilities for improved treatments.",
            "They\u2019re made up of proteins, DNA and other molecules, but no single piece works on its own. Only by seeing how they interact together, across millions of types of combinations, can we start to truly understand life\u2019s processes. In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "Update November 11, 2024: As of November 2024, we have released AlphaFold 3 model code and weights for academic use to help advance research. Learn more about AlphaFold tools. ... Inside every plant, animal, and human cell are billions of molecular machines. They\u2019re made up of proteins, DNA, and other molecules, but no single piece works on its own.",
            "7PNM - Spike protein of a common cold virus (Coronavirus OC43): AlphaFold 3\u2019s structural prediction for a spike protein (blue) of a cold virus as it interacts with antibodies (turquoise) and simple sugars (yellow), accurately matches the true structure (gray). The animation shows the protein interacting with an antibody, then a sugar. Advancing our knowledge of such immune-system processes helps better understand coronaviruses, including COVID-19, raising possibilities for improved treatments.",
            "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.sciencedirect.com/science/article/abs/pii/B9780323998932000026",
          "description": "This chapter gives a brief summary of protein structure prediction. The milestone success of AlphaFold can be attributed to (1) the exploitation of genome-wide residue-residue coevolutionary constraint for structure prediction; (2) the use of a powerful deep learning algorithm to extract structure information from enormous quantities of sequence data and known 3D ...",
          "snippets": [
            "This chapter gives a brief summary of protein structure prediction. The milestone success of AlphaFold can be attributed to (1) the exploitation of genome-wide residue-residue coevolutionary constraint for structure prediction; (2) the use of a powerful deep learning algorithm to extract structure information from enormous quantities of sequence data and known 3D structure data.",
            "This chapter gives a brief summary of protein structure prediction. The milestone success of AlphaFold can be attributed to (1) the exploitation of ge\u2026"
          ],
          "title": "AlphaFold, the successful prediction of three-dimensional protein ...",
          "meta": {
            "query": "AlphaFold 3 advancements in protein structure prediction",
            "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    },
    {
      "utterance": "To ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse, several strategies could be implemented.\n\nFirstly, increasing the accessibility of AlphaFold 3 to a wider audience is crucial. The current limited and proprietary nature of its accessibility raises concerns about equitable access to this cutting-edge technology, potentially hindering scientific transparency and public accountability [60]. One way to address this issue could be by developing open-access platforms or collaborations that allow researchers, especially those from underfunded regions or institutions, to use AlphaFold 3 without financial or logistical barriers [63].\n\nIn terms of data privacy, it is essential to establish robust privacy controls. Ensuring that data used by AlphaFold 3 is anonymized can mitigate privacy concerns. Techniques from marketing analytics platforms, which often have built-in features to anonymize user data, could be adapted to protect individuals' identities while still leveraging data for scientific advancements [65]. This would involve designing user-centric privacy controls that give researchers the ability to manage their data preferences effectively [64].\n\nFurthermore, addressing potential misuse of the technology requires ongoing dialogue with experts in biosecurity, bioethics, and AI safety. DeepMind and Isomorphic Labs have already consulted over 50 experts to assess the biosecurity risks of AlphaFold 3, concluding that the benefits far outweigh the potential risks [61]. Such consultations should continue to evolve as the technology develops, ensuring that any emerging risks are promptly addressed.\n\nFinally, leveraging AlphaFold 3 for global health advancements can contribute to a more equitable distribution of its benefits. Its potential to aid in developing vaccines and treatments for emerging diseases could significantly improve global health security and address neglected diseases in underdeveloped regions [62]. By focusing on these areas, AlphaFold 3 can help bring new hope and healthcare advancements to millions, thereby contributing to a more equitable world.\n\nWhile these strategies highlight promising pathways, it is important to acknowledge that achieving these goals will require concerted efforts from stakeholders across the scientific, regulatory, and ethical domains. Continuous evaluation and adaptation of these measures will be necessary to address any new challenges that may arise.",
      "raw_utterance": "To ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse, several strategies could be implemented.\n\nFirstly, increasing the accessibility of AlphaFold 3 to a wider audience is crucial. The current limited and proprietary nature of its accessibility raises concerns about equitable access to this cutting-edge technology, potentially hindering scientific transparency and public accountability [60]. One way to address this issue could be by developing open-access platforms or collaborations that allow researchers, especially those from underfunded regions or institutions, to use AlphaFold 3 without financial or logistical barriers [63].\n\nIn terms of data privacy, it is essential to establish robust privacy controls. Ensuring that data used by AlphaFold 3 is anonymized can mitigate privacy concerns. Techniques from marketing analytics platforms, which often have built-in features to anonymize user data, could be adapted to protect individuals' identities while still leveraging data for scientific advancements [65]. This would involve designing user-centric privacy controls that give researchers the ability to manage their data preferences effectively [64].\n\nFurthermore, addressing potential misuse of the technology requires ongoing dialogue with experts in biosecurity, bioethics, and AI safety. DeepMind and Isomorphic Labs have already consulted over 50 experts to assess the biosecurity risks of AlphaFold 3, concluding that the benefits far outweigh the potential risks [61]. Such consultations should continue to evolve as the technology develops, ensuring that any emerging risks are promptly addressed.\n\nFinally, leveraging AlphaFold 3 for global health advancements can contribute to a more equitable distribution of its benefits. Its potential to aid in developing vaccines and treatments for emerging diseases could significantly improve global health security and address neglected diseases in underdeveloped regions [62]. By focusing on these areas, AlphaFold 3 can help bring new hope and healthcare advancements to millions, thereby contributing to a more equitable world.\n\nWhile these strategies highlight promising pathways, it is important to acknowledge that achieving these goals will require concerted efforts from stakeholders across the scientific, regulatory, and ethical domains. Continuous evaluation and adaptation of these measures will be necessary to address any new challenges that may arise.",
      "role": "Bioethicist",
      "role_description": " This expert specializes in the ethical implications of new technologies in the field of biology and medicine. They will bring a critical perspective to the discussion, addressing concerns around the commercialization of AlphaFold 3, data sharing practices, and the broader ethical considerations of using AI in biomolecular structure prediction.",
      "queries": [
        "equitable access to AlphaFold 3 benefits",
        "addressing data privacy concerns AlphaFold 3"
      ],
      "utterance_type": "Support",
      "claim_to_make": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
      "raw_retrieved_info": [
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "The limited and proprietary nature ... equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research [38]. By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader ...",
          "snippets": [
            "The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research . By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "Despite current restrictions on access to AlphaFold 3, there is potential for the development of open-source versions by the end of the year . Such efforts would democratize access to this advanced technology, allowing a broader scientific community to contribute to and benefit from its capabilities.",
            "AlphaFold 3 has already established itself as a turning point in the field of computational biochemistry and drug development along with receptor modulation and biomolecular development. With the help of AlphaFold 3 and models similar to this, researchers will gain unparalleled insights into the structural dynamics of proteins and their interactions, opening up new avenues for scientists and doctors to exploit for the benefit of the patient."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
            "placement": "root -> Future of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.reddit.com/r/singularity/comments/1cnp5u7/alphafold_3_is_a_fantastic_breakthrough_and/",
          "description": "336 votes, 140 comments. The model itself is closed source and heavily restricted. Yes, the dataset of all known proteins is available, but Deepmind\u2026",
          "snippets": [
            "Posted by u/AlterandPhil - 336 votes and 140 comments",
            "The model can only be accessed on the cloud using AlphaFold server and each user is limited to 10 predictions per day. Plus, the model cannot be used for commercial purposes nor can predictions for the structures of proteins bound to drugs be made.",
            "Isomorphic Labs, a DeepMind spin-off company in London, is using AlphaFold3 to develop drugs, both through its own pipeline and with other pharmaceutical companies. \u201cWe have to strike a balance between making sure that this is accessible and has the impact in the scientific community as well as not compromising Isomorphic\u2019s ability to pursue commercial drug discovery,\u201d says Pushmeet Kohli, DeepMind\u2019s head of AI science and a study co-author.",
            "\u201cWe have to strike a balance between making sure that this is accessible and has the impact in the scientific community as well as not compromising Isomorphic\u2019s ability to pursue commercial drug discovery,\u201d said Pushmeet Kohli, DeepMind\u2019s head of AI science to Nature reporter Ewen Callaway \u00b7 You decide what this means. ... I don\u2019t think this is relevant to AlphaFold, but I did like Mark Zuckerbergs point when discussing Google\u2019s MedGemini model-"
          ],
          "title": "r/singularity on Reddit: AlphaFold 3 is a Fantastic Breakthrough ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
          "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
          "snippets": [
            "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules",
            "Working together with the research and safety community to take a science-led approach, we have conducted extensive assessments to mitigate potential risks and share the widespread benefits to biology and humanity. Building on the external consultations we carried out for AlphaFold 2, Google DeepMind have now engaged with more than 50 domain experts, in addition to specialist third parties, across biosecurity, research, and industry, to understand the capabilities of successive AlphaFold models and any potential risks.",
            "AlphaFold Server reflects the ongoing commitment to share the benefits of AlphaFold, including the free database of 200 million protein structures.",
            "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through the newly launched AlphaFold Server, an easy-to-use research tool."
          ],
          "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://ncbi.nlm.nih.gov/pmc/articles/PMC11292590",
          "description": "The limited and proprietary nature ... equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research [38]. By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader ...",
          "snippets": [
            "The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research . By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community.",
            "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
            "Despite current restrictions on access to AlphaFold 3, there is potential for the development of open-source versions by the end of the year . Such efforts would democratize access to this advanced technology, allowing a broader scientific community to contribute to and benefit from its capabilities.",
            "AlphaFold 3 has already established itself as a turning point in the field of computational biochemistry and drug development along with receptor modulation and biomolecular development. With the help of AlphaFold 3 and models similar to this, researchers will gain unparalleled insights into the structural dynamics of proteins and their interactions, opening up new avenues for scientists and doctors to exploit for the benefit of the patient."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/meta-multiomics/alphafold-3-a-leap-forward-in-biomolecular-structure-prediction-opportunities-and-limitations-924350af1181",
          "description": "AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and\u2026",
          "snippets": [
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far\u2026",
            "By understanding how gene expression varies with different drug concentrations, researchers can pinpoint the most effective dosages that maximize therapeutic benefits while minimizing side effects. Enhancer and Promoter Scoring: The regulation of gene expression is critically dependent on enhancers and promoters. Cognit predicts how these regulatory elements interact under various conditions, enhancing our ability to manipulate gene expression in disease states. Epigenetic Predictions: Cognit extends its predictive prowess to epigenetic changes, including DNA methylation and chromatin accessibility.",
            "The latest release of DeepMind\u2019s AlphaFold 3 (AF3) represents a monumental stride in the domain of protein structure prediction, establishing new paradigms in accuracy and applicability that far surpass its predecessor, AlphaFold 2 (AF2).",
            "I also talk about the significant limitations of AlphaFold 3 and how companies such as Cognit.AI which is working on simulation of gene regulatory network in a human cell, in-silico can complement in application areas like drug discovery for complex diseases."
          ],
          "title": "AlphaFold 3: A Leap Forward in Biomolecular Structure Prediction ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
          "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
          "snippets": [
            "\u201cAnd you tried that out in the lab physically and you had to go through a few thousand physical tests with each new attempt.\u201d Drug developers can now conduct these experiments computationally at a fraction of the cost using AlphaFold, compared to the time-consuming and resource-intensive process of traditional methods. The benefits of AlphaFold have not gone unnoticed by the scientific community.",
            "\u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed. Serious implementation requires access to a robust hardware architecture, including servers and orchestration tools like Kubernetes and virtual machines.",
            "Last week, Google DeepMind launched AlphaFold 3, a significant update to its predecessor, AlphaFold 2. The latter has profoundly influenced structural biology and biomedicine in recent years while also attracting some skepticism. While AlphaFold 2 could accurately predict the structures of vast swathes of proteins, AlphaFold 3 ups the ante.",
            "A Nature paper, published early as it undergoes further editing, explains that AlphaFold 3 boasts a 58% success rate on ligand binding prediction, compared to 24% for AutoDock Vina, an open-source molecular docking program. AlphaFold also outperformed RoseTTAFold2NA, a machine learning-based tool for predicting 3D structures of protein-RNA and protein-DNA complexes."
          ],
          "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
          "snippets": [
            "However, John Jumper, PhD, one of the senior authors of the AlphaFold 3 article and lead author on AlphaFold 2, reportedly told the press that DeepMind and Isomorphic Labs had consulted more than 50 experts in biosecurity, bioethics, and AI safety and concluded that AlphaFold 3\u2019s marginal biosecurity risks were far outweighed by the system\u2019s potential benefits to science.",
            "Google DeepMind\u2019s renowned protein structure prediction algorithm, AlphaFold, which made a grand leap in solving one of biology\u2019s biggest problems, determining a protein\u2019s 3D structure from its sequence, has received a major update.",
            "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more.",
            "The publication, which is a collaboration between DeepMind and Isomorphic Labs, a London-based company launched in 2021 to build upon DeepMind\u2019s AI research to tackle biological problems, emphasizes AlphaFold 3\u2019s potential to advance therapeutic applications, including drug discovery."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
            "placement": "root -> Future of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deeperinsights.com/ai-blog/alphafold-3-the-key-to-understanding-lifes-building-blocks",
          "description": "AlphaFold 3 revolutionises biology by predicting molecular interactions with unprecedented accuracy, accelerating breakthroughs in drug discovery and synthetic biology.",
          "snippets": [
            "On a global scale, AlphaFold 3\u2019s predictions could aid in rapidly developing vaccines and treatments for emerging diseases, helping to prevent pandemics and improve global health security [source]. Its impact on neglected diseases could be significant, bringing new hope to millions in underdeveloped regions. This could lead to a more equitable distribution of healthcare advancements, improving quality of life worldwide.",
            "The AlphaFold Server is an online platform designed to make the powerful capabilities of AlphaFold easily accessible to researchers worldwide.",
            "The AlphaFold Server not only democratises access to this technology but also promotes global collaboration by providing open access to its advanced protein structure prediction tools.",
            "AlphaFold 3 is a monumental leap that is revolutionising our understanding of life's most fundamental structures [source]. Building on the astounding successes of AlphaFold 2, which already set a new benchmark by predicting protein structures with near-experimental accuracy, AlphaFold 3 takes innovation to an entirely new level."
          ],
          "title": "AlphaFold 3: The Key to Understanding Life's Building Blocks - ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
            "placement": "root -> Future of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://deepmind.google/discover/blog/how-our-principles-helped-define-alphafolds-release/",
          "description": "Our Operating Principles have come to define both our commitment to prioritising widespread benefit, as well as the areas of research and applications we refuse to pursue. These principles have...",
          "snippets": [
            "We had initially considered omitting predictions for which AlphaFold had low confidence or high predictive uncertainty, but the external experts we consulted proved why this was especially important to retain these predictions in our release, and advised us on the most useful and transparent ways to present this information. Equitable benefit could mean extra support for underfunded fields.",
            "This totals over 200 million structures, all freely available on EMBL-EBI\u2019s website with open access licences, accompanied by support resources, such as webinars on interpreting these structures. Building 3D visualisations into the database, with prominent labelling for high-confidence and low-confidence areas of the prediction, and, in general, aiming to be as clear as possible about AlphaFold\u2019s strengths and limitations in our documentation.",
            "Through our discussions with external experts, it became clearer that AlphaFold would not make it meaningfully easier to cause harm with proteins, given the many practical barriers to this \u2013 but that future advances would need to be evaluated carefully. Many experts argued strongly that AlphaFold, as an advance relevant to many areas of scientific research, would have the greatest benefit through free and widespread access.",
            "Our AlphaFold AI system solved the 50-year-old challenge of protein structure prediction \u2013 and we\u2019ve been thrilled to see scientists using it to accelerate progress in fields such as sustainability, food security, drug discovery, and fundamental human biology since releasing it to the wider community last year."
          ],
          "title": "How our principles helped define AlphaFold\u2019s release - Google ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
            "placement": "root -> Future of AlphaFold 3"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://medium.com/advances-in-biological-science/alphafold-3s-advances-and-limitations-in-a-nutshell-5ae0cdd814ea",
          "description": "AlphaFold 3, DeepMind\u2019s latest iteration in biomolecular structure prediction, has generated significant interest within the scientific community. This minireview assesses the model\u2019s advancements\u2026",
          "snippets": [
            "AlphaFold 3, DeepMind\u2019s latest iteration in biomolecular structure prediction, has generated significant interest within the scientific community. This minireview assesses the model\u2019s advancements, its ability to predict complex biomolecular interactions, and its limitations.",
            "Unlike its predecessors, AlphaFold 3 can model interactions between proteins and a variety of other molecules of biological interest, including nucleic acids, ions, and in principle small molecules of any kind.",
            "Despite showing sparks of chemical intuition, AlphaFold 3 exhibits notable deficiencies in certain areas, particularly when compared to AlphaFold 2.",
            "AlphaFold 3 is DeepMind\u2019s and Isomorphic Labs\u2019 new step forward in the application of artificial intelligence to the prediction of biomolecular structures."
          ],
          "title": "AlphaFold 3's Advances and Limitations In a Nutshell | by ...",
          "meta": {
            "query": "equitable access to AlphaFold 3 benefits",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
          "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
          "snippets": [
            "The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research . By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community.",
            "Leveraging advanced deep learning methodologies, AlphaFold 3 has achieved unprecedented accuracy in predicting the three-dimensional structures of proteins, a cornerstone in understanding biomolecular interactions and functions . This capability not only enhances our grasp of biological machinery but also accelerates the pace at which we can address some of the most pressing challenges in medical biology, from antibiotic resistance to the development of malaria vaccines .",
            "This review, by exploring advancements in machine learning and deep learning technologies such as the the innovative use of AI by Bileschi and Colwell  to harness molecular structure predictions and the Gemini model (Google DeepMind Technologies Limited) , will attempt to reveal how AlphaFold 3 sets new benchmarks in the accurate modeling of protein structures and their complexes with ligands. Further, we will explore its applications in drug discovery, providing real-life case studies and examples that underscore its potential. Alongside the success stories, we will also address the challenges and limitations faced by researchers, setting the stage for a discussion on the prospects and developments in leveraging AI, like AlphaFold 3, for breakthroughs in the life sciences .",
            "Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]."
          ],
          "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
          "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
          "snippets": [
            "AlQuraishi added that independently reproducing AlphaFold 3 would be highly valuable to permit training new variants of the system, including potentially training on private data repositories.",
            "\u201cI have no doubt that [the ability to predict molecular interactions with AlphaFold 3] could be a transformative advance for the field,\u201d Wankowicz told GEN Biotechnology. \u201cThat\u2019s why this evokes such a strong response from the scientific community. We want access to it because we know that this is probably really good science.\u201d \u00b7 Nature\u2019s editor-in-chief, Magdalena Skipper, PhD stated that when making a decision on data and code availability, the journal reflects on several factors including \u201cthe potential implications for biosecurity and the ethical challenges this presents.\u201d In such cases, the journal works with authors to provide alternatives that will support reproducibility, such as pseudocode.",
            "Google DeepMind\u2019s renowned protein structure prediction algorithm, AlphaFold, which made a grand leap in solving one of biology\u2019s biggest problems, determining a protein\u2019s 3D structure from its sequence, has received a major update.",
            "In a report published in Nature on May 8, researchers unveiled AlphaFold 3\u2019s expanded predictive capabilities from proteins to a broad spectrum of biomolecular interactions, including DNA, RNA, ligands, and more."
          ],
          "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://en.wikipedia.org/wiki/AlphaFold",
          "description": "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024.",
          "snippets": [
            "AlphaFold 1 (2018) was built on work developed by various teams in the 2010s, work that looked at the large databanks of related DNA sequences now available from many different organisms (most without known 3D structures), to try to find changes at different residues (peptides) that appeared to be correlated, even though the residues were not consecutive in the main chain.",
            "However, the October 2021 update, named AlphaFold-Multimer, included protein complexes in its training data. DeepMind stated this update succeeded about 70% of the time at accurately predicting protein-protein interactions. Announced on 8 May 2024, AlphaFold 3 was co-developed by Google DeepMind and Isomorphic Labs, both subsidiaries of Alphabet.",
            "Open access to source code of several AlphaFold versions (excluding AlphaFold 3) has been provided by DeepMind after requests from the scientific community. The source code of AlphaFold 3 was made available for non-commercial use to the scientific community upon request in November 2024. The AlphaFold Protein Structure Database, a joint project between AlphaFold and EMBL-EBI, was launched on July 22, 2021.",
            "Therefore, it may not perform as well on synthetic proteins or proteins with very low homology to those in the training database. The model's ability to predict multiple native conformations of proteins is limited. AlphaFold 3 version can predict structures of protein complexes with a very limited set of selected cofactors and co- and post-translational modifications.",
            "AlphaFold is an artificial intelligence (AI) program developed by DeepMind, a subsidiary of Alphabet, which performs predictions of protein structure. It is designed using deep learning techniques. AlphaFold 1 (2018) placed first in the overall rankings of the 13th Critical Assessment of Structure ..."
          ],
          "title": "AlphaFold - Wikipedia",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.scarlettculture.com/big-data-privacy-concerns",
          "description": "Big data has become an important part of our everyday lives. Organizations of all kinds and fields are now collecting and analyzing huge amounts of data to learn more about their customers and make better decisions. Big data poses various concerns, notably privacy, and data exploitation.",
          "snippets": [
            "Explore the impact of big data on privacy and learn about the types, applications, and risks associated with collecting and analyzing vast amounts of data.",
            "Here\u2019s a hypothetical scenario that will help you better understand the privacy concerns regarding big data. A major social media platform with billions of users worldwide experiences a catastrophic data breach, shaking the foundations of online privacy. Hackers breached the platform's servers and stole personal data, private messages, and browsing habits. The leaked data has a lot of private information, like people's names, phone numbers, email addresses, and even cash information.",
            "As organizations use the power of big data to drive innovation and gain a competitive edge, they must also be aware of the privacy issues that come with it. Organizations can proactively address big data privacy concerns and protect sensitive information by engaging cybersecurity services from reputable providers.",
            "Organizations can benefit from partnering with cybersecurity service providers to address big data privacy concerns effectively."
          ],
          "title": "Addressing Big Data Privacy Issues | The Scarlett Group",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.forbes.com/sites/robtoews/2021/10/03/alphafold-is-the-most-important-achievement-in-ai-ever/",
          "description": "Machine learning will transform the life sciences in the years ahead.",
          "snippets": [
            "Another database, UniProt, contains the amino acid sequences (without structures) for nearly two hundred million more proteins. The AlphaFold AI model is built with transformers, the same cutting-edge neural network architecture that powers well-known language models like GPT-3 and BERT.",
            "This article is more than 3 years old. ... DeepMind's AlphaFold represents the first time a significant scientific problem has been solved by ...",
            "Before AlphaFold, we knew the 3-D structures for only about 17% of the roughly 20,000 proteins in the human body.",
            "Suddenly, thanks to AlphaFold, we now have 3-D structures for virtually all (98.5%) of the human proteome."
          ],
          "title": "AlphaFold Is The Most Important Achievement In AI\u2014Ever",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://academic.oup.com/nar/article/50/D1/D439/6430488",
          "description": "Thus, we only know the 3D structure of a tiny fraction of all proteins currently known to science. The first release of AlphaFold DB contains over 360 000 predicted structures from 21 model-organism proteomes. Having access to these highly accurate models will greatly impact biology, from enabling structure-based drug design to providing data ...",
          "snippets": [
            "Thus, we only know the 3D structure of a tiny fraction of all proteins currently known to science. The first release of AlphaFold DB contains over 360 000 predicted structures from 21 model-organism proteomes. Having access to these highly accurate models will greatly impact biology, from enabling structure-based drug design to providing data for high-throughput structural bioinformatics research that will tackle fundamental biological questions.",
            "This will be followed by another update in 2022 to include structures for most representative sequences from the UniRef90 data set (>100 million structures). Future updates will also aim to overlay annotations onto the predicted structures and display this information on 2D sequence-feature viewers. AlphaFold DB will enable biomedical scientists to use 3D models of protein structures as a core tool, driving research and innovation across multiple fields by providing open access to an ever-growing number of predicted structures.",
            "A structural biology community assessment of AlphaFold 2 applications Biophysics. ... L.J. et al. . Pfam: The protein families database in 2021. Nucleic Acids Res. ... S. et al. . The InterPro protein families and domains database: 20 years on. Nucleic Acids Res. ... Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures.",
            "The first version of AlphaFold DB contains over 360,000 models of 21 biologically essential species. Proteins are essential macromolecules with vital biological functions and, thus, are involved in a wide range of research activities and medical and biotechnological applications, from fighting infectious diseases to tackling environmental pollution (1,2). Knowledge of the three-dimensional (3D) arrangement of the atoms of a protein can provide essential clues to understanding the roles and mechanisms underpinning protein functions (3,4)."
          ],
          "title": "AlphaFold Protein Structure Database: massively expanding the ...",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://www.nature.com/articles/s41586-021-03819-2",
          "description": "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions ...",
          "snippets": [
            "Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort1\u20134, the structures of around 100,000 unique proteins have been determined5, but this represents a small fraction of the billions of known protein sequences6,7. Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure.",
            "Nature - AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture.",
            "The AlphaFold network directly predicts the 3D coordinates of all heavy atoms for a given protein using the primary amino acid sequence and aligned sequences of homologues as inputs (Fig. 1e; see Methods for details of inputs including databases, MSA construction and use of templates).",
            "This creates a strong bias for atoms to be correct relative to the local frame of each residue and hence correct with respect to its side-chain interactions, as well as providing the main source of chirality for AlphaFold (Supplementary Methods 1.9.3 and Supplementary Fig. 9). The AlphaFold architecture is able to train to high accuracy using only supervised learning on PDB data, but we are able to enhance accuracy (Fig."
          ],
          "title": "Highly accurate protein structure prediction with AlphaFold | Nature",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://evgmedia.com/addressing-data-privacy-concerns/",
          "description": "It\u2019s more important than ever to be transparent about your company\u2019s privacy protection for customers.",
          "snippets": [
            "Goldfarb and Tucker suggest that to use the opportunity wisely, companies do well to, \u201c1. Develop user-centric privacy controls to give customers control. 2. Avoid multiple intrusions. And 3.",
            "With recent concerns coming to light about data privacy and social media, it\u2019s more important than ever to be transparent about your company\u2019s privacy protection for customers. Many consumers are wary of clicking online ads because they are worried about whether their privacy is being protected.",
            "But that\u2019s not the only reason individuals may worry about their privacy. Tony Bradly learned of other concerns regarding data privacy and reported on them earlier this year in his Forbes article, \u201cTop 5 Concerns To Focus On For Data Privacy day.\u201d In the article, he notes five things that businesses should be concerned with.",
            "Provide visitors to your business, whether it be online or in person a way to opt out from your data collection process. By allowing customers to choose not to share information with you, you can better appeal to those who are wary of privacy concerns."
          ],
          "title": "Addressing Data Privacy Concerns | EnVeritas Group",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
            "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://improvado.io/blog/big-data-analytics-privacy-problems",
          "description": "Addressing common challenges in big data analytics privacy. Insights on policy violations, breaches, compliance, and effective solutions for enterprises.",
          "snippets": [
            "When approached correctly, these platforms can also play a significant role in addressing data analytics privacy problems. Marketing analytics platforms often have built-in features to anonymize user data. This means that while the data can be used to understand user behaviors and trends, it doesn't directly identify an individual user. By working with anonymous data, privacy concerns are significantly reduced.",
            "This practice of data minimization reduces the risk of unnecessary data collection and storage, which in turn limits privacy risks. These platforms often come with robust security measures, ensuring that the data stored is protected from breaches. Regular updates and patches ensure that any potential vulnerabilities are quickly addressed.",
            "A prevalent misconception in the realm of data management is conflating data privacy with data safety. While interconnected, these two concepts serve distinct purposes. Data privacy concerns the rights and expectations of data subjects regarding their personal information, dictating how data should be used and shared.",
            "Data privacy, often termed as information privacy, revolves around the proper handling, processing, storage, and usage of data. It's not just about keeping data safe, but ensuring that it's used responsibly and ethically. As big data analytics continues to revolutionize industries, understanding the potential privacy pitfalls becomes paramount."
          ],
          "title": "10 Big Data Analytics Privacy Problems and How to Navigate Them",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
            "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
          },
          "citation_uuid": -1
        },
        {
          "url": "https://github.com/google-deepmind/alphafold3",
          "description": "AlphaFold 3 inference pipeline. Contribute to google-deepmind/alphafold3 development by creating an account on GitHub.",
          "snippets": [
            "You can then run AlphaFold 3 using the following command: docker run -it \\ --volume $HOME/af_input:/root/af_input \\ --volume $HOME/af_output:/root/af_output \\ --volume <MODEL_PARAMETERS_DIR>:/root/models \\ --volume <DATABASES_DIR>:/root/public_databases \\ --gpus all \\ alphafold3 \\ python run_alphafold.py \\ --json_path=/root/af_input/fold_input.json \\ --model_dir=/root/models \\ --output_dir=/root/af_output",
            "There are various flags that you can pass to the run_alphafold.py command, to list them all run python run_alphafold.py --help. Two fundamental flags that control which parts AlphaFold 3 will run are: --run_data_pipeline (defaults to true): whether to run the data pipeline, i.e.",
            "The following databases have been: (1) mirrored by Google DeepMind; and (2) in part, included with the inference code package for testing purposes, and are available with reference to the following: BFD (modified), by Steinegger M. and S\u00f6ding J., modified by Google DeepMind, available under a Creative Commons Attribution 4.0 International License. See the Methods section of the AlphaFold proteome paper for details.",
            "This package provides an implementation of the inference pipeline of AlphaFold 3. See below for how to access the model parameters. You may only use AlphaFold 3 model parameters if received directly from Google."
          ],
          "title": "GitHub - google-deepmind/alphafold3: AlphaFold 3 inference pipeline.",
          "meta": {
            "query": "addressing data privacy concerns AlphaFold 3",
            "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?"
          },
          "citation_uuid": -1
        }
      ],
      "cited_info": null
    }
  ],
  "experts": [
    {
      "topic": "AlphaFold 3\\",
      "role_name": "Pharmaceutical Industry Representative",
      "role_description": "A seasoned professional in the pharmaceutical industry, this speaker will provide valuable insights into how AlphaFold 3's increased speed and efficiency can transform drug discovery processes. They will focus on the practical applications of AlphaFold 3 in terms of cost savings, accelerated development timelines, and the impact on drug candidate designs."
    },
    {
      "topic": "AlphaFold 3\\",
      "role_name": "Research Scientist in Protein Structure Prediction",
      "role_description": "An expert in the field of protein structure prediction, this speaker will bring a scientific perspective to the discussion. They will delve into the technical aspects of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data. Additionally, they will highlight the importance of accurately modeling protein interactions for designing more effective and safer drug candidates."
    }
  ],
  "knowledge_base": {
    "topic": "AlphaFold 3\\",
    "tree": {
      "name": "root",
      "content": [],
      "children": [
        {
          "name": "Development of AlphaFold 3",
          "content": [
            88,
            85,
            86,
            87
          ],
          "children": [
            {
              "name": "Improved accuracy",
              "content": [],
              "children": [
                {
                  "name": "Comparison with Previous Versions",
                  "content": [
                    17,
                    18,
                    19,
                    20,
                    21
                  ],
                  "children": [],
                  "parent": "Improved accuracy",
                  "synthesize_output": "AlphaFold 3, the latest version of the AlphaFold model, has shown significant improvements in accuracy compared to its predecessors. The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools, including far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors, and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2. These results highlight the capability of high-accuracy modeling across biomolecular space within a single unified deep-learning framework[17].\n\nOne of the key advancements in AlphaFold 3 is the improved Evoformer module, a deep learning architecture that underpinned the incredible performance of AlphaFold 2. The model assembles its predictions using a diffusion network, which starts with a cloud of atoms and converges on the most accurate molecular structure over multiple steps. AlphaFold 3's predictions of molecular interactions surpass the accuracy of all existing systems[18].\n\nAlphaFold, developed by Google's DeepMind, has been continuously evolving to integrate the latest AI models into the field to speed up the process and improve accuracy. AlphaFold 2, released in 2020, won the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition, setting a high standard for the subsequent versions. The most recent release, AlphaFold 3, is set to further transform the protein space with its accurate predictions of protein structures and interactions, revolutionizing drug discovery and structural biology[19][20].\n\nMoreover, AlphaFold 3 can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions with a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods. This demonstrates the continuous advancements and improvements made in each iteration of the AlphaFold model[21].",
                  "need_regenerate_synthesize_output": false
                },
                {
                  "name": "Pairformer Module Advancements and Multisequence Alignment Processing",
                  "content": [
                    89,
                    90,
                    91,
                    92,
                    93
                  ],
                  "children": [],
                  "parent": "Improved accuracy",
                  "synthesize_output": "AlphaFold 3 introduces significant advancements in its PairFormer module, enhancing the processing of multi-sequence alignment (MSA) data and structural templates. The PairFormer, which replaces the EvoFormer module from AlphaFold 2, incorporates triangular attention updates to ensure that the structural hypotheses generated at each step satisfy the triangle inequality[89][92].\n\nOne key feature of AlphaFold 3's PairFormer is the generation of a pair representation that guides the iterative refinement of atom positions to create a 3D representation of the molecular structure. This approach allows for a more accurate prediction of protein structures by leveraging the information from MSA data and structural templates[90].\n\nThe PairFormer module plays a crucial role in enabling AlphaFold 3 to predict the joint structure of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues. This updated diffusion-based architecture expands the range of applications in protein modeling and design, showcasing the impact of AlphaFold 3 in revolutionizing the field of structural biology[91].\n\nIn terms of communication with the Structure module, the PairFormer in AlphaFold 3 employs linear projection of the pair representation for tokens i and j to a scalar value. This scalar is then added as a bias term to the attention matrix, allowing for the effective transfer of the structural hypotheses learned by the PairFormer to the subsequent stages of the modeling process[93].",
                  "need_regenerate_synthesize_output": false
                }
              ],
              "parent": "Development of AlphaFold 3",
              "synthesize_output": "AlphaFold 3 has demonstrated substantially improved accuracy over many previous specialized tools[17]. It shows far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors, and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2[17]. These advancements highlight that high-accuracy modeling across biomolecular space is achievable within a single unified deep-learning framework[17].\n\nAt the core of the model is an improved version of the Evoformer module, a deep learning architecture that significantly contributed to the success of AlphaFold 2[18]. AlphaFold 3 utilizes a diffusion network, similar to those used in AI image generators, to assemble its predictions of molecular interactions[18]. This process starts with a cloud of atoms and converges on the final, most accurate molecular structure over multiple steps[18]. The accuracy of AlphaFold 3's predictions surpasses that of all existing systems[18].\n\nThe advancements in accuracy brought by AlphaFold 3 have the potential to transform drug discovery and structural biology[20]. This AI tool accurately predicts protein structures and interactions, offering new possibilities in the field of biomedicine[20]. Additionally, AlphaFold 3 can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions, showing a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods[21]. These improvements underscore the significant leap in accuracy that AlphaFold 3 brings to the realm of protein structure prediction.",
              "need_regenerate_synthesize_output": true
            },
            {
              "name": "Increased speed",
              "content": [
                16,
                13,
                14,
                15
              ],
              "children": [],
              "parent": "Development of AlphaFold 3",
              "synthesize_output": "AlphaFold 3 has shown significant improvements in speed compared to its predecessors. In a repository supporting the running of AlphaFold 3 on a single NVIDIA A100 with 80 GB of memory, the configuration has been optimized to maximize throughput[15]. This setup has been found to be more efficient, at least 2 times faster, across all token sizes, making it suitable for high-throughput applications[15].\n\nAdditionally, the architectural development in AlphaFold 3 includes a completely redesigned Structure Module. The previous \"Invariant Point Attention\" has been replaced with a diffusion model wrapped around a Transformer, simplifying the representation of positions to coordinates in R3[16]. This redesign has contributed to the increased speed of AlphaFold 3 in predicting protein structures.",
              "need_regenerate_synthesize_output": false
            },
            {
              "name": "Advancements in AlphaFold 3",
              "content": [
                53,
                54,
                55,
                56,
                57,
                58,
                59
              ],
              "children": [],
              "parent": "Development of AlphaFold 3",
              "synthesize_output": "AlphaFold 3, developed by Google DeepMind Technologies Limited, represents a significant advancement in protein structure prediction technology. Compared to its predecessor, AlphaFold 2, AlphaFold 3 boasts superior accuracy and speed in predicting protein structures[53][54][55].\n\nOne key improvement in AlphaFold 3 is the inclusion of hardware and memory-optimized geometrical attention building blocks for higher inference throughput. Additionally, the model has expanded its training data to include protein-nucleic acid complexes, post-translational modifications (PTM), and cofactors, allowing for more diverse applications and improved accuracy in predicting protein interactions with other molecules[56].\n\nNotably, AlphaFold 3 has demonstrated a minimum 50% improvement in accuracy for protein interactions compared to existing methods. It has also shown better scaling of the model, achieving a success rate of 54.9% for correctly predicted protein structures with an RMSD of less than 2 A on the PostBusters dataset[56].",
              "need_regenerate_synthesize_output": false
            },
            {
              "name": "Overview of AlphaFold 3",
              "content": [
                1,
                2,
                3,
                4,
                5,
                6,
                7,
                8,
                9,
                10,
                11,
                12
              ],
              "children": [],
              "parent": "Development of AlphaFold 3",
              "synthesize_output": "AlphaFold 3, developed by Google DeepMind Technologies Limited in London, United Kingdom, is the latest version of the biomolecular structure predictor artificial intelligence (AI) model. This new iteration has been described as superior in accuracy and more powerful than its predecessor, AlphaFold 2[1]. The model is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions, and modified residues, spurring a revolution in the modeling of protein structures and interactions[6].\n\nAlphaFold 3 builds upon the success of its predecessors by not only predicting protein folding structures but also predicting the structure and interactions of various molecules such as DNA, RNA, and ligands[7]. This advancement has been lauded for its transformative potential in drug discovery and its ability to revolutionize research by simplifying the prediction of 3D protein structures[9]. The model's upgraded diffusion-based architecture enables it to accurately predict protein-molecule complexes containing DNA, RNA, and other molecules, further expanding its applications in the field of computational structural biology[8].\n\nDespite its groundbreaking capabilities, the release of AlphaFold 3 in May sparked controversy due to DeepMind's decision to withhold the code while providing limited access through a web interface. This move raised questions about the balance between open science and commercial interests, particularly as companies like DeepMind's sister organization Isomorphic Labs leverage AI advancements for drug development[11].",
              "need_regenerate_synthesize_output": false
            }
          ],
          "parent": "root",
          "synthesize_output": "Google DeepMind Technologies Limited recently released AlphaFold 3, the latest version of their biomolecular structure predictor artificial intelligence (AI) model. AlphaFold 3 represents a significant advancement over its predecessor, AlphaFold 2, in terms of accuracy and power[1]. This new version has been praised for its superior accuracy and speed in predicting protein structures, outperforming previous models in the field[2].\n\nThe development of AlphaFold 3 was led by Demis Hassabis and John Jumper, who had previously won prestigious awards for their work on the AlphaFold project, including the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research[3]. Proteins, composed of chains of amino acids that fold into complex 3D structures, play a crucial role in biological functions. AlphaFold 3's ability to accurately predict these protein structures in minutes has revolutionized the field of structural biology and has the potential to transform drug discovery[4].\n\nOne of the key advancements in AlphaFold 3 is its updated diffusion-based architecture, which allows the model to predict the structure of various biomolecular complexes, including proteins, nucleic acids, small molecules, ions, and modified residues[5]. Unlike its predecessor, AlphaFold 3 can predict not only protein folding structures but also the structure and interactions of other molecules, such as DNA, RNA, and ligands[6]. The model's improved accuracy in predicting protein-molecule complexes has been lauded for its transformative potential in drug discovery[7].\n\nThe development of AlphaFold 3 marks a significant milestone in the field of computational structural biology, offering researchers a powerful tool for predicting biomolecular complexes with unprecedented accuracy[8]. By leveraging advanced deep learning methodologies and innovative neural network architectures, AlphaFold 3 has set a new standard in protein structure prediction, paving the way for future advancements in the field[9].",
          "need_regenerate_synthesize_output": false
        },
        {
          "name": "Applications of AlphaFold 3",
          "content": [],
          "children": [
            {
              "name": "Impact on Drug Discovery Speed and Efficiency",
              "content": [
                38,
                39,
                40,
                41,
                42
              ],
              "children": [
                {
                  "name": "Speed and Efficiency Improvements",
                  "content": [
                    32,
                    33,
                    66,
                    67,
                    68,
                    69,
                    70,
                    34,
                    35,
                    36,
                    37,
                    31
                  ],
                  "children": [],
                  "parent": "Impact on Drug Discovery Speed and Efficiency",
                  "synthesize_output": "Speed and Efficiency Improvements\n\nThe introduction of AlphaFold 3 has significantly impacted the speed and efficiency of drug discovery in the pharmaceutical industry. Isomorphic Labs, in collaboration with pharmaceutical companies, is utilizing AlphaFold 3 to tackle real-world drug design challenges, aiming to develop innovative treatments that could potentially transform patients' lives[31]. This collaborative effort highlights the dedication to leveraging the capabilities of AlphaFold 3 to advance medical science and research.\n\nThe traditional approach to pharmaceutical development has often been described as playing roulette, where success relies on a small fraction of drugs to subsidize the rest[32]. AlphaFold's computational approach offers a distinct advantage over conventional medicinal chemistry methods, demonstrating its potential to accelerate the drug discovery process. Previous versions of AlphaFold, available through open-source code, have already made significant contributions to various research areas, such as malaria vaccines, cancer treatments, and enzyme design[33].\n\nThe latest version of AlphaFold has the capability to model how proteins interact with other molecules, offering a new level of insight that was previously limited[34]. Despite some restrictions on access to the tool, scientists can utilize most of its functionalities through the AlphaFold Server, a user-friendly research tool designed to support drug design initiatives[35]. Isomorphic Labs is employing AlphaFold 3 in combination with other AI models to enhance the success of drug design projects, enabling a better understanding of new disease targets and innovative approaches to previously inaccessible targets[36].\n\nAlphaFold 3 provides researchers with confidence scores to gauge the accuracy of predictions, streamlining the drug discovery process and potentially reducing the reliance on time-consuming trial and error approaches in the laboratory[37]. This AI system shows particular promise in the rational design of drugs, offering a more efficient and accurate method for developing therapeutic candidates.\n\nFurthermore, AlphaFold 3 extends its utility to predicting ADME properties, essential for understanding how drugs behave within the body and optimizing clinical trial designs[66]. By providing more accurate and reliable protein structure predictions in a shorter timeframe, AlphaFold 3 can accelerate the drug discovery pipeline, potentially reducing the time and cost required to identify new drug candidates[67]. With at least a 50% improvement in predicting protein interactions compared to existing methods, AlphaFold 3 represents a significant advancement in the field of drug discovery[68].\n\nThe simplified Pairformer module in AlphaFold 3 enhances computational efficiency by reducing the processing of multi-sequence alignment data, improving the overall speed and accuracy of protein structure predictions[70]. These speed and efficiency improvements have the potential to revolutionize drug development processes, leading to faster delivery of new therapies to patients in need.",
                  "need_regenerate_synthesize_output": false
                },
                {
                  "name": "Scalability and Accessibility Impact",
                  "content": [
                    71,
                    72,
                    73,
                    74,
                    75
                  ],
                  "children": [],
                  "parent": "Impact on Drug Discovery Speed and Efficiency",
                  "synthesize_output": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates [71][72][73][74][75]. This technology has the potential to revolutionize drug development processes by guiding researchers in designing drug candidate structures with improved efficacy and reduced side effects. Additionally, AlphaFold 3's ability to predict how ligands bind to target proteins can streamline the drug discovery process and ultimately impact the overall cost of development. The transformative potential of AlphaFold 3 has been described as \"groundbreaking\" and could have a deep impact on drug research and development, potentially leading to faster delivery of new therapies to patients in need.",
                  "need_regenerate_synthesize_output": false
                },
                {
                  "name": "Cost Savings and Accelerated Timelines",
                  "content": [
                    76,
                    77,
                    78,
                    79,
                    80,
                    81,
                    82,
                    83,
                    84
                  ],
                  "children": [],
                  "parent": "Impact on Drug Discovery Speed and Efficiency",
                  "synthesize_output": "AlphaFold 3 offers significant advantages over traditional medicinal chemistry methods in drug discovery processes, potentially bringing cost savings and accelerated timelines to pharmaceutical companies[76][77][78]. The AI program's accuracy in predicting protein-ligand interactions surpasses traditional physics-based methods, even without structural input information, indicating a substantial impact on drug development[79][80][81]. Additionally, AlphaFold 3's ability to predict how proteins bind to DNA and how drugs interact with proteins provides crucial insights for regulating cellular activity and designing more effective therapies, respectively[82][83][84]. This innovative technology is expected to revolutionize the pharmaceutical industry by offering game-changing solutions for drug discovery processes, ultimately leading to cost savings and faster development timelines.",
                  "need_regenerate_synthesize_output": false
                }
              ],
              "parent": "Applications of AlphaFold 3",
              "synthesize_output": "AlphaFold 3 has had a significant impact on the speed and efficiency of drug discovery in the pharmaceutical industry. Isomorphic Labs, in collaboration with pharmaceutical companies, is utilizing AlphaFold 3 to tackle real-world drug design challenges, with the goal of developing new treatments that can potentially transform patients' lives[31]. This collaborative approach highlights the commitment to leveraging the potential of AlphaFold 3 to advance medical science and research.\n\nEarlier versions of AlphaFold, accessible through open-source code, have already facilitated important advancements in various areas such as malaria vaccines, cancer treatments, and enzyme design, showcasing the platform's ability to drive progress in drug discovery processes[33]. The latest version of AlphaFold models how proteins interact with other molecules, expanding its utility in predicting ADME properties crucial for understanding a drug's performance within the body[36][66].\n\nAlphaFold 3's impact extends beyond predicting molecule shapes; it has the potential to revolutionize various fields, accelerate research, and raise ethical considerations[35]. By providing scientists with a confidence score for predictions, AlphaFold offers an estimate of the model's accuracy, thus enabling researchers to make informed decisions[37]. This AI model also encompasses unprecedented breadth and accuracy in predicting the structure and interactions of proteins with other molecules, DNA, RNA, and small molecule ligands[38].\n\nFurthermore, AlphaFold 3 can efficiently predict how ligands will bind to target proteins, guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects[75]. The accuracy of AlphaFold 3 in predicting protein-ligand interactions surpasses traditional physics-based methods, marking a significant advancement in computational biology and offering substantial benefits for drug discovery and development[81].\n\nThe practical applications of AlphaFold 3 in drug discovery processes, along with the potential cost savings and accelerated timelines it can bring to pharmaceutical companies, make it a groundbreaking technology with transformative potential in the field of drug discovery and development[76][79]. Despite initial commercial restrictions, the platform's release as open-source will undoubtedly facilitate academic research and enhance our understanding of disease mechanisms and drug interactions[79].",
              "need_regenerate_synthesize_output": false
            },
            {
              "name": "Comparison with Traditional Methods in Drug Target Identification",
              "content": [],
              "children": [
                {
                  "name": "Improved Drug Target Identification",
                  "content": [
                    50,
                    51,
                    52
                  ],
                  "children": [],
                  "parent": "Comparison with Traditional Methods in Drug Target Identification",
                  "synthesize_output": "The integration of AlphaFold 3 in drug discovery workflows has significantly improved the identification of novel drug targets and the design of new therapeutics compared to traditional methods[50][51][52]. This latest version of the AI model not only predicts the structure of proteins but also how proteins interact with other molecules, including DNA, RNA, small molecule ligands, post-translational modifications, and ions. By providing a comprehensive understanding of molecular systems at a structural level, AlphaFold 3 offers unprecedented breadth and accuracy in structure prediction.\n\nThe incorporation of AlphaFold 3 in drug discovery has opened up exciting possibilities for rational drug development against targets that were previously challenging or considered inaccessible. This breakthrough technology has the potential to revolutionize the field of drug research and development, with implications for the design of more effective and targeted therapeutics. The capabilities of AlphaFold 3 have been described as \"Nobel Prize-worthy\" and have the potential to significantly impact drug R&D, potentially worth hundreds of billions commercially.",
                  "need_regenerate_synthesize_output": false
                },
                {
                  "name": "Comparative Analysis with Traditional Methods",
                  "content": [
                    43,
                    44,
                    45,
                    46,
                    47,
                    48,
                    49
                  ],
                  "children": [],
                  "parent": "Comparison with Traditional Methods in Drug Target Identification",
                  "synthesize_output": "AlphaFold 3 has revolutionized the field of drug discovery by significantly improving the identification of novel drug targets and the design of new therapeutics compared to traditional methods[43][44][45][46][47][48][49]. Its predictive prowess is 50% more accurate than traditional methods, making it a valuable tool for developing new therapeutics. By analyzing data on drug-target interactions and side effects, AlphaFold 3 can identify new therapeutic applications for existing drugs with unprecedented speed and precision[45][48].\n\nOne of the key advantages of AlphaFold 3 is its ability to predict how drugs interact with proteins, enabling scientists to design more effective and targeted therapies by understanding how a potential drug binds to a specific protein[46]. This capability has significantly accelerated the drug discovery process, which traditionally can be slow and expensive. Additionally, AlphaFold 3 can identify protein's 3D structures without the need for years of painstaking trial and error, providing a more cost-effective alternative to traditional lab methods[47].\n\nMoreover, AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins. It surpasses physics-based tools for biomolecular structure prediction, making it the first AI system to do so[48][49]. This accuracy and efficiency make AlphaFold 3 a game-changer in drug discovery, offering a faster and more precise way to simulate vital molecular interactions and create better targets for medications.",
                  "need_regenerate_synthesize_output": false
                }
              ],
              "parent": "Applications of AlphaFold 3",
              "synthesize_output": null,
              "need_regenerate_synthesize_output": true
            }
          ],
          "parent": "root",
          "synthesize_output": null,
          "need_regenerate_synthesize_output": true
        },
        {
          "name": "Future of AlphaFold 3",
          "content": [
            60,
            61,
            62,
            63
          ],
          "children": [
            {
              "name": "Challenges and opportunities",
              "content": [
                64,
                65,
                22,
                23,
                24,
                25,
                26
              ],
              "children": [],
              "parent": "Future of AlphaFold 3",
              "synthesize_output": "Efforts to add more training data have been made to improve the accuracy of AlphaFold 3, but this issue has not been fully resolved, posing a challenge in relying solely on AI predictions without further empirical verification[22]. Unlike its predecessor, AlphaFold 2, the full code of AlphaFold 3 is not publicly available. Access is provided through the AlphaFold Server, which is limited to non-commercial use and restricts the types of molecules that can be studied[22].\n\nFiguring out what shapes proteins fold into is known as the \u201cprotein folding problem\u201d, and has stood as a grand challenge in biology for the past 50 years. In a major scientific advance, the latest version of AlphaFold, AlphaFold 3, has been recognized as a solution to this grand challenge by the organizers of the biennial Critical Assessment of protein Structure Prediction (CASP)[23].\n\nThe commercial opportunities presented by AlphaFold 3 are significant, particularly in the areas of drug discovery and protein design. For example, the Boulder team had spent years unsuccessfully trying to determine a protein's structure before utilizing AlphaFold, which provided the information in just 15 minutes[24]. However, the commercialization of AlphaFold 3 poses ethical considerations that need to be carefully addressed to ensure that the benefits of the technology are not overshadowed by potential costs[25].\n\nImplementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay due to data challenges[26]. Companies looking to utilize AlphaFold 3 are advised to develop user-centric privacy controls to give customers control, avoid multiple intrusions, and prioritize data privacy to ensure equitable access to the benefits of the technology while addressing concerns about potential misuse[64][65].",
              "need_regenerate_synthesize_output": false
            },
            {
              "name": "Collaboration and partnerships",
              "content": [
                27,
                28,
                29,
                30
              ],
              "children": [],
              "parent": "Future of AlphaFold 3",
              "synthesize_output": "AlphaFold 3 is the result of a collaboration between Google DeepMind and Isomorphic Labs[29]. This groundbreaking technology has garnered significant attention for its ability to accurately predict the structure and interactions of all life's molecules[30]. In the development of AlphaFold 3, DeepMind and Isomorphic Labs consulted more than 50 experts in biosecurity, bioethics, and AI safety to address any potential ethical challenges[27]. One key ethical consideration is the need to ensure fairness and inclusivity in the data used to train AlphaFold 3, as bias in AI models can result from biased datasets, leading to skewed predictions[28]. These collaborations and partnerships have been instrumental in the development and ethical considerations surrounding AlphaFold 3.",
              "need_regenerate_synthesize_output": false
            }
          ],
          "parent": "root",
          "synthesize_output": "The future of AlphaFold 3 looks promising, with its unprecedented capability to accurately predict the structure and interactions of all life's molecules[29]. This groundbreaking technology has already made significant advancements in various fields, particularly in drug discovery and protein design[24]. As efforts continue to add more training data and further improve the system, AlphaFold 3 is poised to revolutionize the way scientists study and understand protein folding, a longstanding challenge in biology[23].\n\nOne of the key challenges for the future commercialization of AlphaFold 3 is ensuring equitable access to its benefits while addressing concerns about data privacy and potential misuse of the technology[60]. By implementing user-centric privacy controls and anonymizing user data, companies can help alleviate privacy concerns and ensure responsible use of the technology[64][65]. Additionally, collaboration with experts in biosecurity, bioethics, and AI safety is essential to address ethical considerations associated with the use of AlphaFold 3[27][28].\n\nThe potential of AlphaFold 3 in transforming medical science and research is vast, with the ability to aid in rapidly developing vaccines and treatments for emerging diseases, thus improving global health security[62]. By addressing challenges and limitations and ensuring equitable access to its benefits, AlphaFold 3 can benefit a broader spectrum of the scientific community, ultimately leading to advancements in healthcare and quality of life worldwide[60][63].\n\nAs AlphaFold 3 continues to evolve and expand its capabilities, it is essential for stakeholders to work together to navigate the ethical, privacy, and access challenges that come with such groundbreaking technology. With careful consideration and collaboration, the future of AlphaFold 3 holds great potential in advancing scientific research and benefiting society as a whole.",
          "need_regenerate_synthesize_output": false
        }
      ],
      "parent": null,
      "synthesize_output": null,
      "need_regenerate_synthesize_output": true
    },
    "info_uuid_to_info_dict": {
      "1": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 overview",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 1
      },
      "2": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods.",
        "snippets": [
          "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "AlphaFold 3 overview",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 2
      },
      "3": {
        "url": "https://deepmind.google/technologies/alphafold/",
        "description": "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree ...",
        "snippets": [
          "Made from long chains of amino acids, each has a unique complex 3D structure. But figuring out just one of these can take several years, and hundreds of thousands of dollars. In 2020, AlphaFold solved this problem, with the ability to predict protein structures in minutes, to a remarkable degree of accuracy."
        ],
        "title": "AlphaFold - Google DeepMind",
        "meta": {
          "query": "AlphaFold 3 overview",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 3
      },
      "4": {
        "url": "https://cen.acs.org/analytical-chemistry/structural-biology/AlphaFold-3-offer-structure-prediction/102/i15",
        "description": "Could you just tell me how it binds the DNA?\u201d John Jumper, a director at Google DeepMind, said during a press conference. Unlike past versions, AlphaFold 3, which was codeveloped with drug company Isomorphic Labs and first announced in October, can tackle such interactions.",
        "snippets": [
          "AlphaFold 3 shares many capabilities with the recently published RoseTTAFold All-Atom model. Though it lacks RoseTTAFold\u2019s ability to design new proteins, AlphaFold 3 has one big advantage: a new web server with a simple interface that requires no coding by the user."
        ],
        "title": "AlphaFold 3 to offer structure prediction via web browser",
        "meta": {
          "query": "AlphaFold 3 overview",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 4
      },
      "5": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
        "snippets": [
          "We hope AlphaFold 3 will help transform our understanding of the biological world and drug discovery. Scientists can access the majority of its capabilities, for free, through our newly launched AlphaFold Server, an easy-to-use research tool."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 overview",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 5
      },
      "6": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
        "snippets": [
          "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "AlphaFold 3 overview",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 6
      },
      "7": {
        "url": "https://blog.google/technology/ai/how-we-built-alphafold-3/",
        "description": "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including ...",
        "snippets": [
          "Instead, they got started on AlphaFold 3. This newer model, which the teams at Google DeepMind and Isomorphic Labs launched in May, builds on our previous models by predicting not just protein folding structures, but predicting the structure and interactions of all of life's molecules, including DNA, RNA and ligands (small molecules that bind to proteins)."
        ],
        "title": "How we built AlphaFold 3 to predict the structure and interaction ...",
        "meta": {
          "query": "What is AlphaFold 3",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 7
      },
      "8": {
        "url": "https://www.nature.com/articles/d41586-024-01385-x",
        "description": "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule ...",
        "snippets": [
          "Deepmind\u2019s AlphaFold has revolutionized research by making it simple to predict the 3D structures of proteins, but it has lacked the ability to predict situations where a protein is bound to another molecule. Now, the AI has been upgraded to AlphaFold 3 and can accurately predict protein-molecule complexes containing DNA, RNA and more."
        ],
        "title": "Alphafold 3.0: the AI protein predictor gets an upgrade",
        "meta": {
          "query": "What is AlphaFold 3",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 8
      },
      "9": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "What is AlphaFold 3",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 9
      },
      "10": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "Hassabis and Jumper had previously ... 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins. The 3-D structure is crucial to understanding the biological ...",
        "snippets": [
          "Hassabis and Jumper had previously won the Breakthrough Prize in Life Sciences and the Albert Lasker Award for Basic Medical Research in 2023 for their leadership of the AlphaFold project. Proteins consist of chains of amino acids which spontaneously fold to form the three dimensional (3-D) structures of the proteins. The 3-D structure is crucial to understanding the biological function of the protein."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "What is AlphaFold 3",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 10
      },
      "11": {
        "url": "https://venturebeat.com/ai/google-deepmind-open-sources-alphafold-3-ushering-in-a-new-era-for-drug-discovery-and-molecular-biology/",
        "description": "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic ...",
        "snippets": [
          "When AlphaFold 3 debuted in May, DeepMind\u2019s decision to withhold the code while offering limited access through a web interface drew criticism from researchers. The controversy exposed a key challenge in AI research: how to balance open science with commercial interests, particularly as companies like DeepMind\u2019s sister organization Isomorphic Labs work to develop new drugs using these advances."
        ],
        "title": "Google DeepMind open-sources AlphaFold 3, ushering in a new era ...",
        "meta": {
          "query": "What is AlphaFold 3",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 11
      },
      "12": {
        "url": "https://www.sciencedirect.com/science/article/pii/S0969212624003356",
        "description": "Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field. However, challenges loom f\u2026",
        "snippets": [
          "Author links open overlay panelToni K. Tr\u00e4ger 1 2, Christian T\u00fcting 1 2, Panagiotis L. Kastritis 1 2 3 4Show more ... Computational structural biology aims to accurately predict biomolecular complexes with AlphaFold 3 spearheading the field."
        ],
        "title": "The human touch: Utilizing AlphaFold 3 to analyze structures of ...",
        "meta": {
          "query": "What is AlphaFold 3",
          "question": "Background information about AlphaFold 3\\",
          "placement": "root -> Development of AlphaFold 3 -> Overview of AlphaFold 3"
        },
        "citation_uuid": 12
      },
      "13": {
        "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
        "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
        "snippets": [
          "For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition."
        ],
        "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
        "meta": {
          "query": "AlphaFold 3 speed comparison with AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Increased speed"
        },
        "citation_uuid": 13
      },
      "14": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "Protein monomer LDDT improvement is also significant (paired Wilcoxon signed-rank test, P = 1.7 \u00d7 10\u221234). AF3 has a very similar dependence on MSA depth to AlphaFold-Multimer v.2.3; proteins with shallow MSAs are predicted with lower accuracy (a comparison of the dependence of single-chain ...",
        "snippets": [
          "Protein monomer LDDT improvement is also significant (paired Wilcoxon signed-rank test, P = 1.7 \u00d7 10\u221234). AF3 has a very similar dependence on MSA depth to AlphaFold-Multimer v.2.3; proteins with shallow MSAs are predicted with lower accuracy (a comparison of the dependence of single-chain LDDT on MSA depth is shown in Extended Data Fig."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "AlphaFold 3 speed comparison with AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Increased speed"
        },
        "citation_uuid": 14
      },
      "15": {
        "url": "https://github.com/google-deepmind/alphafold3/blob/main/docs/performance.md",
        "description": "AlphaFold 3 inference pipeline. Contribute to google-deepmind/alphafold3 development by creating an account on GitHub.",
        "snippets": [
          "In contrast, this repository supports running AlphaFold 3 on a single NVIDIA A100 with 80 GB of memory in a configuration optimised to maximise throughput. We compare compile-free inference timings of these two setups in the table below using GPU seconds (i.e. multiplying by 16 when using 16 A100s). The setup in this repository is more efficient (by at least 2\u00d7) across all token sizes, indicating its suitability for high-throughput applications."
        ],
        "title": "alphafold3/docs/performance.md at main \u00b7 google-deepmind/alphafold3",
        "meta": {
          "query": "AlphaFold 3 speed comparison with AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Increased speed"
        },
        "citation_uuid": 15
      },
      "16": {
        "url": "https://www.blopig.com/blog/2024/08/architectural-highlights-of-alphafold3/",
        "description": "Probably the most exciting architectural development in AlphaFold3 is the completely redesigned Structure Module. The old \u201cInvariant Point Attention\u201d is gone, in favour of a diffusion model wrapped around a Transformer. In some ways, this is a simplification: positions are now only represented as coordinates in R3 and the model, conspicuously, no longer explicitly guarantees SE(3...",
        "snippets": [
          "Probably the most exciting architectural development in AlphaFold3 is the completely redesigned Structure Module. The old \u201cInvariant Point Attention\u201d is gone, in favour of a diffusion model wrapped around a Transformer. In some ways, this is a simplification: positions are now only represented as coordinates in R3 and the model, conspicuously, no longer explicitly guarantees SE(3) equivariance."
        ],
        "title": "Architectural highlights of AlphaFold3 | Oxford Protein Informatics ...",
        "meta": {
          "query": "AlphaFold 3 speed comparison with AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Increased speed"
        },
        "citation_uuid": 16
      },
      "17": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "The new AlphaFold model demonstrates ... with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4...",
        "snippets": [
          "The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein\u2013ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein\u2013nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody\u2013antigen prediction accuracy compared with AlphaFold-Multimer v.2.37,8. Together, these results show that high-accuracy modelling across biomolecular space is possible within a single unified deep-learning framework. ... Accurate models of biological complexes are critical to our understanding of cellular functions and for the rational design of therapeutics2,3,4,9."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "AlphaFold 3 accuracy vs AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
        },
        "citation_uuid": 17
      },
      "18": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "At the core of the model is an ... 2\u2019s incredible performance. After processing the inputs, AlphaFold 3 assembles its predictions using a diffusion network, akin to those found in AI image generators. The diffusion process starts with a cloud of atoms, and over many steps converges on its final, most accurate molecular structure. AlphaFold 3\u2019s predictions of molecular interactions surpass the accuracy of all existing ...",
        "snippets": [
          "At the core of the model is an improved version of our Evoformer module \u2014 a deep learning architecture that underpinned AlphaFold 2\u2019s incredible performance. After processing the inputs, AlphaFold 3 assembles its predictions using a diffusion network, akin to those found in AI image generators. The diffusion process starts with a cloud of atoms, and over many steps converges on its final, most accurate molecular structure. AlphaFold 3\u2019s predictions of molecular interactions surpass the accuracy of all existing systems."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 accuracy vs AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
        },
        "citation_uuid": 18
      },
      "19": {
        "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
        "description": "For years, scientists have been ... improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition. Having gone through multiple major iterations, the most recent release, AlphaFold 3, is set to ...",
        "snippets": [
          "For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind. The first version of the technology was released in 2018, but it was 2020\u2019s AlphaFold 2 that made headlines \u2013 winning the prestigious Critical Assessment of Structure Prediction (CASP) 14 competition. Having gone through multiple major iterations, the most recent release, AlphaFold 3, is set to further transform the protein space."
        ],
        "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
        "meta": {
          "query": "AlphaFold 3 accuracy vs AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
        },
        "citation_uuid": 19
      },
      "20": {
        "url": "https://www.drugdiscoverytrends.com/meet-alphafold-3-which-can-accurately-model-more-than-99-of-molecular-types-in-the-protein-data-bank/",
        "description": "Unlike its predecessor, AlphaFold 2, which relied on an architecture optimized for predicting the structure of individual proteins, AlphaFold 3 (AF3) uses a diffusion model that predicts raw atom coordinates. This shift towards a diffusion-based architecture allows AF3 to model an array of biomolecular interactions, including proteins, nucleic acids, small molecules, ions and modified residues with high accuracy...",
        "snippets": [
          "AlphaFold 3 by DeepMind accurately predicts protein structures and interactions, transforming drug discovery and structural biology."
        ],
        "title": "AlphaFold 3 offers even more accurate protein structure prediction",
        "meta": {
          "query": "AlphaFold 3 accuracy vs AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
        },
        "citation_uuid": 20
      },
      "21": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy ...",
        "snippets": [
          "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "AlphaFold 3 accuracy vs AlphaFold 2",
          "question": "How does AlphaFold 3 compare to previous versions in terms of accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Comparison with Previous Versions"
        },
        "citation_uuid": 21
      },
      "22": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Efforts to add more training data ... posing a challenge in relying solely on AI predictions without further empirical verification [1]. ... Unlike its predecessor, AlphaFold 2, the full code of AlphaFold 3 is not publicly available. Access is provided through the AlphaFold Server, which is limited to non-commercial use and restricts ...",
        "snippets": [
          "Efforts to add more training data have been made, yet this issue has not been fully resolved, posing a challenge in relying solely on AI predictions without further empirical verification . ... Unlike its predecessor, AlphaFold 2, the full code of AlphaFold 3 is not publicly available. Access is provided through the AlphaFold Server, which is limited to non-commercial use and restricts the types of molecules that can be studied."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "commercialization challenges of AlphaFold technology",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
        },
        "citation_uuid": 22
      },
      "23": {
        "url": "https://deepmind.google/discover/blog/alphafold-a-solution-to-a-50-year-old-grand-challenge-in-biology/",
        "description": "Proteins are essential to life, supporting practically all its functions. They are large complex molecules, made up of chains of amino acids, and what a protein does largely depends on its unique...",
        "snippets": [
          "Figuring out what shapes proteins fold into is known as the \u201cprotein folding problem\u201d, and has stood as a grand challenge in biology for the past 50 years. In a major scientific advance, the latest version of our AI system AlphaFold has been recognised as a solution to this grand challenge by the organisers of the biennial Critical Assessment of protein Structure Prediction (CASP)."
        ],
        "title": "AlphaFold: a solution to a 50-year-old grand challenge in biology ...",
        "meta": {
          "query": "commercialization challenges of AlphaFold technology",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
        },
        "citation_uuid": 23
      },
      "24": {
        "url": "https://www.forbes.com/sites/robtoews/2021/10/03/alphafold-is-the-most-important-achievement-in-ai-ever/",
        "description": "Machine learning will transform the life sciences in the years ahead.",
        "snippets": [
          "The Boulder team had spent years unsuccessfully trying to determine this protein\u2019s structure; with AlphaFold, they learned it in 15 minutes. When it comes to commercial opportunity and startup activity, there are two applications in particular for which AlphaFold attracts a lot of attention: drug discovery and protein design."
        ],
        "title": "AlphaFold Is The Most Important Achievement In AI\u2014Ever",
        "meta": {
          "query": "commercialization challenges of AlphaFold technology",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
        },
        "citation_uuid": 24
      },
      "25": {
        "url": "https://www.sterlitech.com/blog/post/alphafold-ai-system-can-change-the-world",
        "description": "While 2020 was a difficult time across many metrics, it was an exciting year for protein science!",
        "snippets": [
          "But with great power comes great responsibility, and strong guidance will be needed to ensure that the advantages of this powerful new technology are not overshadowed by the costs. The next and final installment of our three-part series will follow the story of Team AlphaFold as they eagerly joined the fight against COVID-19. ... AlphaFold Team. (2020). AlphaFold: a solution to a 50-year-old grand challenge in biology."
        ],
        "title": "AlphaFold AI System can Change the World",
        "meta": {
          "query": "commercialization challenges of AlphaFold technology",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
        },
        "citation_uuid": 25
      },
      "26": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company ...",
        "snippets": [
          "Given these data challenges, implementing advanced tools like AlphaFold requires meticulous attention to detail and a significant capital outlay. \u201cThe pipeline of tools that you require both before and after AlphaFold to make this into a commercial proposition for a pharmaceutical company or a healthcare company is fairly serious,\u201d Bangert stressed."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "commercialization challenges of AlphaFold technology",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
        },
        "citation_uuid": 26
      },
      "27": {
        "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
        "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
        "snippets": [
          "Nature\u2019s editor-in-chief, Magdalena Skipper, PhD stated that when making a decision on data and code availability, the journal reflects on several factors including \u201cthe potential implications for biosecurity and the ethical challenges this presents.\u201d In such cases, the journal works with authors to provide alternatives that will support reproducibility, such as pseudocode. However, John Jumper, PhD, one of the senior authors of the AlphaFold 3 article and lead author on AlphaFold 2, reportedly told the press that DeepMind and Isomorphic Labs had consulted more than 50 experts in biosecurity, bioethics, and AI safety and concluded that AlphaFold 3\u2019s marginal biosecurity risks were far outweighed by the system\u2019s potential benefits to science."
        ],
        "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
        "meta": {
          "query": "AlphaFold 3 ethical considerations",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
        },
        "citation_uuid": 27
      },
      "28": {
        "url": "https://medium.com/@karena.law/alphafold-3-transforming-the-biological-world-and-drug-discovery-0ef7f4e5643d",
        "description": "Ethical Considerations While the benefits of AlphaFold 3 are undeniable, it is important to address the ethical considerations associated with its use. Bias in AI models can result from biased data sets, leading to skewed predictions. Ensuring fairness and inclusivity in the data used to train ...",
        "snippets": [
          "Ethical Considerations While the benefits of AlphaFold 3 are undeniable, it is important to address the ethical considerations associated with its use. Bias in AI models can result from biased data sets, leading to skewed predictions. Ensuring fairness and inclusivity in the data used to train AlphaFold 3 is paramount."
        ],
        "title": "AlphaFold 3: Transforming the Biological World and Drug Discovery ...",
        "meta": {
          "query": "AlphaFold 3 ethical considerations",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
        },
        "citation_uuid": 28
      },
      "29": {
        "url": "https://www.unite.ai/what-is-alphafold-3-the-ai-model-poised-to-transform-biology/",
        "description": "AlphaFold 3 is an AI model developed through a collaboration between Google DeepMind and Isomorphic Labs. This groundbreaking technology, which has garnered a lot of attention over the past couple of days as deserved, has achieved an unprecedented capability \u2013 accurately predicting the structure ...",
        "snippets": [
          "AlphaFold 3 is an AI model developed through a collaboration between Google DeepMind and Isomorphic Labs. This groundbreaking technology, which has garnered a lot of attention over the past couple of days as deserved, has achieved an unprecedented capability \u2013 accurately predicting the structure and interactions of all life's molecules."
        ],
        "title": "What is AlphaFold 3? The AI Model Poised to Transform Biology - ...",
        "meta": {
          "query": "AlphaFold 3 ethical considerations",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
        },
        "citation_uuid": 29
      },
      "30": {
        "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "AlphaFold 3 predicts the structure and interactions of all of life\u2019s molecules"
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 ethical considerations",
          "question": "What are some of the key ethical considerations that need to be taken into account when it comes to the commercialization of AlphaFold 3 and the sharing of data generated by this technology?",
          "placement": "root -> Future of AlphaFold 3 -> Collaboration and partnerships"
        },
        "citation_uuid": 30
      },
      "31": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives. This collaborative approach underscores the commitment to harnessing the potential of AlphaFold 3 for advancing medical science and research. In summary, AlphaFold 3's introduction marks a pivotal moment in the understanding of biomolecular interactions and the acceleration ...",
        "snippets": [
          "Furthermore, Isomorphic Labs is collaborating with pharmaceutical companies to apply AlphaFold 3 to real-world drug design challenges, aiming to develop new treatments that could change patients' lives. This collaborative approach underscores the commitment to harnessing the potential of AlphaFold 3 for advancing medical science and research. In summary, AlphaFold 3's introduction marks a pivotal moment in the understanding of biomolecular interactions and the acceleration of drug discovery processes."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "How AlphaFold 3 accelerates pharmaceutical research",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 31
      },
      "32": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
        "snippets": [
          "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "How AlphaFold 3 accelerates pharmaceutical research",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 32
      },
      "33": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "Earlier versions of AlphaFold, available through open-source code, were limited primarily by an inability to predict how proteins would interact with other molecules throughout the cell. Even so, they spurred significant progress. \u201cSo far, millions of researchers globally have used AlphaFold 2 to make discoveries in areas including malaria vaccines, cancer treatments, and enzyme design,\u201d according to the Google AlphaFold 3 announcement."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "How AlphaFold 3 accelerates pharmaceutical research",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 33
      },
      "34": {
        "url": "https://www.nature.com/articles/d41586-024-01383-z",
        "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
        "snippets": [
          "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool."
        ],
        "title": "Major AlphaFold upgrade offers boost for drug discovery",
        "meta": {
          "query": "How AlphaFold 3 accelerates pharmaceutical research",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 34
      },
      "35": {
        "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
        "description": "Scientists can access most of its ... research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients. AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, ...",
        "snippets": [
          "Scientists can access most of its capabilities for free through the newly launched AlphaFold Server, an easy-to-use research tool. To build on AlphaFold 3\u2019s potential for drug design, Isomorphic Labs is already collaborating with pharmaceutical companies to apply it to real-world drug design challenges and, ultimately, develop new life-changing treatments for patients. AlphaFold 3\u2019s impact goes far beyond predicting molecule shapes. It can potentially revolutionize various fields, accelerate research, and raise ethical considerations."
        ],
        "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
        "meta": {
          "query": "How AlphaFold 3 accelerates pharmaceutical research",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 35
      },
      "36": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping ...",
        "snippets": [
          "Using AlphaFold 3 in combination with a complementary suite of in-house AI models, Isomorphic Labs is working on drug design for internal projects as well as with pharmaceutical partners. Isomorphic Labs is using AlphaFold 3 to accelerate and improve the success of drug design \u2014 by helping understand how to approach new disease targets, and developing novel ways to pursue existing ones that were previously out of reach."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "How AlphaFold 3 accelerates pharmaceutical research",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 36
      },
      "37": {
        "url": "https://www.theatlantic.com/sponsored/google/ai-powered-future-drug-discovery/3962/",
        "description": "To ground predictions, AlphaFold ... giving researchers an estimate of the model\u2019s accuracy. Science is an iterative enterprise. Trial and error in the laboratory is how progress has traditionally been made. But now, AI systems are poised to dramatically accelerate this painstaking process. One area in which AlphaFold 3 shows particular ...",
        "snippets": [
          "To ground predictions, AlphaFold provides a confidence score, giving researchers an estimate of the model\u2019s accuracy. Science is an iterative enterprise. Trial and error in the laboratory is how progress has traditionally been made. But now, AI systems are poised to dramatically accelerate this painstaking process. One area in which AlphaFold 3 shows particular promise is the rational design of drugs."
        ],
        "title": "The AI-Powered Future of Drug Discovery - Sponsor Content - Google",
        "meta": {
          "query": "How AlphaFold 3 accelerates pharmaceutical research",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 37
      },
      "38": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
        "snippets": [
          "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
        },
        "citation_uuid": 38
      },
      "39": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "This new window on the molecules ... actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open ...",
        "snippets": [
          "This new window on the molecules of life reveals how they\u2019re all connected and helps understand how those connections affect biological functions \u2014 such as the actions of drugs, the production of hormones and the health-preserving process of DNA repair. The impacts of AlphaFold 3 and our free AlphaFold Server will be realized through how they empower scientists to accelerate discovery across open questions in biology and new lines of research."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
        },
        "citation_uuid": 39
      },
      "40": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact ...",
        "snippets": [
          "This expansion is crucial for drug discovery as it includes many drugs under the ligand category. Additionally, AlphaFold 3 can model chemical modifications to these molecules, which play a significant role in the healthy functioning of cells. Disruptions in these processes can lead to disease, thus highlighting the model's potential in understanding and addressing medical conditions [9-11]. Impact on Drug Discovery and Biological Understanding"
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
        },
        "citation_uuid": 40
      },
      "41": {
        "url": "https://time.com/6975934/google-deepmind-alphafold-3-ai/",
        "description": "The innovative AI model, announced on May 8, is likely to dramatically accelerate biological research.",
        "snippets": [
          "In 2021, Google parent company Alphabet announced the creation of Isomorphic Labs, which aims to take an AI-first approach to drug discovery. Researchers from Isomorphic Labs contributed to the development of AlphaFold 3 and, while AlphaFold Server can be used by anyone from non-commercial research, researchers at Isomorphic Labs will have exclusive access to AlphaFold 3 for commercial use."
        ],
        "title": "Google DeepMind\u2019s AlphaFold 3 Could Transform Drug Discovery",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
        },
        "citation_uuid": 41
      },
      "42": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
        "snippets": [
          "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the use of AlphaFold 3 impacted the speed and efficiency of drug discovery in the pharmaceutical industry?",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency"
        },
        "citation_uuid": 42
      },
      "43": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Its predictive prowess is 50% more accurate than traditional methods, making it a valuable tool for developing new therapeutics [6,20]. ... The use of machine learning in drug repurposing has become increasingly important. AlphaFold 3 analyzes data on drug-target interactions and side effects to identify ...",
        "snippets": [
          "Its predictive prowess is 50% more accurate than traditional methods, making it a valuable tool for developing new therapeutics . ... The use of machine learning in drug repurposing has become increasingly important. AlphaFold 3 analyzes data on drug-target interactions and side effects to identify new therapeutic applications for existing drugs."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 vs traditional methods in drug target identification",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
        },
        "citation_uuid": 43
      },
      "44": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "We believe that this broader understanding of the context within which drug targets operate will translate into more effective drugs in the clinic. ... To demonstrate the potential for rational structure-based drug design with AlphaFold 3, we examined TIM-3, an immune checkpoint protein identified as a potential target for cancer immunotherapy following a 2021 publication."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "AlphaFold 3 vs traditional methods in drug target identification",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
        },
        "citation_uuid": 44
      },
      "45": {
        "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
        "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
        "snippets": [
          "This makes AlphaFold3 the perfect tool for drug discovery, ultimately enabling scientists to simulate vital molecular interactions with unprecedented speed and precision, and offering a faster, more cost-effective alternative to traditional lab methods. As scientists use AlphaFold3 to better understand protein structures and interactions, they can also create better targets for medications, better understand side effects, and delve into new areas of protein-drug interactions that may not have previously been fathomable."
        ],
        "title": "Can AlphaFold3's open-source platform revolutionize the way we ...",
        "meta": {
          "query": "AlphaFold 3 vs traditional methods in drug target identification",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
        },
        "citation_uuid": 45
      },
      "46": {
        "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
        "description": "AlphaFold 3, the AI revolutionizing molecular understanding beyond proteins. Explore its power to predict DNA, RNA, and drug structures!",
        "snippets": [
          "Predict how drugs interact with proteins: This is a game-changer in drug discovery. Scientists can design more effective and targeted therapies by understanding how a potential drug binds to a specific protein. One of the most exciting applications of AlphaFold 3 lies in drug discovery. Traditionally, this process can be slow and expensive."
        ],
        "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
        "meta": {
          "query": "AlphaFold 3 vs traditional methods in drug target identification",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
        },
        "citation_uuid": 46
      },
      "47": {
        "url": "https://www.prescouter.com/2024/05/google-deepmind-alphafold-3/",
        "description": "Google DeepMind's AlphaFold 3 improves drug discovery by predicting complex protein interactions and structures with high accuracy.",
        "snippets": [
          "AlphaFold 3 can identify protein\u2019s 3D structures without the meticulous trial and error that entails years of painstaking labor and costly financial investment. AlphaFold 3\u2019s capability to predict protein-ligand interactions is essential for drug discovery. It enables precise modeling of how potential drug molecules bind to their target proteins."
        ],
        "title": "AlphaFold 3: Google DeepMind\u2019s latest AI tech in drug discovery",
        "meta": {
          "query": "AlphaFold 3 vs traditional methods in drug target identification",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
        },
        "citation_uuid": 47
      },
      "48": {
        "url": "https://www.isomorphiclabs.com/articles/alphafold-3-predicts-the-structure-and-interactions-of-all-of-lifes-molecules",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins. AlphaFold 3 is 50% more accurate than the best traditional methods on the PoseBusters benchmark, without needing the input of any structural information, making AlphaFold 3 the first AI system to surpass physics-based tools for biomolecular structure prediction."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 vs traditional methods in drug target identification",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
        },
        "citation_uuid": 48
      },
      "49": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
        "snippets": [
          "AlphaFold 3 achieves unprecedented accuracy in predicting drug-like interactions, including the binding of proteins with ligands and antibodies with their target proteins. AlphaFold 3 is 50% more accurate than the best traditional methods on the PoseBusters benchmark without needing the input of any structural information, making AlphaFold 3 the first AI system to surpass physics-based tools for biomolecular structure prediction."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 vs traditional methods in drug target identification",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Comparative Analysis with Traditional Methods"
        },
        "citation_uuid": 49
      },
      "50": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
        "snippets": [
          "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Improved Drug Target Identification"
        },
        "citation_uuid": 50
      },
      "51": {
        "url": "https://www.nature.com/articles/d41586-024-01383-z",
        "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
        "snippets": [
          "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool."
        ],
        "title": "Major AlphaFold upgrade offers boost for drug discovery",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Improved Drug Target Identification"
        },
        "citation_uuid": 51
      },
      "52": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d ... a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery...",
        "snippets": [
          "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "AlphaFold 3 impact on drug discovery",
          "question": "How has the integration of AlphaFold 3 in drug discovery workflows improved the identification of novel drug targets and the design of new therapeutics in comparison to traditional methods?",
          "placement": "root -> Applications of AlphaFold 3 -> Comparison with Traditional Methods in Drug Target Identification -> Improved Drug Target Identification"
        },
        "citation_uuid": 52
      },
      "53": {
        "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
        "description": "In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again. In this news highlight, we explore the new tech, compare it to its predecessor and take a ...",
        "snippets": [
          "In 2020, the launch of AlphaFold 2, pioneered by Google DeepMind, took the world by storm and marked a new age in protein structure prediction. But now, AlphaFold 3 is transforming the landscape again. In this news highlight, we explore the new tech, compare it to its predecessor and take a look to the future."
        ],
        "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
        "meta": {
          "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
          "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
        },
        "citation_uuid": 53
      },
      "54": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor AlphaFold 2, this innovation has astonished the world with its capacity and speed."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
          "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
        },
        "citation_uuid": 54
      },
      "55": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new ...",
        "snippets": [
          "On 15 July 2021, the AlphaFold 2 paper was published in Nature as an advance access publication alongside open source software and a searchable database of species proteomes. As of February 2025, the paper had been cited nearly 32,000 times. AlphaFold 3 was announced on 8 May 2024. It can predict the structure of complexes created by proteins with DNA, RNA, various ligands, and ions. The new prediction method shows a minimum 50% improvement in accuracy for protein interactions with other molecules compared to existing methods."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
          "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
        },
        "citation_uuid": 55
      },
      "56": {
        "url": "https://medium.com/@falk_hoffmann/promising-alternatives-to-alphafold-3-how-they-work-and-when-to-use-them-ccbcde490b14",
        "description": "Changes include hardware and ... also the comparison to AF3) and better scaling of the model. Based on the reported values in the press release on the PostBusters dataset, it reaches a success rate, measured as correctly predicted protein structure with an RMSD of less than 2 A, of 54.9% and 76.8% if pocket residues are not specified or are specified, respectively. This beats all non-AlphaFold docking methods like Vina, DiffDock and TankBind but is inferior to the new ...",
        "snippets": [
          "Changes include hardware and memory-optimized geometrical attention building blocks for higher inference throughput, an expansion of the training data to protein-nucleic acid complexes and the presence of post-translational modifications (PTM) and cofactors for more applications (see also the comparison to AF3) and better scaling of the model. Based on the reported values in the press release on the PostBusters dataset, it reaches a success rate, measured as correctly predicted protein structure with an RMSD of less than 2 A, of 54.9% and 76.8% if pocket residues are not specified or are specified, respectively. This beats all non-AlphaFold docking methods like Vina, DiffDock and TankBind but is inferior to the new AF3."
        ],
        "title": "Alternatives to AlphaFold 3\u2014 how they work and when to use them ...",
        "meta": {
          "query": "What\u2019s new in AlphaFold 3 compared to AlphaFold 2",
          "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
        },
        "citation_uuid": 56
      },
      "57": {
        "url": "https://bjbas.springeropen.com/articles/10.1186/s43088-024-00503-y",
        "description": "In conclusion, this AlphaFold framework has the ability to yield atomically-accurate structural predictions for a variety of biomolecular interactions, hence facilitating advancements in drug discovery. ... Recent advances in protein structure prediction have witnessed groundbreaking developments, largely propelled by the emergence of advanced machine learning techniques and substantial improvements in algorithmic approaches [1,2,3...",
        "snippets": [
          "In conclusion, this AlphaFold framework has the ability to yield atomically-accurate structural predictions for a variety of biomolecular interactions, hence facilitating advancements in drug discovery. ... Recent advances in protein structure prediction have witnessed groundbreaking developments, largely propelled by the emergence of advanced machine learning techniques and substantial improvements in algorithmic approaches . Key highlights in this dynamic field include the release of AlphaFold2 by DeepMind which marked a watershed moment in protein structure prediction . Leveraging"
        ],
        "title": "AlphaFold-latest: revolutionizing protein structure prediction ...",
        "meta": {
          "query": "AlphaFold 3 advancements in protein structure prediction",
          "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
        },
        "citation_uuid": 57
      },
      "58": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "On May 8, 2024, an article was ... accurate structure prediction of biomolecular interactions [1]. In the rapidly evolving landscape of life sciences, the intersection of artificial intelligence (AI) and biology has heralded a new era of discovery and innovation. At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning ...",
        "snippets": [
          "On May 8, 2024, an article was published by Josh Abramson regarding the successful use of AlphaFold 3 (Google DeepMind Technologies Limited, London, United Kingdom) in the accurate structure prediction of biomolecular interactions . In the rapidly evolving landscape of life sciences, the intersection of artificial intelligence (AI) and biology has heralded a new era of discovery and innovation. At the forefront of this revolution is AlphaFold 3, the latest iteration of Google DeepMind's groundbreaking protein folding AI. Leveraging advanced deep learning methodologies, AlphaFold 3 has achie"
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 advancements in protein structure prediction",
          "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
        },
        "citation_uuid": 58
      },
      "59": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
        "snippets": [
          "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "AlphaFold 3 advancements in protein structure prediction",
          "question": "Can you explain the specific advancements or improvements in AlphaFold 3 that have contributed to its increased accuracy and speed in predicting protein structures?",
          "placement": "root -> Development of AlphaFold 3 -> Advancements in AlphaFold 3"
        },
        "citation_uuid": 59
      },
      "60": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "The limited and proprietary nature ... equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research [38]. By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader ...",
        "snippets": [
          "The limited and proprietary nature of AlphaFold's accessibility raises concerns regarding equitable access to cutting-edge technology. Such restrictions can impact scientific transparency and public accountability, which are crucial for the advancement and democratization of scientific research . By addressing these challenges and limitations, the potential of AlphaFold 3 in transforming medical science and research can be more fully realized, ensuring that this revolutionary technology benefits a broader spectrum of the scientific community."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "equitable access to AlphaFold 3 benefits",
          "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
          "placement": "root -> Future of AlphaFold 3"
        },
        "citation_uuid": 60
      },
      "61": {
        "url": "https://www.genengnews.com/topics/artificial-intelligence/alphafold-3-angst-limited-accessibility-stirs-outcry-from-researchers/",
        "description": "Researchers are angered by the latest update to Google DeepMind\u2019s renowned protein structure prediction algorithm, which published in Nature without the open access code",
        "snippets": [
          "However, John Jumper, PhD, one of the senior authors of the AlphaFold 3 article and lead author on AlphaFold 2, reportedly told the press that DeepMind and Isomorphic Labs had consulted more than 50 experts in biosecurity, bioethics, and AI safety and concluded that AlphaFold 3\u2019s marginal biosecurity risks were far outweighed by the system\u2019s potential benefits to science."
        ],
        "title": "AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers",
        "meta": {
          "query": "equitable access to AlphaFold 3 benefits",
          "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
          "placement": "root -> Future of AlphaFold 3"
        },
        "citation_uuid": 61
      },
      "62": {
        "url": "https://deeperinsights.com/ai-blog/alphafold-3-the-key-to-understanding-lifes-building-blocks",
        "description": "AlphaFold 3 revolutionises biology by predicting molecular interactions with unprecedented accuracy, accelerating breakthroughs in drug discovery and synthetic biology.",
        "snippets": [
          "On a global scale, AlphaFold 3\u2019s predictions could aid in rapidly developing vaccines and treatments for emerging diseases, helping to prevent pandemics and improve global health security [source]. Its impact on neglected diseases could be significant, bringing new hope to millions in underdeveloped regions. This could lead to a more equitable distribution of healthcare advancements, improving quality of life worldwide."
        ],
        "title": "AlphaFold 3: The Key to Understanding Life's Building Blocks - ...",
        "meta": {
          "query": "equitable access to AlphaFold 3 benefits",
          "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
          "placement": "root -> Future of AlphaFold 3"
        },
        "citation_uuid": 62
      },
      "63": {
        "url": "https://deepmind.google/discover/blog/how-our-principles-helped-define-alphafolds-release/",
        "description": "Our Operating Principles have come to define both our commitment to prioritising widespread benefit, as well as the areas of research and applications we refuse to pursue. These principles have...",
        "snippets": [
          "We had initially considered omitting predictions for which AlphaFold had low confidence or high predictive uncertainty, but the external experts we consulted proved why this was especially important to retain these predictions in our release, and advised us on the most useful and transparent ways to present this information. Equitable benefit could mean extra support for underfunded fields."
        ],
        "title": "How our principles helped define AlphaFold\u2019s release - Google ...",
        "meta": {
          "query": "equitable access to AlphaFold 3 benefits",
          "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
          "placement": "root -> Future of AlphaFold 3"
        },
        "citation_uuid": 63
      },
      "64": {
        "url": "https://evgmedia.com/addressing-data-privacy-concerns/",
        "description": "It\u2019s more important than ever to be transparent about your company\u2019s privacy protection for customers.",
        "snippets": [
          "Goldfarb and Tucker suggest that to use the opportunity wisely, companies do well to, \u201c1. Develop user-centric privacy controls to give customers control. 2. Avoid multiple intrusions. And 3."
        ],
        "title": "Addressing Data Privacy Concerns | EnVeritas Group",
        "meta": {
          "query": "addressing data privacy concerns AlphaFold 3",
          "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
          "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
        },
        "citation_uuid": 64
      },
      "65": {
        "url": "https://improvado.io/blog/big-data-analytics-privacy-problems",
        "description": "Addressing common challenges in big data analytics privacy. Insights on policy violations, breaches, compliance, and effective solutions for enterprises.",
        "snippets": [
          "When approached correctly, these platforms can also play a significant role in addressing data analytics privacy problems. Marketing analytics platforms often have built-in features to anonymize user data. This means that while the data can be used to understand user behaviors and trends, it doesn't directly identify an individual user. By working with anonymous data, privacy concerns are significantly reduced."
        ],
        "title": "10 Big Data Analytics Privacy Problems and How to Navigate Them",
        "meta": {
          "query": "addressing data privacy concerns AlphaFold 3",
          "question": "What are some potential ways to ensure equitable access to the benefits of AlphaFold 3 while addressing concerns about data privacy and potential misuse of the technology?",
          "placement": "root -> Future of AlphaFold 3 -> Challenges and opportunities"
        },
        "citation_uuid": 65
      },
      "66": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "AlphaFold 3 extends its utility to predicting ADME properties, which are crucial for understanding a drug's performance within the body. This capability supports the optimization of clinical trial designs by predicting how drugs behave in different biological systems, thereby improving the safety and efficacy of therapeutic candidates ."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 speed and efficiency improvements",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 66
      },
      "67": {
        "url": "https://frontlinegenomics.com/alphafold-3-stepping-into-the-future-of-structure-prediction/",
        "description": "In this news highlight, we explore AlphaFold3, compare it to its predecessor and take a look to the future.",
        "snippets": [
          "These methods were time consuming and costly, and were a major limiting step in drug discovery and development processes in particular. For years, scientists have been attempting to integrate the latest and greatest AI models into the field, in order to speed up the process and improve accuracy. Enter AlphaFold, an artificial intelligence tool developed by Google\u2019s DeepMind."
        ],
        "title": "AlphaFold 3: Stepping into the future of structure prediction - ...",
        "meta": {
          "query": "AlphaFold 3 speed and efficiency improvements",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 67
      },
      "68": {
        "url": "https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/",
        "description": "Our new AI model AlphaFold 3 can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy.",
        "snippets": [
          "In a paper published in Nature, we introduce AlphaFold 3, a revolutionary model that can predict the structure and interactions of all life\u2019s molecules with unprecedented accuracy. For the interactions of proteins with other molecule types we see at least a 50% improvement compared with existing prediction methods, and for some important categories of interaction we have doubled prediction accuracy."
        ],
        "title": "AlphaFold 3 predicts the structure and interactions of all of ...",
        "meta": {
          "query": "AlphaFold 3 speed and efficiency improvements",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 68
      },
      "69": {
        "url": "https://www.deeporigin.com/blog/alphafold-3-exciting-advance-yet-unresolved-major-issues-remain",
        "description": "We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations. Here's what we found.",
        "snippets": [
          "AlphaFold 3, which is the next step of AlphaFold 2, models proteins with possibly modified residues, nucleic acids, small molecules and ions. It uses a single ML model for predictions from input of biopolymer sequences, residue modifications, and ligand SMILES, claiming improved accuracy over specialized tools."
        ],
        "title": "AlphaFold 3: Exciting Advance yet Unresolved Major Issues Remain ...",
        "meta": {
          "query": "AlphaFold 3 speed and efficiency improvements",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 69
      },
      "70": {
        "url": "https://www.creative-biostructure.com/evolution-of-alphafold-protein-structure-prediction.htm",
        "description": "Pairformer Module: One of the most notable changes in AlphaFold 3 is the replacement of AlphaFold 2's Evoformer module with the simpler Pairformer module. This update reduces the amount of multi-sequence alignment (MSA) data that needs to be processed, thereby improving computational efficiency ...",
        "snippets": [
          "Pairformer Module: One of the most notable changes in AlphaFold 3 is the replacement of AlphaFold 2's Evoformer module with the simpler Pairformer module. This update reduces the amount of multi-sequence alignment (MSA) data that needs to be processed, thereby improving computational efficiency without sacrificing accuracy."
        ],
        "title": "The Evolution of AlphaFold: A Milestone in Protein Structure ...",
        "meta": {
          "query": "AlphaFold 3 speed and efficiency improvements",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Speed and Efficiency Improvements"
        },
        "citation_uuid": 70
      },
      "71": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
        "snippets": [
          "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "Impact of AlphaFold 3 on drug discovery",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
        },
        "citation_uuid": 71
      },
      "72": {
        "url": "https://www.nature.com/articles/d41586-024-01383-z",
        "description": "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool.",
        "snippets": [
          "Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool. Latest version of the AI models how proteins interact with other molecules \u2014 but DeepMind restricts access to the tool."
        ],
        "title": "Major AlphaFold upgrade offers boost for drug discovery",
        "meta": {
          "query": "Impact of AlphaFold 3 on drug discovery",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
        },
        "citation_uuid": 72
      },
      "73": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "This builds upon Google DeepMind\u2019s ... with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing ...",
        "snippets": [
          "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "Impact of AlphaFold 3 on drug discovery",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
        },
        "citation_uuid": 73
      },
      "74": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d ... a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery...",
        "snippets": [
          "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D. ... This audio is auto-generated. Please let us know if you have feedback. The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "Impact of AlphaFold 3 on drug discovery",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
        },
        "citation_uuid": 74
      },
      "75": {
        "url": "https://www.theatlantic.com/sponsored/google/ai-powered-future-drug-discovery/3962/",
        "description": "AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but also has the potential to ultimately impact ...",
        "snippets": [
          "AlphaFold 3 can efficiently predict how ligands, a structural component of many drugs, will bind to a target protein, thereby guiding researchers in designing drug candidate structures for improved efficacy and reduced side effects. This not only hastens the drug discovery process but also has the potential to ultimately impact the overall cost of development."
        ],
        "title": "The AI-Powered Future of Drug Discovery - Sponsor Content - Google",
        "meta": {
          "query": "Impact of AlphaFold 3 on drug discovery",
          "question": "The increased speed and efficiency of AlphaFold 3 in predicting protein structures can greatly impact the scalability and accessibility of drug discovery processes in research and pharmaceutical industries. By providing more accurate and reliable protein structure predictions in a shorter amount of time, AlphaFold 3 can accelerate the drug discovery pipeline, reducing the time and cost required for identifying potential drug candidates . This can ultimately lead to more efficient drug development processes and potentially faster delivery of new therapies to patients in need .",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Scalability and Accessibility Impact"
        },
        "citation_uuid": 75
      },
      "76": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s ...",
        "snippets": [
          "The industry\u2019s reliance on a small fraction of drugs to subsidize the rest underscores the high-stakes nature of pharmaceutical development. \u201cIt is basically playing roulette, right? You just have to play roulette enough many times before you hit the jackpot,\u201d Bangert said. AlphaFold\u2019s computational approach offers significant advantages over traditional medicinal chemistry methods."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "AlphaFold 3 pharmaceutical industry benefits",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 76
      },
      "77": {
        "url": "https://www.pharmavoice.com/news/google-alphafold-3-drug-discovery-pharma-buzz/716496/",
        "description": "The \u201cNobel Prize-worthy invention\u201d could be worth hundreds of billions commercially \u2014 and have a deep impact on drug R&D.",
        "snippets": [
          "The artificial intelligence program AlphaFold 3, rolled out by Google DeepMind and Isomorphic Labs earlier this month, has been called \u201cgroundbreaking,\u201d holding transformative potential in drug discovery."
        ],
        "title": "Why AlphaFold 3 is stirring up so much buzz in pharma | PharmaVoice",
        "meta": {
          "query": "AlphaFold 3 pharmaceutical industry benefits",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 77
      },
      "78": {
        "url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4983123",
        "description": "AlphaFold 3, the most recent version of Google's DeepMind artificial intelligence engine (AI) used to predict protein structures, is a breakthrough AI with major significance for monoclonal antibody patents, pharmaceutical patents in general, and the future of drug development and the pharmaceutical industry ...",
        "snippets": [
          "AlphaFold 3, the most recent version of Google's DeepMind artificial intelligence engine (AI) used to predict protein structures, is a breakthrough AI with major significance for monoclonal antibody patents, pharmaceutical patents in general, and the future of drug development and the pharmaceutical industry as a whole."
        ],
        "title": "AlphaFold 3, AI, Antibody Patents, the Future of Broad Pharmaceutical ...",
        "meta": {
          "query": "AlphaFold 3 pharmaceutical industry benefits",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 78
      },
      "79": {
        "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
        "description": "Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.",
        "snippets": [
          "Ultimately, AlphaFold3\u2019s impact on drug discovery and development is expected to be substantial. And, while commercial restrictions currently limit pharmaceutical applications, DeepMind\u2019s decision to make the platform open-source means that academic research will inevitably be able to advance scientists\u2019 understanding of disease mechanisms and drug interactions."
        ],
        "title": "Can AlphaFold3's open-source platform revolutionize the way we ...",
        "meta": {
          "query": "AlphaFold 3 pharmaceutical industry benefits",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 79
      },
      "80": {
        "url": "https://www.drugdiscoverytrends.com/laying-groundwork-alphafold-3-drug-discovery/",
        "description": "With the right approach, AlphaFold 3 promises to streamline drug discovery with advanced biomolecular predictions.",
        "snippets": [
          "Despite this challenge and the significant costs of building the necessary foundation, AlphaFold is an order of magnitude \u2014 or two \u2014 less expensive than traditional methods in medicinal chemistry. \u201cWe\u2019re talking about a completely game-changing technology as far as drug discovery is concerned,\u201d Bangert said."
        ],
        "title": "Laying the groundwork to tap AlphaFold 3's potential in drug ...",
        "meta": {
          "query": "AlphaFold 3 applications in drug discovery",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 80
      },
      "81": {
        "url": "https://venturebeat.com/ai/google-deepmind-open-sources-alphafold-3-ushering-in-a-new-era-for-drug-discovery-and-molecular-biology/",
        "description": "Notably, AlphaFold 3\u2019s accuracy in predicting protein-ligand interactions exceeds traditional physics-based methods, even without structural input information. This marks an important shift in computational biology: AI methods now outperform our best physics-based models in understanding how molecules interact. The impact on drug discovery and development will be substantial. While commercial restrictions currently limit pharmaceutical applications...",
        "snippets": [
          "Notably, AlphaFold 3\u2019s accuracy in predicting protein-ligand interactions exceeds traditional physics-based methods, even without structural input information. This marks an important shift in computational biology: AI methods now outperform our best physics-based models in understanding how molecules interact. The impact on drug discovery and development will be substantial. While commercial restrictions currently limit pharmaceutical applications, the academic research enabled by this release will advance our understanding of disease mechanisms and drug interactions."
        ],
        "title": "Google DeepMind open-sources AlphaFold 3, ushering in a new era ...",
        "meta": {
          "query": "AlphaFold 3 applications in drug discovery",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 81
      },
      "82": {
        "url": "https://www.isomorphiclabs.com/articles/rational-drug-design-with-alphafold-3",
        "description": "We are reimagining the entire drug discovery process from first principles with an AI-first approach.",
        "snippets": [
          "This builds upon Google DeepMind\u2019s foundational work of predicting the structure of proteins with AlphaFold 2, to now include how multiple proteins, DNA, RNA, and small molecule ligands come together and interact, as well as predicting the structural impact of post-translational modifications and ions on these molecular systems. This model is a powerful unified framework for structure prediction, encompassing unprecedented breadth and accuracy. ... This breakthrough opens up exciting possibilities for drug discovery, allowing us to rationally develop therapeutics against targets that were previously difficult or deemed intractable to modulate."
        ],
        "title": "Rational drug design with AlphaFold 3 - Isomorphic Labs",
        "meta": {
          "query": "AlphaFold 3 applications in drug discovery",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 82
      },
      "83": {
        "url": "https://www.labiotech.eu/in-depth/alpha-fold-3-drug-discovery/",
        "description": "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis ...",
        "snippets": [
          "The withholding of the code was largely down to commercial reasons, as co-developer Isomorphic Labs, a DeepMind spinoff company, is using AlphaFold3 internally to speed up its drug discovery efforts. The company currently has partnerships potentially worth $3 billion with Eli Lilly and Novartis aimed at developing multiple drugs."
        ],
        "title": "AlphaFold3: Revolutionizing drug discovery and development",
        "meta": {
          "query": "AlphaFold 3 applications in drug discovery",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 83
      },
      "84": {
        "url": "https://www.analyticsvidhya.com/blog/2024/05/deepmind-ai-alphafold/",
        "description": "By predicting these interactions, AlphaFold 3 can: Reveal how proteins bind to DNA: This helps us understand how genes are turned on and off, crucial for regulating cellular activity. Predict how drugs interact with proteins: This is a game-changer in drug discovery. Scientists can design more effective and targeted therapies by understanding how a potential drug binds to a specific protein. One of the most exciting applications ...",
        "snippets": [
          "By predicting these interactions, AlphaFold 3 can: Reveal how proteins bind to DNA: This helps us understand how genes are turned on and off, crucial for regulating cellular activity. Predict how drugs interact with proteins: This is a game-changer in drug discovery. Scientists can design more effective and targeted therapies by understanding how a potential drug binds to a specific protein. One of the most exciting applications of AlphaFold 3 lies in drug discovery."
        ],
        "title": "AlphaFold 3 Will Change the Biological World and Drug Discovery",
        "meta": {
          "query": "AlphaFold 3 applications in drug discovery",
          "question": "Highlight the practical applications of AlphaFold 3 in drug discovery processes and the potential cost savings and accelerated timelines it can bring to pharmaceutical companies.",
          "placement": "root -> Applications of AlphaFold 3 -> Impact on Drug Discovery Speed and Efficiency -> Cost Savings and Accelerated Timelines"
        },
        "citation_uuid": 84
      },
      "85": {
        "url": "https://www.deeporigin.com/blog/alphafold-3-exciting-advance-yet-unresolved-major-issues-remain",
        "description": "The architectural changes introduced\u2014such as the replacement of the EvoFormer with the Pairformer, and the switch to a diffusion module for predicting atomic coordinates\u2014demonstrate innovative approaches to enhancing model accuracy and efficiency. However, despite these advancements, AlphaFold ...",
        "snippets": [
          "The architectural changes introduced\u2014such as the replacement of the EvoFormer with the Pairformer, and the switch to a diffusion module for predicting atomic coordinates\u2014demonstrate innovative approaches to enhancing model accuracy and efficiency. However, despite these advancements, AlphaFold 3 is not without significant limitations."
        ],
        "title": "AlphaFold 3: Exciting Advance yet Unresolved Major Issues Remain ...",
        "meta": {
          "query": "AlphaFold 3 Pairformer module technical advancements",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3"
        },
        "citation_uuid": 85
      },
      "86": {
        "url": "https://zontal.io/alphafold-rises-with-version-3/",
        "description": "While building upon the foundation ... AlphaFold 2, AF3 boasts several key advancements that set it apart. At its core, the architectural changes are driven by the need to accommodate a wide range of chemical entities without excessive complexity. One of the most notable modifications lies in the replacement of the Evoformer with the simpler Pairformer Module, significantly ...",
        "snippets": [
          "While building upon the foundation laid by its predecessor, AlphaFold 2, AF3 boasts several key advancements that set it apart. At its core, the architectural changes are driven by the need to accommodate a wide range of chemical entities without excessive complexity. One of the most notable modifications lies in the replacement of the Evoformer with the simpler Pairformer Module, significantly reducing the amount of multiple sequence alignment (MSA) processing required."
        ],
        "title": "AlphaFold Rises to New Heights with Version 3",
        "meta": {
          "query": "AlphaFold 3 Pairformer module technical advancements",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3"
        },
        "citation_uuid": 86
      },
      "87": {
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11292590/",
        "description": "Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than its predecessor ...",
        "snippets": [
          "The introduction of novel neural network architectures in AlphaFold 3 has been pivotal in enhancing its predictive capabilities . These innovations include a scaled-down MSA processing unit and the new \"Pairformer,\" which focuses solely on pair and single representations, eliminating the need for MSA representation. This simplification allows for a more focused and efficient prediction process. Additionally, the diffusion module, a new addition to AlphaFold 3, directly handles raw atom coordinates, streamlining the prediction process by eliminating the need for complex rotational adjustments ."
        ],
        "title": "Review of AlphaFold 3: Transformative Advances in Drug Design and ...",
        "meta": {
          "query": "AlphaFold 3 Pairformer module technical advancements",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3"
        },
        "citation_uuid": 87
      },
      "88": {
        "url": "https://harrisbio.substack.com/p/alphafold3-a-foundation-model-for",
        "description": "For those seeking an in-depth technical exploration, I highly recommend a peruse of the extensive supplementary methods paper. Overview of the AlphaFold3 architecture. Sequences, ligands etc are passed through the input embedder and templates and MSA are collected. The Pairformer models interactions between atoms in a latent space before the Diffusion module builds out 3D ...",
        "snippets": [
          "For those seeking an in-depth technical exploration, I highly recommend a peruse of the extensive supplementary methods paper. Overview of the AlphaFold3 architecture. Sequences, ligands etc are passed through the input embedder and templates and MSA are collected. The Pairformer models interactions between atoms in a latent space before the Diffusion module builds out 3D coordinates."
        ],
        "title": "AlphaFold3: A foundation model for biology (?)",
        "meta": {
          "query": "AlphaFold 3 Pairformer module technical advancements",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3"
        },
        "citation_uuid": 88
      },
      "89": {
        "url": "https://www.blopig.com/blog/2024/08/architectural-highlights-of-alphafold3/",
        "description": "AlphaFold3 combines the processing of the MSA and structural templates with the generation of the pair representation. This entire module is now called the PairFormer. As in AlphaFold2, the PairFormer uses triangular attention updates to ensure its structural hypothesis at each step at least ...",
        "snippets": [
          "AlphaFold3 combines the processing of the MSA and structural templates with the generation of the pair representation. This entire module is now called the PairFormer. As in AlphaFold2, the PairFormer uses triangular attention updates to ensure its structural hypothesis at each step at least satisfies the triangle inequality."
        ],
        "title": "Architectural highlights of AlphaFold3 | Oxford Protein Informatics ...",
        "meta": {
          "query": "AlphaFold 3 Pairformer multisequence alignment processing",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
        },
        "citation_uuid": 89
      },
      "90": {
        "url": "https://en.wikipedia.org/wiki/AlphaFold",
        "description": "AlphaFold 3 introduces the \"Pairformer,\" a deep learning architecture inspired by the transformer, which is considered similar to, but simpler than, the Evoformer used in AlphaFold 2. The Pairformer module's initial predictions are refined by a diffusion model.",
        "snippets": [
          "This model begins with a cloud of atoms and iteratively refines their positions, guided by the Pairformer's output, to generate a 3D representation of the molecular structure. The AlphaFold server was created to provide free access to AlphaFold 3 for non-commercial research."
        ],
        "title": "AlphaFold - Wikipedia",
        "meta": {
          "query": "AlphaFold 3 Pairformer multisequence alignment processing",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
        },
        "citation_uuid": 90
      },
      "91": {
        "url": "https://www.nature.com/articles/s41586-024-07487-w",
        "description": "AlphaFold 3 has a substantially updated architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues with greatly improved accuracy over many previous specialized tools.",
        "snippets": [
          "The introduction of AlphaFold 21 has spurred a revolution in modelling the structure of proteins and their interactions, enabling a huge range of applications in protein modelling and design2\u20136. Here we describe our AlphaFold 3 model with a substantially updated diffusion-based architecture that is capable of predicting the joint structure of complexes including proteins, nucleic acids, small molecules, ions and modified residues."
        ],
        "title": "Accurate structure prediction of biomolecular interactions with ...",
        "meta": {
          "query": "AlphaFold 3 Pairformer multisequence alignment processing",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
        },
        "citation_uuid": 91
      },
      "92": {
        "url": "https://www.deeporigin.com/blog/alphafold-3-exciting-advance-yet-unresolved-major-issues-remain",
        "description": "We tested the publicly available AlphaFold 3 instance and have reviewed the paper. Note that access to the full tool is not yet available and is provided only as a server with limitations. Here's what we found.",
        "snippets": [
          "The EvoFormer module of AlphaFold 2 has been replaced with a simpler Pairformer module to reduce MSA processing."
        ],
        "title": "AlphaFold 3: Exciting Advance yet Unresolved Major Issues Remain ...",
        "meta": {
          "query": "AlphaFold 3 Pairformer multisequence alignment processing",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
        },
        "citation_uuid": 92
      },
      "93": {
        "url": "https://www.blopig.com/blog/2024/08/architectural-highlights-of-alphafold3/",
        "description": "AlphaFold3 combines the processing of the MSA and structural templates with the generation of the pair representation. This entire module is now called the PairFormer. As in AlphaFold2, the PairFormer uses triangular attention updates to ensure its structural hypothesis at each step at least ...",
        "snippets": [
          "In many cases, the PairFormer has probably learned a fairly specific hypothesis about the distance between tokens in the final structure. So how is this hypothesis communicated to the Structure module? In AlphaFold3, the pair representation for tokens i and j is linearly projected to a scalar which is then added as a bias term to the attention matrix."
        ],
        "title": "Architectural highlights of AlphaFold3 | Oxford Protein Informatics ...",
        "meta": {
          "query": "AlphaFold 3 Pairformer multisequence alignment processing",
          "question": "Providing insights into the technical advancements of AlphaFold 3's Pairformer module and its implications for processing multi-sequence alignment data.",
          "placement": "root -> Development of AlphaFold 3 -> Improved accuracy -> Pairformer Module Advancements and Multisequence Alignment Processing"
        },
        "citation_uuid": 93
      }
    },
    "info_hash_to_uuid_dict": {
      "765550003877880936": 1,
      "74751555391739383": 2,
      "511304453577564612": 3,
      "1361870866923317042": 4,
      "1356670371393568577": 5,
      "1810207184289784431": 6,
      "997317631403218595": 7,
      "135167265680903924": 8,
      "644808673838000852": 9,
      "1182779137430094711": 10,
      "2026510738529656399": 11,
      "1388876324379865034": 12,
      "2170764133952794417": 13,
      "2269206188779578237": 14,
      "1854319468638553682": 15,
      "1400625780694173916": 16,
      "381250542477588770": 17,
      "2149129175754790586": 18,
      "1163264519271927733": 19,
      "203114590678808311": 20,
      "690385214871163199": 21,
      "2061811425757816104": 22,
      "114164769567348464": 23,
      "517577823083507993": 24,
      "1184335733056670863": 25,
      "360471551508939247": 26,
      "255517402339060120": 27,
      "2263718364349973742": 28,
      "1823511764682111860": 29,
      "1043852011419315019": 30,
      "1727243562257259878": 31,
      "1185002573191670961": 32,
      "1158706818227938652": 33,
      "744142884600536608": 34,
      "748898838625328635": 35,
      "494452670404783431": 36,
      "437322745361525568": 37,
      "98950437046023468": 38,
      "2265619574849752317": 39,
      "383345839928935817": 40,
      "87546626447551871": 41,
      "272675375123678165": 42,
      "1201409104602215839": 43,
      "1455378435631842670": 44,
      "147093134985638464": 45,
      "488461775005917822": 46,
      "433740765110845230": 47,
      "912908860101347530": 48,
      "2009712078530320692": 49,
      "1161920393537873599": 50,
      "724300152142364619": 51,
      "73354757177810478": 52,
      "989955600204357384": 53,
      "1906337280042028717": 54,
      "116041478301122243": 55,
      "407574823802764739": 56,
      "1206907209997387244": 57,
      "1687886362896197669": 58,
      "408964412421679042": 59,
      "729022724319173801": 60,
      "610665220974503758": 61,
      "720038551842422158": 62,
      "301852264084756090": 63,
      "2027698195502394422": 64,
      "1270452507663271802": 65,
      "68672820404099193": 66,
      "1628813150576532147": 67,
      "686065991777628946": 68,
      "2013052893031463192": 69,
      "622381997520103549": 70,
      "1901756808329158103": 71,
      "1617741987324203569": 72,
      "1261114164822842658": 73,
      "1061094886274577723": 74,
      "1942468587381035045": 75,
      "2127388103153300887": 76,
      "1842712065598953422": 77,
      "1864779177254848537": 78,
      "982805589253264362": 79,
      "1006798134203638136": 80,
      "1455151584497727102": 81,
      "1009875918703147928": 82,
      "857201624631800442": 83,
      "977644608655926684": 84,
      "290600862413284227": 85,
      "251979635791850271": 86,
      "2148023648765024200": 87,
      "1131762396692172208": 88,
      "461169783162112088": 89,
      "719813509818730906": 90,
      "1902431797082324703": 91,
      "972731610012786171": 92,
      "451013982320033008": 93
    }
  }
}